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ABSTRACT
Three dimensional cell culture holds great promise both as a method for 
constructing better ex vivo models of tissues, and as a method for creating de novo 
tissue to repair damaged tissue. One of the major issues in biology is that many 
biological systems are controlled by multiple variables, yet it is normal to design 
univariate experiments. This problem can be reduced by designing multivariate 
experiments.
This thesis describes the creation of porous silk scaffolds in which both the pore 
structure can be varied from film-like to fibrous and the pore size can be controlled 
by using 20% v/v formic acid as a solvent and salt particles with a defined particle 
size range to produce salt leached scaffolds. Furthermore, Fourier transform 
infrared spectroscopy indicates that the chemistry of these scaffolds remains 
identical, and image analysis of sections through the scaffolds shows that the 
porosity remains constant. In order to confirm that the scaffolds were not cytotoxic, 
three cell types: primary ligament fibroblasts osteoblast and chondrocyte cell lines 
were grown on scaffold with different pore structures and constant pore size. DNA 
quantification suggests that differences in pore structure affect cell attachment and 
subsequent proliferation.
To better understand how ligament fibroblasts respond to differences in pore size 
and pore structure, a high pressure liquid chromatography protocol for quantifying 
glycosaminoglycans was adapted for use as tissue engineering outcome measure. 
It proved possible to analyse glycosaminoglycans following papain digestion with 
approximately an order of magnitude improvement in the sensitivity of the assay. On 
the basis of a literature review it was predicted that if ligament engineering follows 
the same pattern as development hyaluronic acid content should start high and drop 
rapidly, and the glycosaminoglycan : hydroxyproline ratio should also start high and 
drop rapidly.
Three different pore sizes and three different pore structures were combined in all 
possible combinations to make nine different types of scaffold for fabricated for the 
final experiment. These scaffolds were seeded with ligament fibroblasts from six 
different animals, and sacrificed after 1 day, 1 week, 2 weeks and 3 weeks. DNA, 
hydroxyproline, hyaluronic acid and chondroitin sulphate were quantified. Four 
different independent variables were analysed: time, animal, pore size and pore 
structure. Time, animal and pore size and their interactions affected DNA content. 
Time and animal and time x animal affected hydroxyproline and chondroitin 
sulphate content. Averaged over all the scaffolds glycosaminoglycan/hydroxyproline 
fraction started at 7 at the end of week 1 and dropped to 0.05 by the end of week 3, 
but the hyaluronic acid content was undetectable in most samples at all time points. 
The outcome variables were correlated; hydroxyproline content at week 1 and week 
2 was not significantly correlated with hydroxyproline content at week 3; the only 
variable from the first two weeks to correlate significantly with DNA, hydroxyproline, 
and chondroitin sulphate at week 3 was chondroitin sulphate at week 1 (correlations 
of 0.281, 0.443 and 0.383 respectively). This data suggests that ligament 
engineering is a multistage process, and that the amount of collagen in the first two 
weeks of ligament engineering is unimportant.
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1 Introduction
Much of the interest in engineering replacement ligaments and tendons has 
focused on one of the ligaments inside the knee, the Anterior Cruciate 
Ligament (ACL), as it is frequently ruptured (over 200,000 cases in the USA 
per annum (Weitzel et al. 2002). The ACL accounts for 50% of ligament 
injuries, mostly as the result of sports injuries, and many of these injuries 
lead to permanent disability (Bollen 1998). An addition area of interest is that 
it is thought that osteoarthritis might result from damage to soft tissues such 
as the ACL (Brandt et al. 2006), and by extension, that early intervention to 
restore normal function to damaged soft tissue could prevent osteoarthritis.
The preferred option when surgically reconstructing a ruptured ACL is to use 
an autograft of either hamstring tendon or patellar tendon (Dopirak et al. 
2004; Fu et al. 1999; Fu et al. 2000; Spindler et al. 2004). Two recent long 
term studies of soccer players with ruptured ACLs (Lohmander et al. 2004; 
Von Porat et al. 2004) suggest that the soccer players are at high risk of 
developing osteoarthritis regardless of surgical reconstruction. Cadaveric 
models suggest that these problems might be caused by failure to replicate 
the anatomy of the ACL (Yagi et al. 2002; Yamamoto et al. 2004).
In some patients neither hamstring tendon nor patellar tendon is suitable for 
harvesting and use as an autograft, these problems are particularly common 
when multiple ligaments are being reconstructed, or the original 
reconstruction requires revision. For this population several options are 
available including: allografts, which remain controversial, due to the 
possibility of infection and high cost (Barber 2003; Johnson 2003; McGuire
2003), and the Leeds-Keio polyester ligament which has poor long term 
outcomes (Murray and Macnicol 2004), possibly because the tissue inside 
the ligament is still immature 60 months postoperatively (Nomura et al.
2005).
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1.1 Aims and Objectives
Tissue engineering offers a new approach to solve these problems, but the 
understanding of the cell and matrix biology necessary to engineer ligaments 
is far behind the understanding of cell and matrix biology necessary to 
engineer bone or cartilage. There has also been a much greater research 
effort targeted at bone and cartilage tissue engineering. For these reasons, 
in comparison to cartilage and bone tissue engineering, many fundamental 
questions about ligament engineering remain unanswered. This thesis 
attempts to answer some of these fundamental questions based on the 
mainstream tissue engineering techniques of seeding cells onto scaffolds. It 
is argued that scaffolds with high porosity will result in better cellular 
response (see Section 7.1.3), so this thesis focuses on highly porous 
scaffolds. It is commonly assumed that scaffolds with small (~100pm) pores 
are superior for fibrous tissue engineering, but this assumption is based on 
the formation of fibrous tissue in work trying to regenerate bone in an 
osteogenic environment. Therefore the central question investigated in this 
thesis is the effect of pore size and pore structure on ligament fibroblast 
cells. In order to understand this effect, both cell proliferation and matrix 
synthesis were quantified. In setting up this study much effort was put into 
the question of what would constitute a good outcome, the decision was to 
investigate to what extent hydroxyproline and glycosaminoglycan production 
in engineered ligaments mirrored the results published for these biomarkers 
in fibrous tissue development.
1.2 Outline of the thesis
The next chapter (Chapter 2) is a literature review covering: the biology of 
the ACL; how biomarkers have been used to understand ligament 
engineering and development; the use of bioreactors and biomaterials for 
ligament engineering, and finally a section introducing the multivariate 
statistics used in this thesis. The third chapter introduces the statistics used 
in this thesis. Chapter 4, Materials and Methods, reports the reagents and 
procedures used in this research.
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In the first results chapter, (Chapter 5), a HPLC assay for 
glycosaminoglycans is adapted to work in a tissue engineering context. The 
second results chapter, (Chapter 6), reports with the development of a novel 
highly porous silk scaffold, in which both pore size, and pore structure can be 
varied. The final results chapter (Chapter 7) uses the techniques developed 
in the first two chapters to understand the effect of pore size and pore 
structure on ligament fibroblast proliferation and matrix synthesis.
The final chapter (Chapter 8) summarises the work carried out in this thesis, 
and makes suggestions for future work.
3
2 Literature Review
2. 1 Biology o f Ligame
Meniscus
^  Lateral Collateral
V  Ligament
Lateral Meniscus
2.1.1 Anatomy of the Anterior Cruciate Ligament
The ACL is a helical intraarticular ligament named for its attachment to 
anterior intercondylar area of the tibia. From this attachment it extends 
upwards, backwards and laterally (Figure 2-1) past the posterior cruciate 
ligament (PCL). Together with the PCL it forms the main bond between the 












Diagram of the ligaments and menisci in the right knee
Anterior Cruciate Ligament 













Cross Sectional diagram of the ligaments and menisci in the right knee seen from above 
Figure 2-1 Diagram of the ligaments and menisci in the right knee. (After Snell (2000))
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The anatomy of the ACL will be described by moving from a description of 
the arrangement of collagen molecules at the smallest scale moving up to 
larger scales until the anatomy is described (Figure 2-2). This description is 
based on the work of Clark and Sidles (1990), this agrees with the 
description used by Benjamin and Ralphs (2000) and Silver et al. (2003) 
although the three papers use different terminology. The notable difference 
between this description and that of Yahia and Drouin (1989) is that Clark 
and Sidles could not find the sub-fascicles described by Yahia and Drouin, 












20 to 400 microns
Surrounded by sheets of membrane 
containing nerve and Wood vessels
Figure 2-2 The 5 levels of organisation found by Clark and Sidles (1990)
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Collagen molecules are arranged into fibrils, with the molecules arranged in 
rows and quarter staggered. These fibrils are from 50-300nm in diameter. 
The fibrils themselves are not straight, but run in a wavy pattern; this pattern 
is known as crimp. The wave is typically two dimensional, although in some 
fascicles the wave takes a helical form (Yahia and Drouin 1989).
Fibrils themselves are tightly packed to form bundles known as fibre bundles. 
These fibre bundles are surrounded by a fibrous capsule that are largest in 
the fibrocartilaginous regions near the insertion of the ligament, becoming 
more compact and elongated further away from the insertion. The fibrous 
capsules contain cells arranged in rows.
Fibre bundles are packed together to form fascicles, which have a diameter 
of 20 to 400pm. The fascicles are separated by a membranous septae, the 
number of membranes varies within the ligament, normally there are several 
layers separated by empty space, occasionally fascicles are separated by 
one or even no layers of membrane. Within the membranous septae lie the 
blood and nerve vessels. The divisions between fascicles become more 





Figure 2-3 Distribution of cells within ACL (after Murray and Spector (1999))
The ACL can be divided up into three zones based on the shape of the cells 
within the ligament (Murray and Spector 1999). Moving along the ligament 
from the femur to the tibia, the cells start out looking like typical fibroblasts -
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spindle shaped, the cells become more rounded as the tibia is approached 
becoming first ovoid and then spherical (see Figure 2-3). These ovoid and 
spherical cells occur in the regions of fibrocartilage where the ligament is 
being compressed during movement of the knee. It is worth noting that the 
cell density is five times higher in the fusiform cell zone than the spheroid cell 
zone. The proportion of different shaped cells can change with exercise, the 
ratios of spindle shaped to ovoid cells changed significantly comparing biped 
rats forced to exercise on treadmill and those without exercise (Sakuma et al. 
1993).
The “enthesis” is where the ligament connects to bone, also known as the 
“insertion”. It is thought to balance the different elastic moduli of ligament and 
bone so that local peaks in tension are avoided; at the enthesis the ligament 
becomes fibrocartilaginous and the ligament spread outs out (Benjamin et al. 
2002).
The ACL is mostly composed of collagen (80% by dry weight (Vunjak- 
Novakovic et al. 2004)), this is ~90% collagens I and ~10% collagen III 
(Riechert et al. 2001). Although tendons and ligaments are similar, 
ligaments are thought to be slightly more metabolically active containing 
more cells, and glycosaminoglycans, but slightly less total collagen (Amiel et 
al. 1984).
2.1.2 Biomechanics of the ACL
The ACL has two roles: it is the primary restraint on anterior tibial 
displacement and is a secondary restraint of axial rotation. This section will 
explore the biomechanics of ACL at the level of the fibre bundle, the fascicle 
and as a tissue, using analogies with other ligaments and tendons where 
necessary.
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Figure 2-4 Simplest viscoelastic model -  a spring and damper in parallel
Ligaments are viscoelastic materials; the simplest model of this behaviour is 
to imagine a spring and damper in parallel (Figure 2-4); the properties of the 
damper mimic the way viscoelastic materials flow, the spring models the way 
viscoelastic materials stretch elastically, and the spring and damper are in 
parallel, not series as they ultimately return to their original length.
The three phenomena most associated with viscoelasticity are shown in 
Figure 2-5:
• Creep - a ligament held a constant force will get extended with time
• Stress relaxation - a ligament held at constant length will progressively 
exert less force on its restraint
• Strain rate dependence, if ligaments are strained at low rates then 
they are absorb less energy, fail at a lower ultimate load and less stiff 
than at high strain rates.
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Figure 2-5 Stress relaxation, creep and strain rate dependence (after Woo et al (1997))
The recent work of Screen et al. (2004) provides evidence of what occurs to 
the fibre bundles when a ligament or tendon is under tensile strain. They
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used cell nuclei as markers to enable them to estimate the strain field within 
a fibre bundle by comparing the position of nuclei next to the same fibre 
bundle and the displacement of adjacent fibre bundles by comparing the 
position of cell nuclei either side of a fibre bundle. They found that the strain 
within a fibre bundle was small only reaching -1%  when the fascicle was 
strained 8%. On the other hand the displacement between fibre bundles was 
much larger reaching -4%  when the fascicle was strained 8%. It is important 
to note that this appears to raise an important question about much of the 
work looking at the effects of tensile strain on tendon /ligament fibroblasts, 
the experiments often expose cells to 10% or greater strains when the 
fibroblasts are only strained by -1%  inside a tendon. Figure 2-6 summarises 










-Collagen fibre bundles crimped
Small Applied strain (<4%)
-Crimp straightens
-Fibre Bundles allign 
to loading axis
-Small extension of fibrous 
capsule and cells (-0 .5% )
Larger Applied Strain (>4%)
-Fibre Bundles slide relative 
to each other, with little 
extension (<1%)
-Fibrous Capsules and Cells are 
sheared and compressed by 
movements of fiber bundles
Figure 2-6 Effect of strain on the organisation of tendon (after Screen et al. (2004))
The work of Yamamoto et al. (1999) suggests how ligaments might behave 
at the level of fascicles. They compared the behaviour of fascicles isolated 
from rabbit patellar tendon with whole rabbit patellar tendon. They found that
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the fascicles had 42% of the ultimate tensile strength and 179% of the 
ultimate tensile strain of the whole tendon. They suggest these differences 
are due to the ground substances between the fascicles, mechanical 
interactions between fascicles or different crimp structures. However more 
work is necessary to understand how single fascicles interact to form a 
tendon.
The ACL’s role as the primary restraint of anterior tibial displacement has 
been widely investigated, and the force varies with the angle of flexion (Takai 
et al. 1993). The secondary role of the ACL in resisting internal axial rotation 
fits with its helical structure and lateral position. When the knee is passively 
flexed the ACL generates an internal torque of up to 1.4 Nm (Fukubayashi et 
al. 1982). This is complicated by the effect of compression of the knee upon 
the ACL, which has recently been investigated by Fleming et al. (2001) in 
order to understand the effects of weight bearing. The compression induced 
a 2% strain in otherwise unloaded ACLs and increased ACL strain at low 
anterior tibial loadings (loads < 40N) and low internal torques (torque < 
2Nm).
One major complication when engineering a replacement ACL will be 
replicating the different functions and behaviours of the anteromedial and 
posterolateral bundles. The response of the posterolateral bundle to anterior 
tibial loading varies with the angle of knee flexion and the in-situ force in the 
posterolateral bundle is larger than the anteromedial bundle between 0° and 
45° (Sakane et al. 1997). The anteromedial bundle shows a very constant 
response to anterior tibial loading at knee flexions between 0° and 90° 
(Sakane et al. 1997), it has been hypothesised that the anteromedial bundle 
plays a role in guiding the ACL (Takai et al. 1993). Recent evidence 
suggests that the current methods of ACL repair are failing due to failure to 
replicate the functions of both of these bundles and to position the autograft 
in the correct anatomical position (Yagi et al. 2002; Yamamoto et al. 2004).
The ACL, like many other ligaments, has a section of fibrocartilage. This is 
formed by simultaneous tension and compression. This compression is
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generated in vivo by loading around a pulley (Benjamin and Ralphs 1998; 
Wren et al. 2000). It is not yet known whether the pattern of fibrocartilage in 
ligaments will have to be recreated in vitro when engineering ligaments, 
instead it might be possible to rely upon adaptation to compressive loads 
after surgical insertion of the engineered ligament.
2.1.3 Cell sources for ligament engineering
Three comparisons of different cell sources for ligament engineering have 
been published. The first study compared ACL fibroblasts, adherent bone 
marrow stromal cells (BMSCs) and skin fibroblasts seeded onto a braided 
resorbable suture material (poly(L-lactide/glycolide) multifilaments). On day 
12, total collagen and DNA content were the highest for BMSC seeded 
scaffolds, and least for scaffolds seeded with ACL fibroblasts (van Eijk et al.
2004). Mean DNA content using BMSCs was nearly twice that using ACL 
fibroblasts, and mean total collagen was almost six times higher with 
BMSCs. Neither glycosaminoglycan nor proteoglycan synthesis was 
considered in this paper. These results were supported by the second study 
which found higher proliferation and collagen excretion for BMSCs than ACL 
or medial collateral ligament (MCL) fibroblasts (Ge et al. 2005). The third 
study compared fibroblasts from patellar tendon, Achilles tendon, MCL and 
ACL seeded onto 3D braided poly-l-lactic acid (PLLA) scaffolds and cultured 
for 21 days (Cooper et al. 2006). This study found that ACL fibroblasts 
proliferated slower than the other types of fibroblast, but expressed 
significantly more mRNA for fibronectin and collagens I, & III at 14 days.
There is much debate about what a BMSC is. The standard technique, which 
was used by Van Eijk et al. (2004), is to aspirate the cells from bone marrow, 
and retain the adherent cells. However non-adherent cells treated with 
prostaglandin E2 (PGE2) become adherent and can differentiate into 
oestoblasts (Scutt and Bertram 1995), beyond this their differentiation 
potential has not been characterised. The wisdom of removing non-adherent 
cells has been questioned by the finding that twice as many stem cells as 
assessed by the number of colony forming units fibroblastic (CFU-F) could
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be obtained from BMSCs grown on fibronectin at low cell densities when 
non-adherent cells were kept (D'lppolito et al. 2004). This could either be 
non-adherent cells becoming adherent, non-adherent cells dividing to 
become adherent or the influence of cytokines produced by the non-adherent 
cells.
There is increasing evidence for the view that phenotype of the 
subpopulation of BMSCs with the highest potential for multipotent 
differentiation are small with little cytoplasm from several different groups 
using different methods (Colter et al. 2001; D'lppolito et al. 2004; Zohar et al. 
1997). Although it should be noted that these cells are more multipotent and 
proliferate better than larger cells, the larger cells are still multipotent to some 
extent. There is some evidence whilst the smallest spindle shaped cells are 
best for adipogenesis; slightly wider and older cells are superior for 
chondrogenesis (Sekiya et al. 2002).
More sophisticated methods for isolating stem cells have relied on 
generating antibodies that can be used to separate cells based on cell 
surface markers. This allows enrichment to increase the proportion of CFU- 
F. Selecting CD49+ cells appears to offer the greatest single step enrichment 
of CFU-F (Stewart et al. 2003). However the disadvantage is that not all of 
the CFU-F are recovered, CD49+ fraction recovers less than a quarter of 
CFU-F; the STRO-1+ fraction contains more CFU-F (and a higher 
percentage non-CFU-F reducing the enrichment) than the CD49+ fraction, 
but still recovers less than half of the CFU-F. There are also methods based 
on selecting CFU-F by plating cells at low densities, in these conditions CFU- 
F proliferate much faster, simply as the definition of CFU-F is a cell that 
forms a colony at low cell densities (D'lppolito et al. 2004; Sekiya et al. 
2002). The down side to these techniques are that they require a huge area 
of plastic. Finally, it should be noted that roughly twice as many CFU-F can 
be removed from bone marrow by centrifuging it than by aspiration (Dobson 
etal. 1999).
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BMSCs have not been compared with other multipotent cells for the 
purposes of ligament engineering; the other major source of autologous 
primitive mesenchymal cells is adipose tissue-derived stromal cells (ATSCs). 
ATSCs have several advantages over BMSCs (Strem and Hedrick 2005):
• low morbidity upon harvest;
• stem cell frequency is higher than bone marrow (2% vs. 0.002%) 
meaning that sufficient ATSCs can be harvested without expansion in 
vitro; and
• higher proliferation rates.
The current major disadvantage of ATSCs is that they are poorly 
characterised compared to BMSCs. It is not yet clear if either ATSCs or 
BMSCs have superior differentiation potential. Comparison of osteogenesis 
and chondrogenesis by BMSCs and ATSCs has yielded ambiguous results: 
(Im et al. 2005) found that BMSCs differentiated better towards bone and 
cartilage than ATSCs as assessed by the bone biomarkers alkaline 
phosphatase and Von Kossa staining, and histological cartilage biomarkers 
for collagen II and GAGs. Whereas (Hattori et al. 2004) found that they were 
equivalent for osteogenesis as assessed by alkaline phosphatase, 
osteocalcin production, and mineral deposition; (Lee et al. 2004b) also found 
that ATSCs and BMSCs were similar when it came to osteogenesis and 
chondrogenesis and both cell types expressed CD29, CD44, CD90, and 
CD105. It is possible that differences in the isolation techniques used in the 
two papers account for the differences. Im et al. (2005) used an erythrocyte 
lysis buffer to remove erythrocytes (red blood cells); Lee et al. (2004b) 
removed non-adherent cells including erythrocytes by washing with 
phosphate buffered saline (PBS). One option to improve the isolation of 
multipotent ATSCs would be to plate ATSCs at low cell densities to select 
CFU-F.
There remains a substantial problem with using BMSCs for ligament and 
tendon engineering: the differentiation of BMSCs into ligament fibroblasts is 
far from fully understood. This problem manifests itself in two ways: BMSCs 
sometimes form bone when implanted in collagen gels into tendon defects
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(Harris et al. 2004); and very similar conditions to those claimed to 
differentiate BMSCs into ligament fibroblasts are claimed to differentiate 
BMSCs into smooth muscle cells (SMCs).
Harris et al (2004) hypothesised that the formation of ectopic bone was due 
to the large number of cells used, resulting in excessive contraction of the 
collagen gel. This hypothesis was supported by two subsequent papers. The 
formation of ectopic bone by BMSCs do not appear to be a function of the 
age of the animal used to supply the cells (Dressier et al. 2005). Reducing 
the cell-collagen ratio appears to eliminate the formation of ectopic bone 
(Juncosa-Melvin et al. 2005). It remains unclear whether this will be a 
generic problem, or it is limited to highly contractible biomaterials such as the 
collagen gels used in these studies. It might be anticipated that BMSCs could 
be seeded at higher densities on stiffer materials without being contracted. 
Alternatively, it could be that the formation of ectopic bone is driven by the 
increased stiffness of the collagen gel, resulting from the contraction of the 
collagen gel. Matrix stiffness is known to be able to control BMSC 
differentiation (Engler et al. 2006), with stiffer environments promoting 
osteogenesis. The role of biological factors in formation of ectopic bone is 
largely unknown; it might be possible to block this process by the addition of 
specific growth factors, or by selecting BMSCs with specific surface markers 
(the BMSCs that formed ectopic bone were adherent BMSCs that had not 
been selected further for specific surface markers).
Perhaps more problematic is the reported differentiation of BMSCs into 
SMCs under almost identical conditions to those reported to differentiate 
BMSCs into ligament fibroblasts. Cyclical tensile strain combined with 
cyclical torsion has been reported to differentiate BMSCs into ligament 
fibroblasts (Altman et al. 2002b). Similarly, cyclical uniaxial tensile strain has 
been reported to differentiate cells into smooth muscle cells (Kurpinski et al.
2006). There has also been a report of differentiation into smooth muscle 
cells by transforming growth factor (31 (TGF-|31), one of the principal signals 
responsible for cellular responses to cyclical tension (Ross et al. 2006). 
Given that it is unlikely that the difference in cell type can be explained by the
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differences in mechanical loading environment as many ligaments and 
tendons are not rotated; the data are more persuasive that cells have been 
differentiated into smooth muscle cells than ligament fibroblasts. One of the 
key markers for making this attribution is the presence of a-smooth muscle 
actin (a-SMA), a protein associated within contraction. One of the cell types 
within ligament, myofibroblasts, also express a-SMA; but these a-SMA 
positive myofibroblasts only account for 10-20% of ACL cells (Murray and 
Spector 1999). There is no data on the number of a-SMA positive cells in the 
reports above, but Zhang et al (2005) who culture BMSCs on intestinal sub­
mucosa, which is rich in basic fibroblast growth factor (bFGF) and TGF-(3 
(Voytik-Harbin et al. 1997), report that over 95% of the cells are a-SMA 
positive. A report of BMSC differentiation towards a ligament / tendon 
fibroblast phenotype triggered by low doses of bFGF also found elevated a- 
SMA levels (Hankemeier et al. 2005). Further, Ross et al (2006) report high 
levels of smoothelin-B mRNA, which is a smooth muscle cell marker reported 
to be absent in myofibroblasts. In conclusion, neither growth factors, nor 
mechanical stimulation have been conclusively demonstrated to differentiate 
BMSCs into ligament fibroblasts; on the contrary, there is evidence that 
BMSCs are differentiating into smooth muscle cells, not ligament fibroblasts.
Due to the lack of conclusive evidence for the differentiation of BMSCs into 
ligament fibroblasts, primary ligament fibroblasts will be used for this study 
as they are already differentiated. Table 2-1 summarises the advantages and 
disadvantages of cell types discussed in this section. Human primary tissue 
is unavailable for this study (although potentially ACL fibroblasts could be 
harvested from ruptured ligaments for clinical use), so ovine tissue will be 
used as sheep are closer to human scale than mice or rats, and are 
extensively reared in the UK. This allows them substantial freedom of 
movement, which should make them a more appropriate model for ligament 
repair than more sedentary animals as ligament injury is primarily a sports 
injury.
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Table 2-1 Possible cell sources for ligament tissue engineering
Cell source Advantages Disadvantages
Skin Fibroblasts Easily to isolate and culture 
Higher matrix synthesis and 
proliferation than ACL 
fibroblasts (van Eijk et al. 2004)
It is unclear how they differ from 
ACL fibroblasts
Trans-differentiation pathway is 
unknown
BMSCs Higher matrix synthesis and 
proliferation than ACL 
fibroblasts (van Eijk et al. 2004) 
Multipotent
Heterogeneous phenotype (Colter 
et al. 2001)
Can form ectopic bone in tendon 
repair (Harris et al. 2004)
Unclear to what extent phenotype 
in “ligament” differentiation is that 
of a smooth muscle cell not a 
ligament fibroblast
ATSCs Multipotent
High stem cell frequency
No published research on 
ligament differentiation
MCL or tendon 
fibroblasts
Higher proliferation than ACL 
fibroblasts (Cooper et al. 2006)
Lower matrix synthesis than ACL 
fibroblasts (Cooper et al. 2006)
ACL fibroblasts Higher matrix synthesis than 
MCL and tendon fibroblasts 
(Cooper et al. 2006)
Already differentiated to the 
correct phenotype
Lower matrix synthesis and 
proliferation than BMSCs or skin 
fibroblasts (van Eijk et al. 2004)
2.1.4 Biomarkers for ligament engineering
As the confusion between BMSCs differentiating into ligament fibroblasts and 
smooth muscle cells in the above section demonstrates, appropriate choice 
of biomarkers is essential in regenerative medicine, and results can be highly 
misleading if this is insufficient or inappropriate biomarkers are used. This 
section will consider the use of extracellular matrix (ECM) molecules as 
markers for ligament engineering. Beyond their role purely as biomarkers, it 
will also discuss how these molecules are synthesised, and their function. 
Biomarkers will be discussed further in Chapter 5. Table 2-2 summarises this 
section.
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Table 2-2 Summary of selected biomarkers for ligament engineering
Biomarker Notes Desired outcome
Collagen Major component of 
ligament
Unclear what mRNA levels 
mean
90% collagen I : 10% collagen 
III
Collagen crosslinks Different tissues have 





Proteoglycans Many proteoglycans can 
be measured such as 
decorin, fibromodulin, 
aggrecan and lumican
Positive for decorin and 
biglycan
Negative for aggrecan
Glycosaminoglycans Longitudinal data exists on 
glycosaminoglycan levels 
in collagen fibrogenesis
High dermatan sulphate in 
mature in tissue 
See section 7.1.4 for more 
detail
Glycoproteins A variety of different 
glycoproteins are present 
in the matrix
Positive for Tenascin C if 
mechanically stimulated 
Negative for bone sialoprotein
2.1.5 Collagen
The most widely measured biomarkers for ligament engineering are various 
measures of collagen synthesis since the ACL is mostly composed of 
collagen (80% by dry weight (Vunjak-Novakovic et al. 2004)). Of this, -90%  
collagen I and -10% collagen III (Riechert et al. 2001). The most common 
assays for collagen are quantifying mRNA for collagen I and III. The 
limitation of this approach is that mRNA for collagens I and III are necessary 
for their synthesis, but they are not sufficient. It is hard to draw conclusions 
about collagen synthesis from collagen mRNA levels. In Moreau et al 
(2005b) various combinations of growth factors were applied to BMSCs 
seeded onto bundles of twisted silk fibres. Significant differences were found 
by a ELISA for collagen I between combinations in which TGF-p1 was used 
and combinations in which TGF-(31 was not used, but no significant
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differences were found by quantifying collagen I mRNA. The process of 
collagen synthesis is outlined below.
Collagen synthesis is a complex process with several post-translation 
modifications occurring. This section will focus on synthesis and crosslinking 
of the fibrillar collagens type I and III. The first of these is hydroxylation of 
some of the lysine and proline residues by lysyl hydroxylase and prolyl 4- 
hydroxylase respectively (Kagan 2000). The activity of prolyl 4-hydroxylase is 
dependent on both coenzyme A and vitamin C (ascorbate). Collagen 
synthesis can be increased by increasing the concentration of coenzyme A 
(Mio et al. 2001) and by adding ascorbate to the media (Fermor et al. 1998). 
The hydroxylation of lysine by lysyl hydroxylase requires iron (Knott and 
Bailey 1998). Some of the hydroxylysine residues are further modified by 
glycosylation, which can by catalysed by either a glycosyl transferase or lysyl 
hydroxylase 3 (Wang et al. 2002). The function of these glycosylated 
residues is unclear; control of fibril diameter has been suggested as a 
possible function (Knott and Bailey 1998).
A signal peptide is cleaved as collagen is secreted to the ECM. In the ECM 
the N  and C propeptides are removed by procollagen N  & C proteinases. 
The N  and C propeptides serve two functions: they increase the solubility of 
collagen, and they limit lateral growth of the fibril (Silver et al. 2003). A/- 
proteinase cleaves the A/-propeptide from collagens I and II, but does not 
cleave denatured collagen I or II and it has been suggested this might act as 
a quality control step (Prockop et al. 1998). The main source of collagen for 
tissue engineering experiments - collagen obtained from animal tissue by 
acid hydrolysis, has been shown to be denatured by the failure of N- 
proteinase to remove the A/-propeptide (Prockop et al. 1998).
Collagen crosslinking in vivo is started by the deamination of lysine or 
hydroxylysine to create reactive aldehyde groups (allysine or 
hydroxyallysine). These aldehyde groups then react with either: lysine, 
hydroxylysine, allysine or hydroxyallysine. The main reducible crosslink in 
the ACL is dehydroxylysinonorleucine (Fujii et al. 1994), created by an
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allysine group reacting with a hydroxylysine group, or a hydroxyallysine 
group reacting with a lysine (Reiser et al. 1992). One or two further reactions 
with a nearby histidine or hydroxylysine will result in a reduced crosslink 
(which amino acid and the number of further reactions depend upon the type 
of crosslink). In the ACL, hydroxypyridinium is the most common non­
reducible crosslink. Hydroxypyridinium is formed by the reaction of 
hydroxyallysine with hydroxylysine to form
dehydrodihydroxylysinonorleucine. Dehydrodihydroxylysinonorleucine then 
reacts with hydroxylysine to form hydroxypyridinium (Reiser et al. 1992). 
Some degree of control of crosslinking is given by the differences in 
hydroxylation of lysine residues in different tissues, different amounts of 
hydroxylation result in different crosslinks (Pornprasertsuk et al. 2004). The 
position of crosslinking is determined by a precise sequence of amino acids, 
these limited positions correspond to the quarter staggered arrangement of 
collagen fibrils. As tissues age they undergo crosslinking by non-enzymatic 
glycation, this changes the mechanical properties of tendon and ligament 
and is thought to be involved in some connective tissue disorders (Reddy
2003).
Collagen fibrils are normally assembled outside the cell. One exception is in 
the embryo, where tendon collagen fibrils are initially assembled inside the 
cell in the Golgi to plasma membrane carriers known as fibripositors. In the 
fibripositors, collagen is assembled into 28nm fibrils, with the N and C 
propeptides cleaved inside the cell. These fibripositors are not present in 
postnatal tendons (Canty et al. 2004).
Understanding the process of collagen synthesis suggests several other 
possible biomarkers beyond mRNA for collagen I and III, such as the 
collagen crosslinks. By measuring mRNA for the various steps in collagen 
synthesis it might be possible to understand better how to improve processes 
to synthesise more collagen. The pattern of lysine hydroxylation and 
subsequent collagen crosslinking is tissue specific, for instance patellar 
tendon has low dihydroxylysinonorleucine and high
histidinohydroxymerodesmosine whereas the ACL has high
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dihydroxylysinonorleucine and low histidinohydroxymerodesmosine (Amiel et 
al. 1986). These patterns might be used to help to distinguish the various 
types of ligament and tendon from one another.
2.1.6 Glycosaminoglycans and proteoglycans: role in collagen 
fibre bundles
Tendons and ligaments are commonly classified as “fibre reinforced 
composites” (a fibre such as collagen, glass or carbon are deposited in a 
resin or viscous matrix; fibreglass is a fibre reinforced composite) and this 
description of their material properties is used to model their mechanical 
behaviour (Ker 1999). However, research into the role of proteoglycans in 
ligaments and tendons is beginning to suggest that they are much more 
complex structures and this research provides a more satisfactory 
explanation of their exceptional properties.
The proteoglycans of particular interest to ligament engineering are the small 
leucine rich proteoglycans (SLRPs). These are currently thought to have 
three major roles:
• regulation of collagen fibrillogenesis by controlling fibril diameter,
• binding transforming growth factor to prevent fibrosis
• controlling cell proliferation -  decorin (an SLRP) interacts with the 
epidermal growth factor receptor (EGFR) to increase p21 which itself 
causes an arrest in cell cycle (lozzo 1999).
Recent evidence suggests that proteoglycans are important in determining 
the mechanical properties of ligaments and tendons (Scott 2003).
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Disaccharide Xi x2 X3
ADi-OS H H H
ADi-4S H so3- H
ADi-6S scv H
ADi-UA2S H H so3-
ADi-disE so3- so3- H
ADi-disB H so3- so3-
ADi-disD S03- H so3-
ADi-triS S03- so3- S 03-
Figure 2-7 GAG structures. Table shows the structures of chondroitin sulphate 
disaccharides (after Esko (1999)).
Proteoglycans consist of a protein core linked to a glycosaminoglycan (GAG) 
-  a polysaccharide that consists of a repeated chain of disaccharides: one 
uronic acid and one acetylated amino sugar. Chondroitin / dermatan sulphate 
is the main GAG present in tendon and ligament. Chondroitin sulphate (CS) 
consists of a chain of the disaccharide [-4 glucuronic acid (GIcA) [31-3 N-
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acetylgalactosamine (GalNAc) /31- ], with sulphation of some hydroxyl 
residues (see Figure 2-7). Dermatan sulphate (DS) is formed by a 
modification of the CS polymer by epimerizing some of the GIcA sugars to 
Idouronic Acid (IdoA), which increases the flexibility of the polymer (Vynios et 
al. 2002). CS and DS are linked to a serine residue in the protein core by an 
O-linked tetrasaccharide.
The strongest evidence for a role of proteoglycans in creating the mechanical 
properties of ligament comes from studies of knock-out mice. The role of 
single knock-outs of proteoglycans is far from straightforward: biglycan and 
fibromodulin knock out mice show a reduction in the ultimate tensile strength 
and stiffness of tendons in knock-out mice (Jepsen et al. 2002; Young et al.
2002), whereas decorin knock out mice show an increase in ultimate tensile 
strength and stiffness (Robinson et al. 2004b). There is evidence that 
knocking out one proteoglycans increases expression of other proteoglycans 
to compensate: lumican expression increases in fibromodulin knock-out mice 
and lumican fibromodulin double knock out mice have weaker tendons than 
single knock out mice (Jepsen et al. 2002). There is also some evidence of 
an interaction between biglycan and decorin which might explain the 
increased ultimate tensile strength of decorin knockout mice: a synergistic 
effect upon bone of biglycan and decorin double knock out has been found 
(Corsi et al. 2002). Analysing the effects of various factors on the mechanical 
strength of tendon from decorin knock-out mice showed that the GAG 
content was the most important factor in determining the load at failure and 
the stiffness of the tendon (Robinson et al. 2004a).
One possibility for the involvement of proteoglycans in ligament strength is 
their role in fibril fusion. This effect changes during development. In the 
mouse flexor digitorium tendon, both lumican and fibromodulin initially limit 
the diameter of collagen fibrils as they are being assembled. When fibrils 
begin to fuse, lumican initially promotes this fusion. However, as the mouse 
matures lumican expression drops to a barely detectable levels, and 
fibromodulin promotes fibril growth. Mature lumican knock-out mice have 
tendon phenotypes similar to wild-type mice, but mature fibromodulin knock
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out mice have smaller fibrils than wild-type (Ezura et al. 2000). It has also 
been suggested that the prevalence of different types of GAGs might affect 
fibril fusion. During development, hyaluronic acid is the predominant GAG 
when the ligament is young and the fibrils are narrow (average diameter less 
than 60 microns). This is replaced by chondroitin sulphate, which is thought 
to limit the expansion of tendon fibrils beyond ~150nm. Above this limit, 
chondroitin sulphate is replaced by dermatan sulphate (Parry et al. 1982).
Intriguingly, HA improves the mechanical strength of the bone-tendon 
junction in a healing patellar tendon after three weeks, but not six weeks 
(Yagishita et al. 2005). This result, combined with the fact that HA is 
produced by very immature tendons suggests that HA is important to initiate 
tendon formation.
Chondroitin sulphate and dermatan sulphate have been shown to from 
bridges between adjacent fibrils (Cribb and Scott 1995). The molecular 
nature of these bridges is as yet unknown. However the bridges would need 
to be extensible to play a role in the mechanical strength of the ligament, 
several possibilities for the molecular nature of these bridges exist:
•  L-iduronate has alternative conformations that would allow it to extend 
under tension; there is a higher ratio of IdoUA/GlcUA in extensible 
tissues such as tendon and skin than rigid ones such as cartilage and 
cornea (Scott 2003).
• Some chondroitin sulphate and dermatan sulphate molecules self­
aggregate to from bridges between adjacent collagen fibrils. The 
preferred state of these bridges is one of minimal energy, when all the 
hydrogen and hydrophobic binding sites are involved. Mechanical 
stress can extend these CS/DS bridges by moving them to less 
favourable arrangements (Scott 2003).
•  A computational model of chondroitin-6-sulphate polymer suggests 
that the molecule itself is highly extensible, as extension from a wavy 
form at low strain to a linear molecule at 800% strain could be 
modelled (Redaelli et al. 2003).
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The role of these bridges has yet to be elucidated. Tendon fascicles treated 
with chondroitinase ABC, to remove hyaluronic acid, chondroitin sulphate 
and dermatan sulphate, do not become significantly weaker, although they 
appear to have lower stiffness than normal. The picture might be complicated 
by the removal of GAGs allowing new non-physiological interactions between 
the fibrils (Screen et al. 2005b). It is possible that glycosaminoglycans are 
predominately acting through interactions with cells to determine mechanical 
properties, and are principally determining the stiffness, but not the strength 
of the ECM.
As biomarkers, the SLRPs decorin and biglycan have been used (Moreau et 
al. 2005a). However it is not clear what different levels of these SLRPs 
mean, nor is it clear what the levels of these SLRPs should be. Aggrecan 
has also been used (Moreau et al. 2005a), as it is useful as a negative 
biomarker for the presence of large amounts of aggrecan would suggest the 
formation of either fibrocartilage or cartilage. Glycosaminoglycans have 
potential as biomarkers for ligament and tendon engineering, which will be 
discussed further in Chapter 5.
2.1.7 Glycoproteins as biomarkers
Another biomarker of ligament engineering is fibronectin (Cristino et al. 
2005). This is a glycoprotein that appears to be important for linking the ECM 
to cells via a domain that binds integrins (Mardilovich et al. 2006). In normal 
tendons, the levels of fibronectin are higher in the membrane that surrounds 
the fibrous core than the fibrous core, and higher still in the synovium 
surrounding the membrane (Brigman et al. 1994). Early synthesis of 
fibronectin appears to help BMSCs respond to mechanical tension (Chen et 
al. 2006), although this work has not prevented fibronectin synthesis to prove 
that fibronectin is important. This early synthesis fits with what is known 
about tendon healing, in response to injury, fibronectin levels increase early 
in the membrane (epitenon) surrounding the fibrous core (endotenon) of the 
tendon, there is also a delayed increase in fibronectin levels in the 
endotenon (Gelberman et al. 1991). Thus, elevated levels of fibronectin that
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subsequently decline can be considered a marker for tendon repair, which 
might be important to tendon and ligament engineering. The membranes that 
surround the fibrous core of the tendon / ligament should be richer in 
fibronectin than the fibrous core.
Laminin has also been used as a biomarker (Cristino et al. 2005). Laminin is 
so rare in the ACL that it has been used as a way of identifying blood vessels 
in the ACL by staining their basement membranes (Petersen and Tillmann
1999). In contrast to fibronectin, laminin does not appear to be up-regulated 
in response to tendon injury (Jozsa et al. 1989). As an outcome marker, 
laminin would come into its own to identify blood vessels if the co-culture of 
ligament cells and endothelial cells was being studied.
Tenascin is found in a number of tissues exposed to mechanical stress 
(Chiquet-Ehrismann and Tucker 2004). Tenascin-C levels are higher in 
regions of tendons subject to compression (Mehr et al. 2000). In general, 
levels of tenascin-c are elevated in parts of tissues subject to tension, and 
highest in fibrocartilaginous regions, subject to both tension and compression 
(Jarvinen et al. 2000), part of the function of tenascin-C appears to be 
inhibition of cell attachment (Chiquet-Ehrismann and Tucker 2004), so its 
presence might explain the spherical morphology of cells in fibrocartilaginous 
regions (Mehr et al. 2000). Western-blotting identifies two isoforms of 
tenascin-C, a 200kDa form and a 300kDa form, the 200kDa is found in 
normal and degenerating tendons, whilst the 300kDa form was only found in 
degenerating tendons (Riley et al. 1996). Thus tenascin-C could be used to 
detect cells responding to mechanical stress. High levels of tenascin-C might 
indicate the presence of fibrocartilage; this could be confirmed with histology. 
Western blotting might be able to detect aberrant regeneration by detecting 
the 300kDa form of tenascin-C.
Finally, bone sialoprotein is used in a similar way to aggrecan as a negative 
marker of ligament differentiation, although its absence indicates that cells 
are not differentiating into bone (Altman et al. 2002b; Cristino et al. 2005). 
However bone sialoprotein is a late marker of bone differentiation (Young et
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al. 2002). Therefore elevated levels of bone sialoprotein may not be detected 
immediately even when cells are differentiating into osteoblasts to form bone.
2.2 Biomaterials
The ideal biomaterial for ligament engineering would have several properties:
• Good mass transfer of nutrients and waste
• Means of attaching cells throughout the scaffold
• Appropriate mechanical behaviour
• Degradation rate suited to ligament synthesis
• Sites to stimulate cell surface receptors
• High Specific Surface Area
• Low immunogenicity
• Optimal pore size
There are other properties that might be advantageous that have not been 
proven to be advantageous yet. For instance, many scaffolds include 
glycosaminoglycans, as glycosaminoglycans are self-aggregating (Scott 
1992) these scaffolds might provide “hooks” on the scaffold for newly 
synthesised ECM to bond with.
Mass transfer, the diffusion of nutrients to cells through biomaterials, is a 
major limitation in tissue engineering (Yang et al. 2001), as the time taken for 
nutrient diffusion is proportional to the square of the distance travelled. In 
vivo there are blood vessels in the fascicles (Clark and Sidles 1990), so cells 
are no further than 200pm from a blood supply. In vitro there is no 
vasculature, presenting a major problem as assemblies of cell aggregates 
larger than 1 mm diameter invariably develop necrotic cores in conventional 
bioreactors due to insufficient oxygen (Unsworth and Lelkes 2000); the axial 
diameter of ACL averages 4.7mm in women and 5.6mm in men (Anderson et 
al. 2001). This is complicated by the fact that the importance of nutrient 
transfer in the ACL is poorly understood. On one hand ACL fibroblasts are 
metabolically relatively inactive (Fermor et al. 1998), and low oxygen 
tensions increase proliferation and collagen synthesis. On the other hand
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poor vascularisation is thought to be a limiting factor in ACL healing (Bray et 
al. 2003), and primitive ligament cells differentiated from marrow stromal 
cells may proliferate and mature faster at normal oxygen tensions (21%). In 
addition, adding sodium bicarbonate to the culture medium to increase its 
buffering capacity against acidification improves the quality of engineered 
cartilage (Robinson et al. 2004a). This suggests that it might be the 
increased concentration of lactic acid from anaerobic respiration that is 
harmful, not the lack of oxygen (as with ligament reducing the oxygen 
tension can increase matrix synthesis (Saini and Wick 2004); adding lactic 
acid to reduce the extracellular pH does reduce matrix synthesis, this 
reduction can be prevented if the lactic acid is buffered by sodium 
bicarbonate (Wilkins and Hall 1995).
A review of cartilage engineering concludes that higher initial cell density 
improves final matrix quality, although it does not affect the final cell density 
(Darling and Athanasiou 2003). A higher cell density will require more 
nutrients and a scaffold with good mass transfer properties. There are three 
main ways of modifying a biomaterial to increase mass transfer through it:
•  Larger pore size facilitates convection in the presence of fluid flow 
within the biomaterial, which makes mass transfer faster.
•  High porosity will not only help improve flow in the scaffold, but
provide empty space to be filled by newly synthesised ECM.
• Better interconnected pores. This is measured by tortuosity -the
distance the molecule has to travel divided by the thickness of the
material.
For the cells to grow on the scaffold they first need to attach to it. Two factors 
are known to affect this. First the diameter of the fibres within a scaffold has 
been shown to affect the attachment of some cell types, such as osteoblasts 
(Ma et al. 2005). Secondly, attachment of MC3T3-E1 cells shows a strong 
correlation with the specific surface area of collagen-GAG scaffolds (O'Brien 
et al. 2005). Unfortunately there’s a trade off between optimal specific 
surface area and optimal mass transfer. According to the Hagen-Poiseuille
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equation, (which produces good approximations of permeability from the 
material properties for porous structures with porosities of less than 80%) the 
intrinsic permeability is inversely proportional to the square of specific 
surface area (Sander and Nauman 2003).
There are two options for the mechanical behaviour of the biomaterial: either 
start with a material with a low stiffness and ultimate tensile strength and rely 
on the ligament engineering process to make the construct stiffer and 
increase in ultimate tensile strength. This approach was used by Altman et al 
(2002b) and Goulet et al (2000) when they chose a hardened collagen gel as 
a biomaterial (if a collagen gel containing cells is left for a couple of days the 
cells will contract it: which increases collagen concentration and helps align 
collagen fibres (Wallace and Rosenblatt 2003). Hardened collagen gels did 
result in ligament-like constructs.
The alternative is to start with a biomaterial whose mechanical properties are 
similar to those of a ligament, this approach has been taken by Altman et al 
(2002a) and Chen et al (2003) who used silk as a biomaterial. A direct 
comparison between these approaches has yet to be carried out, but 
comparing between the results published in the two separate papers (by the 
same group) it seems that the collagen gel system expresses twice as much 
collagen I at 14 days as the best silk system, although this does not control 
for other variables such as the degradation rates of the two different 
polymers.
If cyclical stretching is used it will also be necessary to ensure that the 
mechanical properties of the biomaterial are compatible with the stretching 
protocol. The biomaterial must be capable of taking at least at much strain as 
the protocol uses. Furthermore the material should not be permanently 
deformed by repeated stretching. (Kim and Mooney 2000) compared Poly(L- 
lactic acid)-bonded polyglycolide fibre-based scaffolds and type I collagen 
sponges as scaffolds for engineering smooth muscle and found that cyclic 
strain permanently deformed the polymer scaffold, but not the collagen gel
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and that cells grown on the polymer scaffold contained less elastin than 
those grown on the collagen I sponges.
Work on tissues other than ligament suggests that the rate at which the 
scaffold degrades is a critical variable. Work on peripheral nerve 
regeneration looked at varying the degradation rate of a collagen scaffold by 
varying the extent of cross-linking showed that nerve regeneration was best 
at an intermediate rate of degradation (Harley et al. 2004). The rate of 
scaffold degradation has also been shown to be a critical variable in skin 
regeneration (Yannas et al. 1989). There’s limited evidence that the same is 
true for chondrocytes (Tognana et al. 2005).
The biomaterial needs to be bioactive to have some way of emulating the 
ECM-cell interactions. Whereas a collagen gel will interact with cells, as the 
collagens process binding sites the cells recognise, a biomaterial such as silk 
will not possess these same binding sites. However materials such as silk 
can be chemically modified to include binding sites. Chen et al (2003) 
modified their silk based biomaterial with RGD sites that many integrins 
recognise. This modification with RGD almost trebled the amount of collagen 
I expressed by ACL fibroblasts and resulted in nearly a five-fold increase in 
collagen I expression by bone marrow stromal cells.
The material should have low immunogenicity so as not trigger an immune 
response when the implant is inserted.
Finally, there is no sound evidence as to the optimal pore size for ligament 
engineering. Cooper et al (2005) suggested that a size of 200-250pm was 
ideal. However this conclusion was based upon an a limited investigation 
that looked at replacing tendons with a woven tape made of fine-gauge 
stainless steel using two weaving designs to give two different porosities; the 
tape was inserted into the metacarpals of beagle hounds. The only result 
given was that the greatest interfacial bonding strength occurred after twelve 
weeks with the tape with a pore size of 250pm (Konikoff et al. 1974); the 
pore size of the other tape was not given. This would not be a good test of
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pore size for tendon or ligament engineering, as the interfacial bonding 
strength would be determined by the extent of bone ingrowth, not tendon 
regeneration. This conclusion is supported by the evidence on the effect of 
pore size on bone ingrowth: a pore size of at least 150pm is thought to be 
necessary for bone ingrowth into a scaffold (Petite et al. 2000), and a pore 
size of over 300pm is thought to be optimal (Karageorgiou and Kaplan 2005). 
This issue will be returned to in Chapter 7.
There is also the issue of how to attach the construct, when the ACL has 
ruptured. One option that has been studied in a goat model is to use 
demineralised bone as a biomaterial inserted into bone (Jackson et al. 1996), 
but regeneration was found to be slow in this system, and the same 
questions arise about using demineralised bone as any other xenograft. 
Another option that might promote faster and better healing would be to 
tissue engineer the enthesises; Mutsuzaki (2004) have developed a 
technique that hybridises calcium phosphate with a tendon graft that 
replicates at least some of the features of the enthesis. Table 2-3 
summarises the materials that have been used for ligament engineering.
Table 2-3 Materials used for ligament engineering
Material Advantages Disadvantages




















Silk is composed of three major components: the core fibre made up of a 
heterodimer of silk fibroin heavy chain and light chain proteins, 6 
heterodimers bind non-covalently with the glycoprotein P25 (Inoue et al. 
2004), and the sericin coat a glue like protein (Altman et al. 2003). This 
section will consider the properties of silk fibroin from the silkworm, Bombyx 
mori, in more detail.
The sericin component appears to be responsible for almost all problems 
with biocompatibility and hypersensitivity (Altman et al. 2003). Fortunately it 
is easily removed by a degumming process (Altman et al. 2002a). Little is 
known about the role of P25. Silk fibroin has a number of properties that 
make it a very interesting biomaterial: biocompatible (Altman et al. 2003), 
biodegradable ((Altman et al. 2003), thermally stable (Nakamura et al. 1994), 
with good mechanical properties (Altman et al. 2003).
Silk fibroin has a long history of use as a suture (Altman et al. 2003), and as 
surgical thread (Bunning et al. 1994). Silk films implanted into rats trigger an 
milder inflammatory response than either PLA or collagen films, further in 
vitro cells grown on silk films express lower levels of the inflammation 
markers lnterleukin-1 p and COX-2 (Meinel et al. 2005).
According to the US Pharmacopoeia, an absorbable biomaterial is one that 
“loses most of its tensile strength within 60 days post-implantation”. Under 
this definition silk fibroin is not an absorbable biomaterial, but it does degrade 
within a longer timeframe, losing most of its tensile strength within a year and 
being unrecognizable at the site of implantation within two years (Altman et 
al. 2003). Recently, a silk biomaterial has been developed where the silk is 
dissolved in an aqueous solvent rather than the traditional organic solvents. 
This biomaterial is degraded by proteases within 21 days, much faster than 
biomaterials made with organic solvents, although the time for absorption in 
vivo of this new material is unknown (Kim et al. 2005b).
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Silk fibroin is a very thermally stable protein, intramolecular and 
intermolecular hydrogen bonds are broken between 150 and 180°C, then the 
silk filament begins to gradually lose weight at 175 °C (Nakamura et al. 
1994). These properties are in stark contrast to the typical properties of 
proteins which undergo conformational change well below 100°C. This 
thermal stability of silk has been exploited as part of the degumming process 
for removing sericin (Altman et al. 2002a). Further it suggests that it would be 
possible to sterilise silk-based biomaterials by autoclaving them, rather than 
merely sanitising them with 70% ethanol solution, which is the usual method 
for tissue engineering scaffolds.
Perhaps the major reason for interest in silk is its exceptional mechanical 
properties. These depend somewhat upon the method of fabrication, but 
ultimate tensile strengths of typically over 500 MPa, combined with Young’s 
moduli of 5-17 GPa and %strain at break of 4-20% have been reported 
(Altman et al. 2003). As silk is stronger than the tendon, porous scaffolds can 
be made of silk that possess similar mechanical properties to ligament 
(Altman et al. 2002a). One of the unique properties of silk is its strength in 
compression (Altman et al. 2003; Bunning et al. 1994), this would make it an 
attractive option for both the ligament itself and the bony enthesises.
Silk fibroin has at least three crystalline structures: Silk I, Silk II and random 
coil (Magoshi et al. 1994). Silk II, consisting of p-sheets, is the most stable 
form and is insoluble in water. To make silk-based biomaterials silk is 
normally regenerated in a strong salt solution: this changes the crystalline 
structure of silk fibroin from type II to type I, a distorted p-turn structure. Type 
I is soluble in water and organic acids such as 1,1,1,3,3,3 hexafluoro-2- 
propanol (HFIP). Freeze drying below -20°C promotes a shift to random 
coils. Once the silk is in solution as random coils or silk I, it can be cast as a 
film or scaffold and converted to silk II by methanol (Ha et al. 2005), the 
shear stress creating by drawing silk into fibres can also convert it to silk II 
(Magoshi et al. 1994).
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2.2.2 Cross-linking
Crosslinking of collagen is much better understood than crosslinking of silk. 
In the case of collagen, crosslinking can chemically link adjacent collagen 
molecules changing the material properties of the scaffold. Crosslinking can 
also be used to add useful molecules to the scaffold such as GAGs or RGD 
peptides. The effect of crosslinking is hard to predict a priori, for instance 
crosslinking of Dermal Sheep Collagen was found to decrease its tensile 
strength (Olde Damink et al. 1996), whereas it can strengthen collagen gels 
(Charulatha and Rajaram 2003). The exact location of the amino acids 
crosslinked seems to be important (Charulatha and Rajaram 2003); as does 
whether the crosslinks are between and within collagen molecules or 
between microfibrils (Sung et al. 2003). A complication when crosslinking silk 
is that crosslinking can affect the crystalline structure of the molecule and 
induce a shift from beta sheets to random coils (Sampaio et al. 2005).
Crosslinking can either be done with chemicals or by physical methods, such 
as heat treatment or irradiation. Physical methods have the advantage that 
they do not introduce any potentially cytotoxic chemicals, although these 
processes might induce cytotoxic changes in the materials being crosslinked. 
The more major disadvantage is that there is a trade off between the extent 
of crosslinking and potential onset of degradation of the molecules being 
crosslinked (Khor 1997).
Initially, glutaraldehyde was widely used for crosslinking biomaterials. 
However when implanted subcutaneously in rats and compared to other 
crosslinking reagents for crosslinking collagen, it triggered an increased 
infiltration of neutrophils and became more calcified than the other scaffolds; 
A/-(3-dimethylaminopropyl)-A/'-ethylcarbodiimide hydrochloride (EDC) : N- 
hydroxysuccinimide (NHS) crosslinking on the other hand produced a much 
milder cellular reaction and an optimal collagen matrix (van Wachem et al. 
1994).
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EDC/NHS produces a zero-length crosslink between a carboxylic acid group 
and an amine group. Various factors have been shown to affect the extent of 
crosslinking with EDC/NHS: pH, the ratio of EDC:NHS, the ratio of 
EDC:COOH groups, reaction volume, ethanol, and the reaction time (Pieper 
et al. 2000; Pieper et al. 1999). This is particularly useful for crosslinking 
compounds containing amine groups, such as peptides to silk fibroin, as silk 
fibroin is richer in carboxylic acid groups than amine groups (Xia et al. 2004).
Recently there has been a lot of interest in genipin as chemical crosslinker. 
The chemistry of the crosslinking reaction has not been elucidated in detail, 
but it appears that it can react with amine groups, further it can react with 
itself to from bridges between two amine groups (Chen et al. 2004). Genipin 
has been shown to be much less cytotoxic than glutaraldehyde (Sung et al. 
1998); only at high concentrations (50ppm) is it more genotoxic than a 
negative control, whereas glutaraldehyde is genotoxic (Tsai et al. 2000); 
although a direct comparison of the relative cytotoxicity of EDC/NHS and 
Genipin is yet to be made. Genipin has an advantage over EDC/NHS when 
crosslinking collagen in that it creates more intermicrofibrillar crosslinks 
which affect the mechanical properties of the scaffold (Sung et al. 2003). The 
disadvantage of this method for silk crosslinking is that silk fibroin has few 
amine groups (Xia et al. 2004) limiting the extent of crosslinking.
Another option for crosslinking is to use enzymes. Lysyl oxidase is the 
enzyme that crosslinks collagen in vivo, whilst it has not been purified in 
sufficient quantity to be applied as a crosslinking reagent, it has been 
possible to up-regulate lysyl oxidase activity by transfecting cells with 
additional copies of the lysyl oxidase gene (Elbjeirami et al. 2003). This 
approach is limited by the limited understanding of how to make gene 
therapy safe, as shown by the death of a patient on a clinical safety trial 
(Raper et al. 2003). Tranglutaminase crosslinks glutamine and lysine in the 
presence of calcium, it has been successfully used to crosslink collagen 
(Orban et al. 2004), but cannot crosslink protein to other classes of molecule 
such as polysaccharides. Mushroom tyrosinase has been used to cross-link 
chitosan (a polysaccharide) to silk, but this induced a change from the (3
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sheet form of silk to random coils (Sampaio et al. 2005) which is thought to 
be undesirable.
Table 2-4 Summary of chemical crosslinking methods
Crosslinking agent Crosslink formed Notes





EDC NHS Carboxylic acid and 
amine group
Zero length crosslink
Genipin Links amine groups and 
forms bridges between 




Lysyl oxidase Proline or 
Hydroxyproline to 
Lysine or Hydroxylysine
The natural collagen 
crosslink
Enzyme has not been 




The final option is ionic crosslinking; a collagen-chitosan-glycosaminoglycan 
complex has been made without chemical crosslinking (Berthod et al. 1994). 
The degree of acetylation of the chitosan controls the strength of the 
crosslinking (Collombel et al. 1992). Unusually in this case the ionic bonds 
between the molecules are strong enough to prevent the GAGs from being 




The purpose of using a bioreactor for ligament tissue engineering is to allow 
a 3D construct to be mechanically manipulated and to control the 
physiochemical environment (e.g. concentrations of 02, CO2, pH and 
temperature). The process of engineering a ligament can be broken down 
into three steps:
• differentiation of the cells to ligament cells,
•  proliferation of the cells, and
• maturation of the cells into a mature ligament.
One of the aims of bioreactor design is to combine these steps into an 
efficient process. So far research has focused on maturation and 
differentiation; there have been two attempts to engineer such a bioreactor.
Several simple bioreactors have been designed that allow cell seeded 
collagen gels to be cyclically stretched (Cho et al. 2004; Garvin et al. 2003; 
Langelier et al. 1999; Peperzak et al. 2004; Yahia et al. 1991).
The simplest bioreactors are those that use static strain to mechanically 
stimulate cells. These consist of two poles in a dish, and biomaterial placed 
on the dish that contracts to from a three dimensional scaffold suspended 
between in the two posts. The first of these used a collagen gel as the 
biomaterial and after twelve weeks the construct had an ultimate tensile 
strength of 0.14 MPa. Blocking collagen crosslinking with p- 
aminopropionitrile suggested that much of this increase in ultimate tensile 
strength was due to collagen crosslinking (Huang et al. 1993). A recent 
experiment used tendon fibroblasts seeded in monolayer on lumican in 
culture dishes coated with SYLGARD to allow the tendon monolayer to peel 
off the dish and contract. This showed that, after four weeks, the tendon 
fibroblasts in vitro could form constructs with ultimate tensile strength of 2 
MPa, and morphology resembling embryonic tendon (Calve et al. 2004). It is 
not clear if it would be possible to scale this technique up to form large 
ligaments like the ACL.
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The cyclical strain bioreactor designed by Langelier et al. (1999) allowed the 
maturation of ACL fibroblast seeded collagen gels into a tendon-like 
constructs with cells orientated parallel to the direction of strain (Goulet et al.
2000). Several authors have looked at the effect of 2D cyclical tensile strain 
upon ligament cells, and the expression of the main protein markers of 
ligament maturation. Cyclical strain increases gene expression of collagens I 
and III by ACL fibroblasts. TGF-(31 is a key messenger in this response as 
the expression of the collagens can be significantly reduced by anti-TGF-p1 
antibodies (Hsieh et al. 2000; Kim et al. 2002). Five percent strain at 1Hz has 
been to shown to upregulate collagen synthesis in tendon fascicles ex vivo, 
without affecting GAG synthesis or cell proliferation (Screen et al. 2005a).
The bioreactor of Altman et al (2002c) is more sophisticated than the other 
reactors mentioned in other ways: it can both cyclically stretch and twist the 
construct, and it can control the physicochemical environment including 
partial pressures of 02, CO2 and N2 (Figure 2-8). This bioreactor allowed 
them to demonstrate that combined cyclical tensile strain (10%) and 
rotational strain (90°, 25%) at 0.0167 Hz applied to a collagen gel seeded 
with mesenchymal progenitor cells into ligament like construct with a helical 
organisation reminiscent of the ACL. The mesenchymal progenitor cells had 
apparently differentiated into ligament fibroblasts based on production RNA 
for tenascin-C, and collagens I and III (Altman et al. 2002b). This reactor 
allowed them to simultaneously differentiate into ligament-like cells and 
mature them into a ligament-like construct which had a helical organisation 
















Peristaltic pump /  s.
Figure 2-8 Schematic of Altman et al (2002c) bioreactor for ligament production
The effect of different mechanical loading strategies is poorly understood. 
Howard et al (1998) have looked at the effect of different strains upon 
periodontal ligament fibroblasts (PDLF), they found that 5% strains increased 
collagen I and fibronectin production, decreasing tropoelastin production 
relative to static controls, whilst 10% strains still increased fibronectin 
production and decreased tropoelastin production, but had no effect on 
collagen I relative to static controls. Agarwal et al. (2003) found that in 
osteoblast-like periodontal ligament cells high cyclical tensile strain (IQ- 
18.5%) up-regulated proinflammatory signals (cyclooxygenase-2 (COX-2) 
mRNA expression and PGE2 synthesis) via lnterleukin-1 fi-induced 
translocation of the transcription factor nuclear factor-xB, whilst low cyclical 
tensile strain (2-8%) prevented this translocation. Frequency is another 
important variable; tenocytes stretched at 5% at 1Hz expressed vascular 
endothelial growth factor, unlike cells stretched at 0.5Hz (Petersen et al.
2004). Finally, the duration of stretching appears to be important: the 
proliferation rate and apoptosis increased when tenocytes where stretched 
by 5% at 1Hz for a day; after two days stretching, heat shock protein 72 was 
expressed and proliferation and apoptosis decreased (Barkhausen et al.
2003).
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As explained in the biomaterials section (Section 2.2) mass transfer of 
nutrients and waste is a major issue in tissue engineering. However this not 
just a biomaterials problem, bioreactors also have a role to play. Either the 
body could used to improve mass transfer as rapid neovascularisation 
occurs in vivo, starting within 20 days of surgery and being complete after 3 
months (Fu et al. 1999), this could be used as part of an in vivo tissue 
engineering strategy.
Alternatively, the bioreactor could be designed to improve mass transfer in 
vitro: the design of Altman et al. (2002c) perfuses media through the 
biomaterial, and around the biomaterial, reducing the distance media has to 
diffuse through the boundary layer; mechanical stimulation might be used to 
create negative pressure within the construct, sucking fresh media in 
(Langberg et al. 1999); or the vasculature could be artificially replicated with 
biodegradable hollow fibres.
Bioreactor designs utilising fluid flow induced shear stress as the mechanical 
stimulus have been widely used for cartilage engineering (Darling and 
Athanasiou 2003), but have yet to tested for ligament engineering. Although 
it is known that fluid flow triggers nitric oxide and PGE2 release, decreases 
tissue non-specific alkaline phosphatase activity in PDLF (van der Pauw et 
al. 2000), and increases intracellular calcium levels in ACL and MCL 
fibroblasts (Hung et al. 1997), signals that should affect the differentiation, 
proliferation or maturation of ligaments. However, only an effect on matrix 
metalloproteinase (MMP) 1 & 3 levels in tendon cells (Archambault et al. 
2002) has been shown so far. Fluid flow induced shear stress might be 
effective because ligament fibroblasts are in the “viscous phase” between the 
fibre bundles (Puxkandl et al. 2002), and the fibrous capsule is sheared 
between adjacent fibre bundles (Screen et al. 2003). Mechanically 
stimulating cells with fluid flow will also allow the cells to benefit from better 
mass transfer which increases with fluid flow. Table 2-5 summarises the 
bioreactor discussed in this section.
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Table 2-5 Summary of bioreactors for ligament and tendon tissue engineering
Mechanical regime Key Papers Advantages and 
disadvantages
Static tension Huang et al (1993) 
Calve et al (2004)
Very simple
Stimulates less collagen 
synthesis than dynamic 
tension
Calve et al (2004) 
technique appears 
promising for small 
constructs
Cyclical tensile strain Langelier et al. (1999) 
Screen et al. (2005a)
Increased collagen 
synthesis relative to static 
culture
Cyclical tensile and strain Altman et al (2002c) Better replicates the 
mechanical forces on the 
ACL
Differentiates BMSCs into 
a structure resembling 
ACL
Fluid flow Improved mass transfer of 
nutrients
Not yet demonstrated for 
ligament engineering
2.3.1 Interactions between biomaterials and bioreactors
The work of Screen et al. (2004) described above has shown that the 
mechanical forces on ligament/tendon fibroblasts in vivo are different to 
those investigated by investigators looking at the effect of mechanical forces 
upon ligament/tendon fibroblasts. Often the fibroblasts are placed under 
much greater tensile strains than occur in vivo and the effect of the shear 
stresses created by the displacement of one fibre bundle relative to another 
have yet to be investigated. Whilst it is known that when tendons & ligaments 
are compressed between bones their response is to form fibrocartilage, it is 
not known what effect the compression of the fibroblasts by the movement of
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fibre bundles has. Replicating these forces upon the cells in vitro will require 
consideration of both bioreactor and biomaterial.
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2.4 Aims and Objectives
The overall aim of this project was to quantify the effects of pore size and 
pore structure on ligament tissue engineering. An essential part of this 
project was the data analysis following quantification of ligament tissue 
engineering.
The work was carried out to meet the following objectives:
• Allowing pore size and pore structure to be controlled within porous 
silk scaffolds
• Characterisation of the novel silk scaffolds
• Quantification of glycosaminoglycan production within 3d tissue 
constructs
• Quantification of the effects of pore size and pore structure on 
ligament fibroblast proliferation and matrix synthesis
• Use of appropriate statistics to study interactions between variables
• Comparison of results to existing literature on ligament development 
to see if any combincation of pore size and pore structure helps to 
recapitulate development
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3 Statistics: introduction to factorial ANOVA
3.1 Introduction
As the effects of multiple variables on ligament engineering are being 
considered an appropriate choice of statistics is necessary. There are 
essentially two problems in statistics when trying to determine if an 
independent variable has an effect on a dependent variable: type I error: 
deciding that there is an effect when there is not (i.e. a false positive), and a 
type II error: concluding that there is no effect when there is an effect (i.e. a 
false negative). The probability of a type I error should be determined by 
setting an appropriate alpha level, typically this is 5%. In others words, in the 
experiment the statistics should be used in such a way that there is a 5% 
chance of incorrectly concluding that there is an effect when there is not.
Often experiments are designed so that t-tests can be used to determine 
whether or not there is a significant difference between two groups. 
However, where there are three or more groups to compare this approach 
risks increasing the chance of a type I error; every time another group is 
compared the chance of a type I error increases, if 14 comparisons are made 
then the chance of type I error is over 50%. One solution to this problem is to 
make a correction to the level of statistical significance for individual tests; 
the simplest correction is the Bonferroni correction, in which the alpha level is 
divided by the number of tests carried out, for 10 separate tests the alpha 
level would have to be reduced to 0.5% from 5% to ensure that the chance of 
a type I error is not increased. The problem with this approach is that it 
greatly increases the chance that a real effect is not detected, a type II error.
The solution to this problem is to use more appropriate statistical tests. For 
more than two groups this involves using analysis of variance (ANOVA). 
Modern statistical software calculates ANOVA on the basis of a regression 
model. When there is a single independent variable, ANOVA tests whether 
that variable has a significant impact on the dependent variable. This thesis 
makes extensive use of factorial ANOVA, which compares data on a single
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outcome variable when multiple independent variables. A complete 
explanation of factorial ANOVA is beyond the scope of this section, instead 
this section will first introduce the mathematics behind factorial ANOVA with 
a worked example using notation from Field (2005), using additional 
equations from Cardinal and Aitken (2006) and Hays (1994); it will then use 
examples to demonstrate how some of the key concepts when using factorial 
ANOVA.
3.2 Worked example of factorial ANOVA
First, the effect of “Factor A” upon glycosaminoglycan production in 
chondrocytes and MSCs will be calculated to show how the mathematics 
works. (All the data for this section has been randomly generated.) The raw 
data for this calculation is given in Table 3-1. Analysis of variance works by 
comparing the variance that can be explained by the independent variables 
with the variance that cannot be explained. To do this first the total sum of 
squares (SSt) must be found, this can be broken down into the model sum of 
squares (SSm), and the residual sum of squares (SSr). The total sum of 
squares is given by the total variance of all the scores (s2grand), times the 
degrees of freedom (N-1), see Equation 3-1.
SST =  S 2 grand {N  — 1)
Equation 3-1 Total sum of squares
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Table 3-1 Glycosaminoglycan production by chondrocytes and MSCs at different 
concentrations of Factor A
Chondrocytes
Cone. Factor A 
(ng)
8 11 14 17
9 .8 2 1 0 .7 4 1 3 .1 9 1 5 .3 8
1 1 .5 5 1 0 .5 7 1 7 .0 5 1 8 .8 4
4 .4 5 6 .9 9 1 3 .8 8 1 5 .9 0
5 .8 0 1 2 .3 3 1 5 .2 0 1 9 .0 5
6 .3 4 4 .4 9 1 2 .8 0 1 9 .4 9
8 .6 2 8 .5 4 1 6 .5 9 1 3 .6 9
Total 46.58 53.67 88.70 102.35
Mean ( Xgroup) 7.76 8.94 14.78 17.06
Variance ( s ^oup) 7.23 8.23 3.17 5.70
MSCs
Cone. Factor A 
(n g )
8 11 14 17
1 2 .1 8
1 3 .4 6
1 5 .7 6
1 4 .3 8
2 0 .2 5
1 4 .8 1
7 .6 2
9 .8 3
1 6 .6 6
1 0 .1 1
1 3 .9 3
1 3 .7 4
7 .9 8
8 .9 3
1 2 .0 4
6 .1 4
1 2 .1 4  
1 6 .5 4
8 .0 3
6 .3 8
8 .7 2  
1 1 .4 6
4 .7 3  
8 .1 0
Total 90.85 71.90 63.78 47.41
Moan ( xgroup) 15.14 11.98 10.63 7.90
Variance ( s 2^ ) 7.76 11.17 13.86 5.15
Treating all of the results as one gives the variance as 17.955 (Table 3-2), 
there are 48 results so N=48. Hence the total sum of squares is:
SST = 17.955(48-1)
= 843.885
The model sum of squares is given by the sum of the number of scores in a 
group ( n^oup) times the square of mean each group of scores ( xgroup) minus
the mean of all the scores (xgrarUi ; Equation 3-2). Essentially this compares 
the mean of each group of scores to the overall mean, and then weights the
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result to account for the size of the group. The more different the means of 
each group are to the overall mean the more variance that must be 
explained.
= 'Sy  n v r n u n i x g rouP ~  X  grand )
Equation 3-2 Model sum of squares
Table 3-2 Mean and variance of scores from Table 3-1
9 .8 2 1 0 .7 4 1 3 .1 9 1 5 .3 8
1 1 .5 5 1 0 .5 7 1 7 .0 5 1 8 .8 4
4 .4 5 6 .9 9 1 3 .8 8 1 5 .9 0
5 .8 0 1 2 .3 3 1 5 .2 0 1 9 .0 5
6 .3 4 4 .4 9 1 2 .8 0 1 9 .4 9
8 .6 2 8 .5 4 1 6 .5 9 1 3 .6 9
1 2 .1 8 7 .6 2 7 .9 8 8 .0 3
1 3 .4 6 9 .8 3 8 .9 3 6 .3 8
1 5 .7 6 1 6 .6 6 1 2 .0 4 8 .7 2
1 4 .3 8 1 0 .1 1 6 .1 4 1 1 .4 6
2 0 .2 5 1 3 .9 3 1 2 .1 4 4 .7 3
1 4 .8 1 1 3 .7 4 1 6 .5 4 8 .1 0
Total 5 6 5 .2 3
Mean ( X g ra n d  ) 1 1 .7 8
Variance ( s 2 g r a n d ) 1 7 .9 5 5
This can be calculated using the figures from in Tables 3-1 and 3-2:
SSM = 6 (7.76 - 11.78)2 + 6(8.94 - 11.78)2 + 6(14.78 - 11.78)2 + 6(17.06 - 
11.78)2 + 6(15.14 - 11.78)2 + 6(11.98 - 11.78)2 + 6(10.63 - 11.78)2 + 
6(7 .90-11.78)2
= 6 (-4.02)2 + 6(-2.84)2 + 6(3)2 + 6(5.28)2 + 6(3.36)2 + 6(0.20)2 + 6(- 
1.15)2 + 6(-3.88)2
= 96.96 + 48.39 + 54 +167.27 + 67.78 + 0.25+7.94+90.22 
= 532.8
For a factorial ANOVA SSM has to be broken down further into main effects 
and interactions. The main effects correspond to the two independent
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variables: concentration of factor A and cell type; there is one interaction 
between these variables concentration of factor A x cell type. The sum of 
squares for each of these effects and interactions needs to be calculated. 
For main effects this is calculated using the same equation as the SSm, 
changing ngroup and xgrouP to reflect the sum of squares being calculated.
Starting with the concentration of factor A (SSA) the equation now subtracts 
the mean for each concentration of Factor A ( x coiumn) from the overall mean 
(xgrand), squares the result, and multiplies by the number of results in each 
column (ncolumEquation 3-3).
Table 3-3 Glycosaminoglycan production with respect to concentration of Factor A
Cone. Factor 
A (ng) 8 11 14 17
9 .8 2 1 0 .7 4 1 3 .1 9 1 5 .3 8
1 1 .5 5 1 0 .5 7 1 7 .0 5 1 8 .8 4
4 .4 5 6 .9 9 1 3 .8 8 1 5 .9 0
5 .8 0 1 2 .3 3 1 5 .2 0 1 9 .0 5
6 .3 4 4 .4 9 1 2 .8 0 1 9 .4 9
8 .6 2 8 .5 4 1 6 .5 9 1 3 .6 9
1 2 .1 8 7 .6 2 7 .9 8 8 .0 3
1 3 .4 6 9 .8 3 8 .9 3 6 .3 8
1 5 .7 6 1 6 .6 6 1 2 .0 4 8 .7 2
1 4 .3 8 1 0 .1 1 6 .1 4 1 1 .4 6
2 0 .2 5 1 3 .9 3 1 2 .1 4 4 .7 3
1 4 .8 1 1 3 .7 4 1 6 .5 4 8 .1 0
Total 145.42 136.57 166.48 166.76
Mean ( Xcoiumn) 11.19 10.51 12.81 12.83
Variance 20.77 10.42 11.54 27.05
SSA -  2^ ncolumn \X  column X  Srand j
Equation 3-3 Sum of squares for concentration of Factor A
Using the values from Tables 3-2 and 3-3:
SSA = 12(11.19 - 11.78)2 + 12(10.51 - 11.78)2 + 12(12.81 - 11.78)2 + 
12(12.83-11.78)2
=12(-0.59)2 + 12(-1.27)2 + 12(1.03)2 + 12(1.05)2
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= 4.1772 + 19.3548 + 12.7308 + 13.23 
= 49.49
S S B — ^ ^ n row\X r°w  Xgrand J
Equation 3-4 Sum of squares for cell type
Table 3-4 Glycosaminoglycan production with respect to cell type
Chondrocytes
9 .8 2 1 0 .7 4 1 3 .1 9 1 5 .3 8
1 1 .5 5 1 0 .5 7 1 7 .0 5 1 8 .8 4
4 .4 5 6 .9 9 1 3 .8 8 1 5 .9 0
5 .8 0 1 2 .3 3 1 5 .2 0 1 9 .0 5
6 .3 4 4 .4 9 1 2 .8 0 1 9 .4 9
8 .6 2 8 .5 4 1 6 .5 9 1 3 .6 9
Total 291.29
Mean ( ) 12.14
Variance 21.08
MSCs
1 2 .1 8 7 .6 2 7 .9 8 8 .0 3
1 3 .4 6 9 .8 3 8 .9 3 6 .3 8
1 5 .7 6 1 6 .6 6 1 2 .0 4 8 .7 2
1 4 .3 8 1 0 .1 1 6 .1 4 1 1 .4 6
2 0 .2 5 1 3 .9 3 1 2 .1 4 4 .7 3
1 4 .8 1 1 3 .7 4 1 6 .5 4 8 .1 0
Total 273.94
Mean ( X ro w ) 11.41
Variance 15.34
The same process applies to cell type (SSB) using Equation 3-4 and the data 
from Table 3-2 and 3-4:
SSB = 24(12.14- 11.78)2 + 24(11.41 - 11.78)2 
= 24(0.36)2 + 24(-0.37)2 
= 3.11 +3.29 
= 6.40
The interaction effect (S S a x b )  can be calculated by multiplying the square of 
the mean for each group minus the means for the relevant row and column 
plus the overall mean by the number of results in each group (Equation 3-5). 
Essentially, this is comparing the mean of each group to the mean for each
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column and row then weighting them for the number of results in each group. 
The more that the means of the groups differ from the means predicted by 
the means of the columns and rows, the greater the interaction effect.
S S  Axb  =  ^  group (* 8rouP ~  X  column — Xrow + X  grand )
Equation 3-5 Sum of squares for the interaction effect
Table 3-5 Mean glycosaminoglycan production by group, row and column
7 .7 6 8 .9 4 1 4 .7 8 1 7 .0 6 1 2 .1 4
1 5 .1 4 1 1 .9 8 1 0 .6 3 7 .9 0 1 1 .4 1
1 1 .1 9 1 0 .5 1 1 2 .8 1 1 2 .8 3
Table 3-5 summarises the means for each group, row and column
Tables 3-1, 3-3, and 3-4, together with the overall mean from Table 3-5 this 
data can be used with the equation for the sum of squares for the interaction 
effect (Equation 3-5) to find the interaction effect:
SSaxb = 6(7.76 - 12.14 - 11.19 +11.78)2 + 6(8.94-12.14-10.51 +11.78)2 + 
6(14.78 - 12.14 -  12.81 +11.78)2 + 6(17.06 -12.14-12.83+11.78)2 + 
6(15.14 -  11.41- 11.19 +11.78)2 +6(11.98 -  11.41 -10.51 +11.78)2 + 
6(10.63 -  11.41- 12.81 +11,78)2 +6(7.90 -  11.41- 12.83+11,78)2 
=6(-3.79)2 + 6(-1.93)2 + 6(1.61)2 + 6(3.87)2 + 6(4.32)2 + 6(1 84)2 
+ 6(-1.81 )2 + 6(-4.56)2
= 86.18 + 22.35 + 15.55 + 89.86 + 111.97 + 20.31 + 19.66 + 124.76 
= 490.65
The next step is to calculate the residual sum of squares (SSr), which 
represents the variance that is not explained by the two independent 
variables (and their interaction). This can be calculated as the sum of the 
group variance ( 5 2group) times the number of results in each group minus one 
(Equation 6-7).
S S r ~  ^  S group ( n group ~
Equation 3-6 Residual sum of squares
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The residual sum of squares can be calculated with the data from Table 3-1:
SSr = 7.23(6-1) + 8.23(6-1) + 3.17(6-1) + 5.70(6-1) +7.76(6-1) + 11.17(6-1) 
+13.86(6-1)+ 5.15(6-1)
= 311.35
The next step is to convert the sums of squares into mean squares by 
dividing the number of degrees of freedom. For the two main effects the 
number of degrees of freedom is one less than the number of categories in 
that group, for the interaction effect the number of degrees of freedom is the 
multiple of the degrees of freedom for the main effects, and for the residual 
sums of squares it the number of results in each group minus one times the 
number of groups. Therefore the mean squares are as follows:
MSA = 4 9 .4 9 / ( 4 - 1 )  = 16.50 
MSB = 6 .4 0 / ( 2 - 1 )  = 6.40 
MSaxb = 490.65 / (3 x 1) = 163.55 
M S r = 311.35 / (6 x (6-1)) = 10.38
These are then converted into F-ratios by dividing the mean square for the 
effect or interaction by the residual mean square:
F a  = 16.50/10.38= 1.59 
FB = 6.4/10.38 = 0.62 
Faxb = 163.55/10.38 = 15.76
These F-ratios can be looked up in a table of critical F-ratios in conjunction 
with the degrees of freedom for the main effect or interaction and the residual 
to find the probability that the result occurred by chance. Table 3-6 
reproduces a small part of this critical F-ratio table relevant to these results, it 
can be seen that the F-ratios for both of the main effects are below the level 
necessary for statistical significance (1.59 < 2.92 and 0.62 < 4.17), but the F- 
ratio for the interaction is significant at the 0.01 level (15.76 > 3.47).
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Table 3-6 Critical F-ratios for residual degrees of freedom = 30
p
Degrees of freedom (effect / interaction)
1 2 3 4 5 6
.05 4.17 3.32 2.92 2.69 2.53 2.42
.01 7.56 5.39 4.51 4.02 3.70 3.47
3.2.1 Effect size
Calculating the effect size for significant effects determines what proportion 
of the variance in the experiment they account for, allowing comparison of 
how important different significant results are. There are multiple definitions 
of effect size. For simplicity, this thesis will focus on one of the most useful 
versions: u>2 (Cardinal and Aitken 2006). This is defined as the proportion of 
the total population variance in Y attributable to effect A (Equation 3-7). As 
this estimates population variances, this effect size can be generalised 
beyond the results in a given experiment. The equation used to calculate w2 
is given in Equation 3-8. (N.B. This can only be used for fixed effects, for this 
thesis this is sufficient as there are only fixed effects and no random effects).
Equation 3-7 Definition of io2
_ SSA - d f AxMSerror 
MS + SS tota,
Equation 3-8 Calculation of u)2
For the interaction between concentration and cell type the effect size is 
calculated as below:
<y2 AxB = (490.65 -  3 x 10.38) / (10.38 + 843.89)
6>2 axb = 459.51 / 854.27 
O f  AxB = 0.54
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Therefore it is estimated that the interaction between cell type and 
concentration of Factor A accounts for 54% of the variance in the population. 
As u)2 is a measure of the proportion of the population variance an effect 
accounts for, co2 values from an experiment will typically add up to less one, 
as the experiment will normally be run on a sample from the population, not 
the entire population
In this thesis results will be reported with an F-ratio and degrees of freedom, 
together with a significance level (calculated by statistical software) and an 
effect size where they are significant, this format is shown in Table 3-7 for 
the above results.
Table 3-7 Results of worked (hypothetical) example showing format for results
Variable / Interaction F value Probability Effect size
Concentration of Factor A F(3,30) = 1.59
Cell type F(1,30) = 0.62
Concentration of Factor A x Cell 
type
F(3,30)= 15.76 0.00000003 0.54
These results can also be viewed graphically. Figure 3-1 shows the effect of 
Factor A on GAG production the absence of a statistically significant 
difference can be seen from the 95% confidence interval bars. Figure 3-2 
shows the effect of cell type on glycosaminoglycan production again it is 
clear that there are not significantly differences. Figure 3-3a shows the 
interaction between cell type and Factor A concentration here it is clear that 
at 8ng/ml of Factor A MSCs produce more GAG than chondrocytes do and at 
17ng/ml chondrocytes produce more GAG than MSCs do. This illustrates a 
key point about interactions: significant interactions indicate that the gradient 
of two (or more) lines is different this can be shown more clearly with a line 
chart (Figure 3-3b). In this example there is a dramatic difference in gradient; 
one of the examples in the next section will show that a more subtle 
difference in gradient can be significant.
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Factor A Concentration 
(ng/ml)
Figure 3-1 Effect of Factor A concentration on glycosaminoglycan production. Error 
bars show 95% confidence interval.
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Figure 3-3 The interaction between cell type and Factor A concentration (a) bar chart 
and (b) line chart. Error bars show 95% confidence intervals.
3.3  A d va n tag es  o f  fac to ria l A N O V A
This section will consider some of the advantages of factorial ANOVA over 
more widely used methods. A common experiment in tissue engineering and 
musculoskeletal science is to add a growth factor to cells and then measure 
the effect of that growth factor at several time points. In the next hypothetical 
example, Uber Growth Factor is added to chondrocytes and the effect 
relative to a control on GAG production measured every 5 days for 20 days.
■  Control
Uber 





n .3 0 -  
O





Figure 3-4 Bar chart showing GAG production in response to Uber Growth Factor. 
Error bars show 95% confidence intervals.
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Figure 3-4 summarises the data for this comparison. If this data were 
analysed in the conventional manner for tissue engineering by independent t- 
tests to compare the samples the results would be as shown in Table 3-8. If 
an alpha level of 0.05 is used, these results demonstrate that there’s a 
significant difference between the control and the samples treated with Uber 
Growth Factor on all four days that GAG was measured. However, as this is 
one experiment the alpha level of 0.05 needs to be corrected if multiple t- 
tests are run, using the Bonferroni correction this reduces the alpha level to 
0.0125 from 0.05, making the result on day 5 non-significant.
















5 10 15 20
Time (days)
Figure 3-5 Line chart showing GAG production in response to Uber Growth Factor.
Table 3-9 shows the results of a factorial ANOVA carried out on the data. 
This demonstrates a major advantage of factorial ANOVA, which is that it 
tests more hypothesises than t-tests do. In addition to showing that the cells
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produce more GAG in response to Uber Growth Factor, this ANOVA shows 
that as time progresses the cells produce more GAG, and that there’s an 
interaction, the gradient of GAG production in response to Uber Growth 
Factor is different to that of the control. Note that in this example, the 
difference in gradient is much more subtle than that in the previous example 
(compare Figures 3-5 and 3-3b), this is reflected in the much smaller effect 
size for the interaction. The effect size shows that in this experiment, most of 
the variance (82%) is accounted for by differences due to time (Table 3-9).
Variable / Interaction F value Probability Effect size
Time F(2,30) = 267.68 1.68E-26 0.82
Uber Growth Factor F(1,30) = 121.74 1.05E-13 0.12
Time x Uber Growth Factor F(6,30) = 4.45 0.009 0.01
Table 3-9 Factorial ANOVA of hypothetical Uber Growth Factor experiment
If necessary, a simple effects analysis can be carried out to determine if Uber 
Growth Factor has an effect on all four days that GAG production was tested. 
This involves doing a one way ANOVA on each day’s result to see if there’s 
an effect of Uber Growth Factor. Table 3-10 shows the results. By analysing 
the results in this way there is a significant difference between the cells 
treated on all four days, whereas when t-tests were used, there was no 
difference on day 5; this is because by analysing multiple variables more of 
the total variance is accounted for, reducing the residual mean square thus 
increasing the F-ratio as the mean square for the effect/interaction is divided 
by a smaller number, thereby increasing the chance of a significant result. By 
using factorial ANOVA the chance of a type II error is reduced, the 
alternative would be to use t-tests and run the experiment with a larger 
sample size, making it more expensive and time consuming.
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Variable F value Probability
Uber Growth Factor within day 5 F(1,40) = 9.14 0.004
Uber Growth Factor within day 10 F(1,40) = 66.95 <0.001
Uber Growth Factor within day 15 F(1,40) = 30.08 <0.001
Uber Growth Factor within day 20 F(1,40) = 28.91 <0.001
Table 3-10 Simple effects analysis of the effect of day in the hypothetical Uber Growth 
Factor experiment
3.4 C onc lu s ions
Using multivariate experimental designs and factorial ANOVA gives three 
major advantages over the conventional statistical analysis for tissue 
engineering: the chance of a type II error is reduced without expensive 
increases in sample size; more hypothesises are tested by a single 
experiment, giving more information; and the calculation of effect size allows 
comparison of the relative importance of the independent variables. The 
consensus is that a significant result should have a probability of type I error 
of level than 0.05; by one widely used convention (Cohen 1988): a small 
effect explains 1% of the total variance (co2 = 0.01), a moderate effect is 6% 
of the total variance (u)2 = 0.06), and a large effect explains 25% of the total 
variance (u)2 = 0.25).
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4 Materials and Methods
4.1 M ateria ls
4.1.1 Materials for cell culture (Section 4.2.1)
Material Supplier Code
Ascorbate-2-phosphate Sigma-Aldrich, Poole, Dorset A-8960
DMEM Invitrogen, Paisley, Scotland 32430100
Fetal calf serum (FCS) Sigma-Aldrich, Poole, UK F7524
ITS Liquid media supplement Sigma-Aldrich, Poole, UK 13146
MEM non-essential amino acid solution Sigma-Aldrich, Poole, UK M7145
Penicillin-streptomycin Sigma-Aldrich, Poole, UK P0781
Phosphate buffered saline (PBS) Sigma-Aldrich, Poole, UK D8537
Serological 6 well plates Fisher Scientific, 
Loughborough, UK
TKT-220-006R
Sodium pyruvate Sigma-Aldrich, Poole, UK S8636
T150 flasks Triple red, Long Crendon,, 
UK
2020300
Tissue culture dishes Fisher Scientific, 
Loughborough, UK
TKT-110-070A
Trypan blue Sigma-Aldrich, Poole, UK T8154
4.1.2 Materials for silk processing and scaffold preparation  




Sigma-Aldrich, Poole, UK 105228-100G
Acetic acid Fisher Scientific, 
Loughborough, UK
124040025
Ascorbate-2-phosphate Sigma-Aldrich, Poole, Dorset A-8960
Crepe silk Hobbycraft, Bristol, UK n/a
Formic acid Fisher Scientific, 
Loughborough, UK
14793-2500
GRGDS peptide Merck, Beeston, UK 03-34-0027
Lithium bromide Sigma-Aldrich, Poole, UK 213225





Sigma-Aldrich, Poole, UK 03449
/V-Hydroxysulfosuccinimide (NHS) Sigma-Aldrich, Poole, UK 130672
Slide-a-Lyzer cassette (3500 MWCO) Perbio, Cramlington, UK 66130
Sodium carbonate Sigma-Aldrich, Poole, UK S7795
Sodium Chloride Sigma-Aldrich, Poole, UK S9888
Sodium Chloride (small particles) British Salt Fine 60





10% Formal saline VWR, Lutterworth, UK 36136
DPX mountant VWR, Lutterworth, UK 360294H
Technovit 7100 Taab Laboratories 
Equipment, Aldermaston, UK
T-218
Potassium bromide Sigma-Aldrich, Poole, UK 22,186-4
4.1.4 Materials for DNA and hydroxyproline assays (Sections
4.3.4 - 4.3.6)
Material Supplier Code
70% Perchloric acid Fisher Scientific, 
Loughborough, UK
P/1280/PB08
Acetic acid Fisher Scientific, 
Loughborough, UK
124040025
Chloramine T Sigma-Aldrich, Poole, UK 31274
Citric acid Sigma-Aldrich, Poole, UK C0759
Cysteine hydrochloride Sigma-Aldrich, Poole, UK C8005
Ethylenediamine tetraacetic acid (EDTA) Sigma-Aldrich, Poole, UK E9884
Hydrochloride acid Fisher Scientific, 
Loughborough, UK
H/1200/PB17
l-Hydroxyproline Sigma-Aldrich, Poole, UK 56250
Methanol Fisher Scientific, 
Loughborough, UK
M/4058/17
Papain Sigma-Aldrich, Poole, UK P3125
59
P-Dimethylaminobenzaldehyde Sigma-Aldrich, Poole, UK 15,647-7
Phosphate buffered saline (PBS) Sigma-Aldrich, Poole, UK D8537
Picogreen Invitrogen, Paisley, UK P-7589
Poly-l-lysine coated slides Agar Scientific, Stansted, UK L4345
Propan- 1-o\ Sigma-Aldrich, Poole, UK 402893
Sodium acetate (3H20) Sigma-Aldrich, Poole, UK S5889
Sodium Hydroxide Sigma-Aldrich, Poole, UK S5881
Sodium phosphate, dibasic Sigma-Aldrich, Poole, UK S9763
Tris-EDTA buffer Sigma-Aldrich, Poole, UK T-9285
4.1.5 Materials for GAG analysis (Section 4.3.7)
Material Supplier Code
0.5pm frit. Hichrom, Reading, UK HI-102
Acetronitrile Fisher Scientific, 
Loughborough, UK
A/0626/17
Boric acid VWR, Lutterworth, UK 27410
Chondroitin sulphate A Sigma-Aldrich, Poole, UK C9819
Chondroitin sulphate C Sigma-Aldrich, Poole, UK C4384
Ethanol Fisher Scientific, 
Loughborough, UK
E/0650DF/17
Hyaluronic acid Sigma-Aldrich, Poole, UK 17771
Hydrochloride acid Fisher Scientific, 
Loughborough, UK
H/1200/PB17
Partisil-5PAC column Capital analytical 5GM125
Sulphuric acid Fisons, Ipswitch, UK
Trizma base Sigma-Aldrich, Poole, UK T1503
Unsaturated Chondro-Disaccharide kit AMS Biotechnology 400571
A Di-disB Dextra Laboratories C3205
A Di-HA Dextra Laboratories C3209
4.2  E x p e rim e n ta l M ethods
4.2.1 Cell culture
Passage 3 anterior cruciate ligament fibroblasts were obtained by explanting 
the anterior cruciate ligaments from the left and right stifles of a sheep 
(Graystone Ltd, Hull, UK). Stifles were supplied on ice; within 24 hours of
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slaughter; from sheep approximately 10 months old. Each ligament was 
divided between two tissue dishes (92mm diameter x 17mm high). The cells 
were grown at 37°C with 5% CO2 in DMEM supplemented with penicillin- 
streptomycin, 200pM ascorbate-2-phosphate, 10% fetal calf serum (FCS) 
and MEM non-essential amino acid solution, which was changed three times 
a week. At the first passage the cells from the two ligaments were pooled, 
and transferred to T150 flasks.
MG63 cells (human osteoblast-like cell line) were grown using DMEM 
supplemented with penicillin-streptomycin, 1mM sodium pyruvate, 10% FCS, 
and MEM non-essential amino acid solution; ATDC-5 cells (mouse 
chondrocyte cell line (Atsumi et al. 1990)) were grown in DMEM 
supplemented with penicillin-streptomycin, ITS liquid media supplement, and 
10% FCS.
For the work described in Chapter 6, cells were frozen at passage 3 at 5-10 
million cells per cryotube in a mixture of 500pl FCS : 300pl DMEM : 200pl 
DMSO. For the work reported in Chapter 7 cells were not frozen prior to 
utilisation. Prior to cell culture, scaffolds were soaked overnight in media with 
the same composition as the media that would be used for subsequent cell 
culture on the scaffolds.
To seed the scaffolds with cells, the number of viable cells was counted 
using trypan blue and a haemocytometer. Seven hundred thousand viable 
cells were seeded by placing the cells and 3ml of media into a well of a 
serological 6 well plate (to limit cell attachment to the plate) followed by the 
scaffold. The 6 well plates were cultured at 37°C, and 5% CO2 on an orbital 
shaker set to rotate at 100rpm.
4.2.2 Preparation of regenerated silk fibroin
Regenerated silk fibroin was prepared by a method based on that of Nazarov 
et al (2004). Crepe silk was first degummed to remove any remaining sericin 
protein. Two grams of crepe silk were weighed out and cut into strips.
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Meanwhile 1L of 0.02M sodium carbonate was brought to boil. The strips of 
silk were placed into the boiling sodium carbonate solution and boiled for 30 
minutes. Then the strips were removed and washed thoroughly in reverse 
osmosis water (roH20; equivalent purity to double distilled water), and left to 
dry at room temperature (12-25°C).
Next the strips were dissolved in lithium bromide solution by placing them 
into 10ml of a 9.5M lithium bromide solution and leaving them for four hours 
to dissolve. To remove the lithium bromide, the solution was dialysised 
against roH20 . The solution was injected into a hydrated 3500 molecular 
weight cut off Slide-a-Lyzer cassette; then the cassette was placed into 2L of 
roH20 , which was changed after 2 hours, then changed a second time and 
left overnight. The resulting solution was then placed into a 100ml freeze 
dryer bulb, and frozen by rotating the bulb in liquid nitrogen until all the 
solution was frozen. The bulb was then placed onto the freeze dryer and 
freeze dried. For the work in Chapter 6, the regenerated silk fibroin (SF) was 
removed from the bulb and kept sealed in a sample tube at room 
temperature (15-25°C) until use. For the work in Chapter 7, the SF was used 
immediately after removal from the bulb.
4.2.3 Solubility of silk in aqueous organic acid solutions
In order to improve the connections between pores, aqueous organic acid 
solvents were considered to increase the solubility of salt, without increasing 
to the point that small salt crystals were completely dissolved. Formic acid, 
acetic acid and 1,1,1,3,3,3 hexafluoro-2-propanol (HFIP) were tested. 
Approximately 100mg of SF was weighed out, and the exact weight 
recorded. This weight was used to prepare solvent by mixing 4 volumes of 
roH20  to 1 volume of formic acid in a 15ml centrifuge tube to make a 20% 
v/v formic acid : water solvent; the volume of solvent made was determined 
to be the quantity required to dissolve all the SF to make a 5% w/v solution. 
This procedure was repeated changing the ratio of formic acid : water to 
make 40%, 60% and 80% v/v solutions. 10%w/v and 15%w/v concentrations 
of silk were also tested with 20%, 40%, 60% and 80% v/v solvents. Aqueous
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acetic acid and aqueous HFIP solvents were tested at 10%w/v SF with 20 - 
80% v/v acid solvents. Subsequently, the process was repeated with 
aqueous formic acid saturated with sodium chloride with 10 - 90% formic 
acid.
4.2.4 Scaffold preparation
First, SF was dissolved in either formic acid or 20% v/v formic acid to make a 
10% w/v solution; the solution was left overnight to allow the SF to 
completely dissolve. Initially, scaffolds were made with 0.3ml of this solution. 
This was pipetted into a PTFE mould with holes 15 mm diameter by 5 mm 
high, consisting of two plates: one plate with holes through to make the 
scaffolds, and a bottom plate that was bolted on to seal it. Then 0.6g of 
sodium chloride was added. Then scaffolds were left for 10 minutes, after 
this time they were covered with parafilm for 24 hours. After the parafilm was 
removed the scaffolds were left for a further 24 hours to allow the solvent to 
evaporate, at this point the bottom plate of the mould was removed and the 
scaffolds were left for a further 24 hours to allow all the solvent to evaporate. 
The scaffolds were then pressed out of the mould into methanol (MeOH) and 
left for 30 minutes prior to salt leaching. For the salt leaching process the 
scaffolds were left in roh^O for 24 hours changing the water four times. The 
process for regenerating silk and scaffold fabrication is outlined in Figure 4-1.
As the initial procedure did not produce scaffolds with replicable structures, 
several variations were tried. The variations on the method all involved 
changing the “Cast in mould using salt as a porogen step” in Figure 4-1.
In the original method (Method A), 0.3ml of 10% w/v silk solution was 
pipetted into the mould then 0.6g of salt was added and given 10 minutes to 
settle. In Method B the 0.6g of salt was placed in the mould prior to the 
addition 0.3ml of the 10% w/v silk solution. Method C was similar to method 
b, but 1g of salt was used in the place of 0.6g. Method D was another 
variation of Method B, the 0.6g of salt was placed in the mould followed by 
0.6ml of 5% w/v silk solution. In Method E, the 0.6g of salt was placed in the 
mould followed by 0.4ml of 7.5% w/v silk solution. Method F was a variation 
of Method A, immediately after the silk solution was added to the salt, a
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PTFE lid was placed on top of silk solution. Table 4-1 summarises these 
methods.
Disolve silk fabric in 
lithium bromide
Freeze dry silk 
solution
Cast in mould using 
salt as a porogen










Dialyse silk solution 
against water to 
remove lithium 
bromide
Figure 4-1 Outline of the process for regenerating silk and fabricating porous silk 
scaffolds
Table 4-1 The five different methods of silk scaffold fabrication with 20% v/v formic 
acid




% w/v Silk Teflon cover
A 0.6 Before 10 No
B 0.6 After 10 No
C 1 After 10 No
D 0.6 After 5 No
E 0.6 After 7.5 No
F 0.6 Before 10 Yes
To understand the effects of saturated silk solutions, scaffolds were also 
made with Method B with 40% and 80% formic acid saturated with sodium 
chloride.
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For FTIR analysis, scaffolds made with methanol coagulation were 
compared to scaffolds made without the use of methanol. For cell culture and 
porosity studies scaffolds were made with 0.05g of SF dissolved at either 
7.5% or 10% w/v in 20% v/v formic acid and compared to scaffolds made 
with 10% w/v silk dissolved in formic acid. These scaffolds were soaked in 
methanol for 30 minutes, then cut to 2mm height with the aid of a 2mm high 
polycarbonate guide. In addition, for Chapter 7, a hole punch was used to cut 
the scaffolds to 7mm diameter. Scaffolds for cell culture were autoclaved to 
ensure sterility, no changes in scaffold appearance were observed.
4.2.5 RGD decoration
To decorate the silk scaffolds with GRGDS peptide (Merck, Beeston, 
Nottingham), a solution of A/-(3-dimethylaminopropyl)-/\/-ethylcarbodiimide 
(EDC; 0.5mg/ml) and A/-hydroxysulfosuccinimide (NHS; 0.7mg/ml) was filter 
sterilised. Scaffolds were transferred to the EDC:NHS solution at a 
concentration of 1 scaffold per ml. After 15 minutes the scaffolds were 
washed with sterile roH20  and transferred to a sterile solution of GRGDS 
peptide (0.1 mg/ml) in PBS (pH6.5) for 2 hours. After two hours the scaffolds 
were washed twice with sterile roH20 .
4.3 Analytical methods
4.3.1 Scanning electron microscopy of silk scaffolds
For the first SEM session, silk scaffolds were removed from roH20 , cut in 
half, each half was placed into an Eppendorf tube and the lid of the tube was 
pierced. The eppendorfs were placed into a 100ml freeze dryer bulb then into 
a -80°C freezer for two hours to ensure that they were thoroughly frozen. For 
the subsequent sessions, whole scaffolds were placed into bijoux tubes with 
their lids pierced; then the tubes were placed into a polycarbonate chamber, 
which was transferred to -80°C for two hours. The bulb or chamber was then 
transferred to the freeze dryer and the scaffolds freeze dried overnight. The 
dry scaffolds were then frozen one at a time in liquid nitrogen, freeze
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fractured, mounted and gold coated for SEM. SEM was carried out with a 
JEOL JSM6310 scanning electron microscope.
4.3.2 Fourier transform infrared spectra of silk scaffolds
Fourier transform infrared (FTIR) spectroscopy can be used to characterise 
the crystalline structure of silk because the positions of three peaks shift due 
to hydrogen bonding when the structure changes from random coil to 
crystalline silk II (Ha et al. 2005). Silk scaffolds were oven dried, then frozen 
in liquid nitrogen and ground into a powder in a mortar and pestle. FTIR 
results from this powder suggested that it was contaminated with water, 
presumably gained during the freezing and grinding. So this powder was 
then freeze dried with 200pl roH20 added. Approximately two milligrams of 
powdered scaffold was added to 30mg of potassium bromide and pressed 
into a disk. FTIR spectra were measured on a Bruker Equinox 55 
spectrophotometer at a resolution of 4cm'1 averaging 100 scans.
4.3.3 Light microscopy and image analysis
To ensure that none of the scaffold was lost during the processing of slides 
for light microscopy, scaffolds were cut into half and embedded into 
Technovit 7100 after overnight fixation with 10% formal saline (VWR, 
Lutterworth, Leicestershire). Sections were cut to 5pm thickness and placed 
onto poly-Mysine coated slides. Slides were air dried then stained with 
Methyl Blue, washed in four changes of roH20, then air dried a second time, 
prior to covering with a coverslip and DPX mountant.
Images were analysed with the aid of macros in ImageJ 
(http://rsb.info.nih.gov/ij) that removed the background, split the image into 
red, green and blue channels, then selected the red channel, which was 
automatically thresholded, and recorded the fraction of black pixels in the 
thresholded image (see Figures 4-2 and 4-3 for an example). This fraction 
was used to calculate the porosity for each of the images analysed. For each
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scaffold 20 images were averaged, and for each type of scaffold 
measurements from 3 scaffolds were taken.
Figure 4-2 Example images for image analysis: left -  sample section, and right -  
background
Figure 4-3 Images from Figure 4-2 during processing for image analysis: (a) post­
background removal, (b) red channel of image (a), and (c) after thresholding.
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4.3.4 DNA quantification
To quantify DNA, scaffolds were rinsed twice with PBS, then the cells were 
lysed by placing the scaffolds in Tris-EDTA buffer, then freezing at -80°C. 
Following sample thawing DNA concentration was determined by using 
Picogreen. DNA standards were made from 10-1000ng/ml. One hundred 
microlitres of each standard or sample was pipetted into a well of a 96 well 
plate, and then 30pl of picogreen solution was added. Emission was read at 
520nm following excitation at 480nm. Standards were run in triplicate and 
samples in duplicate. Figure 4-4 shows a representative sample curve.
300
250 y = 25.052x - 7.5383 
R2 = 0.9942^  200 





Figure 4-4 Representative standard curve for DNA quantification
4.3.5 Papain digestion
For the work reported in Chapter 7 matrix quantification followed DNA 
quantification. Scaffolds were removed from the Tris-EDTA buffer and 
transferred to a microcentrifuge tube containing 0.5ml of papain buffer (see 
Appendix A) containing 0.5mg of papain. Samples were then transferred to a 
microcentrifuge tube heater (Grant QBT2) set to 60°C and left for 16 hours. 
Blank papain digests were run as above without scaffolds, i.e. 0.5mg papain 
in 0.5ml of papain buffer at 60°C for 16 hours. Samples were then stored at 
4°C prior to analysis
6 8
4.3.6 Hydroxyproline analysis
One hundred microlitres of papain digest was taken and 100pl of 1.18 
specific gravity hydrochloric acid was added to form an approximately 6M 
solution of hydrochloric acid to hydrolyse the collagen amino acids. This 
solution was heated to 110°C in sealed eppendorfs in a Grant QBT2 heater. 
To ensure that the eppendorfs remained sealed their lids were weighted 
down with a large steel block. After three hours the heater was switched off, 
and allowed to cool.
Once cool the pH was adjusted to 6.5 with 6M sodium hydroxide. The 
samples were freeze dried, and dissolved in 200pl of roH20. Standards from 
0-30pg/ml were prepared with l-hydroxyproline and hydroxyproline assay 
buffer (Appendix A). Fifty microlitres of standard or sample were aliquoted 
into wells of a 96 well plate, and 100pl of oxidising solution added to each 
well. Samples were run in duplicate, and standards were run in triplicate. The 
plate was shaken for 5 minutes, then 100 pi of Ehrlich’s reagent (Appendix 
A) was added. After the plate was incubated at 60°C in an oven for 45 
minutes, absorbance was read at 570nm. Figure 4-5 shows a representative 
sample curve from this procedure.
0.8 -1 y =  0 .0 1 7 X  +  0 .0 5 4 1  
R 2 =  0 .9 7 3 3g 0.6 -
0  T -  1---------------------- 1---------------------- 1-----------------------1
0  1 0  2 0  3 0  4 0
microg/ml
Figure 4-5 Representative standard curve for hydroxyproline analysis
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4.3.7 Analysis of glycosaminoglycans
HPLC system
The HPLC system consisted of: a Shimadzu SCL-10AVP system controller, 
a Shimadzu SPD-10AWP UV-vis detector, a Shimadzu SIL-10ADVP auto 
injector, and a Shimadzu LC-10ADVP pump, a Shimadzu DGU-14A 
degasser, connected to a PC running Shimadzu Class VP V5.032 software 
for data logging and analysis. A Whatman Partsil-5 PAC column (5pm, 
250mm x 4.6mm i.d) was protected by a 0.2pm frit.
Glycosaminoglycan preparation for digestion
A 100pl sample of papain digest was taken and the glycosaminoglycans 
were precipitated by adding 700pl of ethanol and cooling at -20°C for four 
hours (Skandalis et al. 2003). The precipitate was pelleted by centrifuging for 
10 minutes at 13,400g in a MSE micro-centaur centrifuge. The supernatant 
was discarded, and the pellet was dissolved in 40pl of roH20. Alternatively, 
for digestion of commercially purified glycosaminoglycans, chondroitin 
sulphate A or C, or hyaluronic acid was dissolved in roH20 at 1pg/pl, and 
40pl of this solution was used.
Glycosaminoglycan digestion
Either 15 pi of 250pM Tris-HCL (pH 8.0) (Zebrower et al. 1991) or 20pl of 
100pM Tris-acetate (pH 8.0) (Koshiishi et al. 1998) were added to the 40 pi 
of glycosaminoglycan/sample. The desired concentration of enzyme was 
dissolved in 20pl of roH20 (0.025U for quantifying ligament matrix 
production), and the samples were incubated at 37°C for the desired period 
(16 hours for ligament matrix characterisation). After digestion 300pl of 
ethanol was added and the solution was kept for four hours at -20°C. The 
samples were then centrifuged at 13,400g in a MSE micro-centaur centrifuge 
for 10 minutes to pellet any undigested glycosaminoglycans. The 
supernatant was kept and evaporated until the samples were dry.
Glycosaminoglycan standard preparation
The standards (A Di-OS, A Di-4S, A Di-6S, A Di-diSE A Di-diSo, and A Di-triS 
from the unsaturated chondro-disaccharide kit, along with A Di-diSe and A
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Di-HA) were made into stock solutions at 1|jg /1|jl in roh^O. To use the 
standards, the desired amount was added to a microcentrifuge tube, and 
then dried to remove water.
HPLC of samples
The dry samples were taken and dissolved in 500pl of the mobile phase of 
48% acetonitrile, 14% methanol and 38% aqueous buffer (0.5M Tris, 0.1 M 
boric acid, 23.4mM sulphuric acid, adjusted to pH8.0 with HCI). The 
standards for quantifying glycosaminoglycans following papain digestion 
were made by dissolving the dried standards in 500pl of mobile phase, the 
dissolving the dried supernatant from a blank papain digestion in the same 
500pl. The HPLC system was operated at a flow rate of 0.7ml/min, and 
samples were detected by absorbance at 229nm (Zebrower et al. 1991). For 
Chapter 7, all dissacharides other than ADi-HA (see Figure 2-7) were added 
to calculate total chondroitin sulphate (CS).
4.4 Statistics
For Chapter 6, one or two way analysis of variance was used to determine 
statistical significance dependent on the number of independent variables. 
Where data was not homogenous, it was transformed by taking the square 
root (cell attachment) or the reciprocal (osteochondral). Tukey HSD was 
used as a post hoc test to better understand the nature of any significant 
differences.
For Chapter 7, factorial ANOVA was used to determine statistical 
significance. As there were four dependent variables in this experiment a 
Bonferroni correction was applied to the alpha level to reduce it from 0.05 to
0.0125. Post hoc analysis was carried out used the Games-Howell test, 
where the ANOVA indicated there were significant differences. Dependent 
variables from different days were correlated with Pearson’s correlation. 
Statistics are discussed further in Chapter 3.
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5 Implementation of HPLC GAG analysis
5.1 Introduction
5.1.1 Glycosaminoglycans as biomarkers
In order to understand better how to engineer ligament, biomarkers need to 
be identified that will enable quantitative analysis of ligament engineering 
processes to determine the strengths and weaknesses of those processes. 
These biomarkers should ideally possess four characteristics:
1. longitudinal data should be available to enable comparison of the 
engineered ligament with tissue at several stages of development;
2. the levels of the biomarker should diverge in health and disease;
3. the biomarker should be relevant to the function of the tissue;
4. the biomarker should not confound multiple tissues (especially 
important when cells are being differentiated).
Not all biomarkers will possess all four properties, but tissue engineering 
should aim to develop panels of biomarkers for each tissue of interest that 
combine these properties. An important example of how failure to consider 
these properties can cause problems is highlighted by the recent work on 
chondrogenesis showing that BMSCs constitutively express aggrecan, and 
that type X collagen is sometimes produced by BMSCs undergoing 
chondrogenesis before they produce type II collagen (Mwale et al. 2006). 
This means that researchers have potentially been confounding normal 
BMSC behaviour with differentiation of hypertrophic cartilage.
As discussed in Section 2.1, mRNA of collagen types I, II & III, glycoproteins 
(bone sialoprotein, tenascin-C, laminin and fibronectin) and proteoglycans 
(aggrecan, decorin and biglycan) have been as used biomarkers when 
engineering ligament or tendon (Cristino et al. 2005; Moreau et al. 2005a; 
Sahoo et al. 2006). A major limitation of this approach is that mRNA does not 
necessarily result in protein synthesis, for instance, post-translational failure 
of collagen lysine hydroxylation by prolyl-4-hydroxylase results in collagen 
being retained in the endoplasmic reticulum (Walmsley et al. 1999).
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Figure 5-1 Glycosaminoglycan levels against mass-average fibril diameter: (a) 
hyaluronic acid, (b) chondroitin sulphate, and (c) dermatan sulphate. Plotted from 
data from Parry et al (1982), excludes data points for Dupuytren’s contracture.
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The current biomarkers for ligament suffer from several other limitations: 
ligament differentiation is indicated by a higher ratio of collagen I I I : collagen I 
than skin or tendon (Altman et al. 2002b), but fibrosis potentially increases 
the collagen 111:1 ratio (el Nabout et al. 1989). Bone sialoprotein, collagen II 
and aggrecan are potentially useful as negative markers of stem cell 
differentiation; their sustained presence would suggest that the stem cells 
are not differentiating correctly. For the other biomarkers, the problem is one 
of limited information about how much of the biomarker should be present at 
any given stage of ligament engineering. Perhaps the most extensively 
studied of these biomarkers is decorin. Both increased and decreased 
decorin levels can result in fibrotic changes (Reed and lozzo 2002), but there 
is not the longitudinal data necessary to specify required levels of decorin 
during ligament engineering. It would be very useful to have a biomarker for 
ligament engineering with extensive longitudinal data.
The literature review for this work identified glycosaminoglycans as useful 
biomarkers for ligament engineering. The key paper from this literature 
review provides longitudinal data for glycosaminoglycan levels across 
several species in both skin and tendon (Parry et al. 1982). This paper 
showed a consistent pattern of glycosaminoglycan levels as the collagen 
fibrils matured (Figure 5-1). Thin, immature fibrils contain mostly hyaluronic 
acid, with some chondroitin sulphate. As the fibrils mature and grow laterally 
the percentage of glycosaminoglycan that is hyaluronic acid drops. 
Hyaluronic acid is replaced by chondroitin sulphate and dermatan sulphate. 
Above fibril diameters of about 200nm, the percentage of chondroitin 
sulphate begins to drop and dermatan sulphate becomes the dominant 
glycosaminoglycan. These results are supported by work from a different 
group that identified a strong relationship between age and 
glycosaminoglycan levels rat tail tendon (Scott et al. 1981). This work 
showed a rapid drop of hyaluronic acid levels, and an increasing percentage 
of glycosaminoglycan as dermatan sulphate (Figure 5-2), although the 
method used appears to underestimate the amount of hyaluronic acid 
compared to other work on rat tail tendon (Aukland 1991; Aukland et al. 
2001; Parry et al. 1982), and human rotator cuff tendons (Riley et al. 1994);
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this might be due to a the cetylpyridinium chloride precipitation method used 
in the Scott et al (1981) paper not precipitating all the hyaluronic acid (Huey 
et al. 1990). In addition, the Scott et al (1981) paper shows that levels of both 
sulphated glycosaminoglycans and hyaluronic acid drop as the tendon ages. 
Unfortunately there is no longitudinal work on glycosaminoglycan levels in 
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Figure 5-2 Percentage of total glycosaminoglycan content as hyaluronic acid (HA), 
chondroitin sulphate (CS) and dermatan sulphate (DS) against time in rat tail tendon 
using data plotted from Scott et al. (1981).
Glycosaminoglycans meet the other requirements of an ideal biomarker at 
least in part. It has been shown the rotator cuff tendonitis results in elevated 
levels of hyaluronic acid, chondroitin sulphate and dermatan sulphate (Riley 
et al. 1994). This suggests that abnormal glycosaminoglycan levels might be 
common to fibrotic conditions beyond tendonitis, although there is no 
published work to confirm or deny this.
There is some evidence for glycosaminoglycans playing an important role in 
ligament and tendons. Hyaluronic acid based biomaterials appear to 
enhance the differentiation of BMSCs towards a ligament fibroblast 
phenotype (Cristino et al. 2005); hyaluronic acid also appears capable of
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improving tendon healing (Yagishita et al. 2005). These results fit with a role 
for hyaluronic acid in initiating ligament development and repair. Chondroitin 
sulphate has been shown to be a better predictor of structural mechanical 
properties (failure load, and stiffness) of rat tail tendon than fibril diameter, 
fibril area, or hydroxyproline content (Robinson et al. 2004a); similarly 
chondroitin sulphate per unit mass of tendon is a better predictor of material 
properties (failure stress, and modulus) than fibril diameter, fibril area, or 
hydroxyproline content per unit mass (Robinson et al. 2004a). This strongly 
suggests that chondroitin sulphate levels are associated with the mechanical 
function of tendon, and probably ligament.
Glycosaminoglycan levels vary from tissue to tissue, making it them 
potentially useful markers of differentiation. Cartilage contains much more 
sulphated glycosaminoglycan than ligament (Price et al. 1996), and 
sulphated glycosaminoglycan levels are widely measured as an useful 
biomarker in cartilage tissue engineering (Dickinson et al. 2005). In bone 
glycosaminoglycans are catabolised prior to matrix mineralisation (Baylink et 
al. 1972), whilst synovium has high levels of hyaluronic acid (Price et al. 
1996). These differences between musculoskeletal tissues show that 
glycosaminoglycans are useful as biomarkers to help to distinguish 
differentiation pathways.
5.1.2 Options for GAG analysis
The simplest methods for quantifying glycosaminoglycans rely on their 
differing physicochemical properties. Several methods exist to precipitate 
specific glycosaminoglycans at different concentrations of solvents or salts, 
for instance using acetone (Volpi 1994), alcian blue in combination with 
guanidine-HCL (Bjornsson 1993), or cetylpyridinium chloride (Cleland and 
Sherblom 1977). These methods have the advantage of simplicity, but more 
recent techniques provide more information about the precise composition of 
the glycosaminoglycans. There are also questions about whether all these 
tests precipitate all the glycosaminoglycan of interest (Huey et al. 1990).
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Perhaps the most widely used test for glycosaminoglycans in tissue 
engineering is to quantify sulphated glycosaminoglycans with 
dimethylmethylene blue (Dickinson et al. 2005). The advantage of this 
technique is its simplicity and speed. The disadvantages are that it does not 
quantify the separate glycosaminoglycan disaccharides or distinguish 
chondroitin sulphate, dermatan sulphate, keratin sulphate, or heparin from 
each other, and by definition it does not detect unsulphated 
glycosaminoglycans.
More powerful techniques use enzymes to break glycosaminoglycans into 
disaccharides. The most widely used enzyme is chondroitinase ABC, which 
has the ability to degrade hyaluronic acid, chondroitin sulphate and dermatan 
sulphate into disaccharides (Figure 2-7 shows the structure of these 
dissacharides). Heparin, heparan sulphate and keratin sulphate cannot be 
analysed with the use of this enzyme, but for ligament engineering the most 
interesting glycosaminoglycans are those that can be broken down by 
chondroitinase ABC. A variation on using chondroitinase ABC, is to use 
chondroitinase AC and chondroitinase B separately, this allows more precise 
quantification of the levels of dermatan sulphate (Lee et al. 2004a).
One of the most powerful of all the glycosaminoglycan analysis techniques is 
fluorophore-assisted carbohydrate electrophoresis. This combines gel 
electrophoresis with a fluorescent probe following enzymatic digestion and 
chemical modification of the disaccharides (Calabro et al. 2000). The major 
advantage of this technique over the other techniques considered is that the 
non-reducing termini of chondroitin sulphate can also be quantified allowing 
estimation of the average length of chondroitin sulphate chains.
The final option considered was high performance chromatography (HPLC) 
which uses the HPLC columns to separate the glycosaminoglycans, which 
are then detected and quantified by either their absorbance of UV light at 
approximately 230nm (Imanari et al. 1996), or by coupling them to a 
fluorophore, exciting the fluorophore and then measuring the emission (Volpi 
2000). Of these two alternatives, fluorescence is the more sensitive
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technique (Imanari et al. 1996), but is limited by the availability of fluorescent 
detectors. The alternative is to use UV detection. One of the limitations of 
using UV detection is that most of the published methods do not separate all 
the disaccharides produced by chondroitinase ABC (Imanari et al. 1996), a 
particular problem is the separation of the unsulphated chondroitin sulphate 
disaccharide from the hyaluronic acid as the are isomers (Figure 2-7). Two 
methods were considered in more detail (Murata and Yokoyama 1987; 
Zebrower et al. 1991) as they separated hyaluronic acid from chondroitin 
sulphate, and quantified more of the chondroitin sulphate disaccharides than 
other methods (Imanari et al. 1996). Of these two methods the Zebrower et 
al (1991) method results better separated peaks, so this was selected as the 
method to implement. A minor issue is that the ADi-UA2S and ADi-6S 
disaccharides run at almost the some time; this is of limited importance as 
ADi-UA2S is typically much rarer than ADi-6S, and both are monosulphated 
chondroitin sulphate disaccharides.
5.1.3 Outline of experimental work
It was decided to modify the HPLC method used by Zebrower et al (1991) to 
determine GAGs in tissue engineering ligaments due to the availability of the 
appropriate equipment. This method has previously been to quantify 
glycosaminoglycans in chicken tendons (Hae Yoon et al. 2003), but no 
record exists of it being used for analysis of constructs produced by tissue 
engineering. There are two issues to resolve: first, the enzymatic digestion 
protocol used by Zebrower et al (1991) used 0.5U of chondroitinase ABC for 
16 hours per sample. This is prohibitively expensive for analysing large 
numbers of samples. Second, the analysis needs to be coupled to a method 
for digesting the construct suitable for other quantitative analyses. The 
review of glycosaminoglycan analysis by HPLC carried out by Imanari et al. 
(1996) states that 0.05U of chondroitinase ABC for three hours is sufficient to 
digest 100pg of glycosaminoglycan. Therefore the first task will be to 
determine how different amounts of chondroitinase ABC affect the digestion 
of glycosaminoglycans separated with the Zebrower et al. (1991) method. 
The second task is to couple the glycosaminoglycan digestion to a method
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for digesting tissue engineered constructs. Papain digestion is commonly 
used to digest constructs (Hoemann et al. 2002), so this chapter will attempt 
to couple papain digestion to HPLC analysis of glycosaminoglycans.
5.2 Materiais and Methods
Methods for papain digestion are detailed in Section 4.3.5. Methods for 
HPLC analysis of glycosaminoglycans are detailed in Section 4.3.7.
5.3 Results
This section details the results found when establishing that the HPLC 
protocol could correctly separate disaccharides; that glycosaminoglycans 
could be digested into their constituent disaccharides, and that 
glycosaminoglycans could be extracted with papain without affecting the 
results.
5.3.1 Initial studies -  to obtain reproducible separation of peaks
Initially, it was decided to digest chondroitin sulphate A and C to attempt to 
replicate the separation of the peaks published in Zebrower et al (1991). As 
the original paper used a quantity of enzyme that would have been 
prohibitively expensive, digestions were tested with much less enzyme, as 
complete digestion was possible with much less enzyme (Koshiishi et al. 
1998). Figure 5-3 shows the results of digesting chondroitin sulphate A with 
0.05U and 0.0005U of chondroitinase ABC for 16 hours. The identity of these 
peaks was based on their running order, this order was later confirmed by 
running disaccharide standards on the column (Figure 5-5). These results 
show that the largest peak is ADi-4S, the major component of chondroitin 
sulphate A. Some of the peaks appear to be different sizes, but this is 
complicated by the rising baseline. If the peaks are different sizes, it 
suggests that amount of enzyme affects the results of the digestion.
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Figure 5-3 Chromatograms of chondroitin sulphate A digested with 0.05U and 0.0005U 
of chondroitinase ABC
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Figure 5-4 Chromatograms of chondroitin sulphate C digested with 0.05U and 0.0005U 
of chondroitinase ABC
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The experiment was repeated with chondroitin sulphate C, digested for 16 
hours with 0.05U and 0.005U of chondroitinase ABC (Figure 5-4). This time 
the largest peak is the ADi-6S, the principal component of chondroitin 
sulphate C. Again the peaks appear to be different sizes with different 
quantities of enzyme. In this case it appears to be a shift from ADi-4S to ADi- 
OS with the change from 0.005U to 0.05U. This suggests that amount of 
enzyme affects the results of the digestion.
Finally, a set of commercial standards was run to confirm that the retention 
times of the disaccharides were repeatable (Figure 5-5). This showed that 
the retention times were very similar; the small differences are probably 
attributable to subtle differences between the runs (e.g. room temperature, 
variations between batches of mobile phase).
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Figure 5-5 CS disaccharide standards compared to chondroitin sulphate A and 
chondroitin sulphate C runs
5.3.2 Optimisation of digestion protocol
As the first runs showed that changing the concentration of enzyme affected 
the size of the peaks, it was decided to investigate this phenomenon further. 
For these experiments 0.025U of enzyme were used with 40pg of 
glycosaminoglycan. The digestion buffer was varied between the 250pM
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Tris-HCI (pH 8.0) used by Zebrower et al. (1991) and the 100pM Tris-acetate 
(pH8.0) used by Koshiishi et al (1998).
The results of digesting chondroitin sulphate C for 0.5, 1, 2, 4, and 16 hours 
in Tris-acetate buffer showed that there were strong peaks after 0.5 hours 
digestion (Figure 5-6a). These peaks strangely disappeared after 1 and 2 
hour digestions (Figures 5.6b & c), only to reappear after 4 hours and remain 
at 16 hours (Figures 5.6d & e). The 0.5 hour peaks were the largest peaks.
A similar pattern occurs when digesting chondroitin sulphate C in Tris-HCI 
buffer. The peaks are present at 0.5 hours (Figure 5-7a), then disappear at 1 
hour and 2 hours (Figures 5-7b & c). The peaks reappear after 4 hours 
diggestion (Figure 5-7d), and remain at 16 hours digestion (Figure 5-7e). The 
largest peaks occur at 0.5 hours, although the falling baseline caused 
difficulty in estimating the size of the peaks at 16 hours
The pattern changes subtely when hyaluronic acid is digested in Tris-acetate 
buffer. The peak for the appears after 0.5 hours digestion (Figure 5-8a), the 
peaks disappear at 1 and 2 hours digestion (Figure 5-8b), and remerge after 
4 hours digestion. The peak remains at 16 hours (Figure 5-8c), although 
interference from the baseline (Figure 5-9) makes it difficult to determine the 
peak’s exact area. Peaks from the digestion of chondroitin sulphate appear 
with the hyaluronic acid peaks (Figure 5-8).
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Figure 5-6 Chondroitin sulphate C digested in Tris-acetate buffer for: (a) 0.5 hours, (b) 
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Figure 5-7 Chondroitin sulphate C digested in Tris-HCI buffer for: (a) 0.5 hours, (b) 1 
hour, (c) 2 hours, (d) 4 hours, and (e) 16 hours.
Finally, the results from digesting hyaluronic acid in Tris-HCI buffer are 
slightly different to the previous results, prior to four hours digestion there are
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no peaks from the digestion of hyaluronic acid, the only peaks present are 
chondroitin sulphate peaks at 0.5 hours (Figure 5-10a). After 4 hours 
digestion the only peak present is the peak from the digestion of hyaluronic 
acid (Figure 5-10c). This peak remains after 16 hours digestion and has a 
higher area (Figure 5-1 Od).
Correlating the results from digesting with Tris-actetate and Tris HCI reveals 
that the two digestions give similar, but not identical results (Figure 5-11).
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Figure 5-8 Digestion of hyaluronic acid in Tris-acetate buffer for (a) 0.5 hours, (b) 2 
hours, and (c) 16 hours
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Figure 5-9 Detailed view of the ADi-HA peak produced by digesting hyaluronic acid in 
Tris-acetate buffer for 16 hours.
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Figure 5-10 Digestion of hyaluronic acid in Tris-HCI buffer for (a) 0.5 hours, (b) 2 
hours, (c) 4 hours, and (d) 16 hours
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Figure 5-11 Comparison of the absorbance following digestion of hyaluronic acid and 
chondroitin sulphate for 0.5,1, 2, 4 and 16 hours using Tris-acetate or Tris-HCI buffer
5.3.3 HPLC following papain digestion
The last question to be answered was whether digesting samples with 
papain would affect the analysis. To do this, blank papain digestions were 
run (i.e. papain digestion without a substrate) and then treated as a sample 
and digested with 0.025U of chondroitinase ABC in Tris-HCI buffer for 16 
hours. The results showed that papain resulted in noise following the longer 
solvent front that would overlap with the disaccharides (Figure 5-12).
The solution to this problem was to run the disaccharide standards dissolved 
in the solution resulting from a blank papain digestion to create a set of 
standards that took account of the way that papain would elevate the reading 
for several of the disaccharides. Standards of ADi-HA, ADi-OS, ADi-6S, ADi- 
4S, ADi-diSD, ADi-diSB, ADi-diSE, and ADi-triS were made at concentrations 
of 1, 2, 4, and 8ng/pl by adding them to blank papain digestions processed 
with chondroitinase ABC. This approach resulted in high R2 values for the 
standards, with all but one standard having R2 values over 0.98, and the one 
exception being above 0.95 (Table 5-1 and Figure 5-13). The ADi-triS peak 
was not detected at the 1 and 2ng/pl levels.
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Table 5-1 Correlation coefficients for disaccharide standards
5.4 Discussion
5.4.1 Sensitivity and repeatability
These results show that it is possible to modify the separation procedure 
used by Zebrower et al. (1991) to allow quantification of glycosaminoglycan 
disaccharides as an outcome measure for tissue engineering. Using a more 
up-to-date chromatography system appears to increase the sensitivity of the 
technique to the point where as little as 20ng of disaccharide can be 
detected on each injection (or 80ng for ADi-triS). This is almost an order of 
magnitude more sensitive than achieved by Zebrower et al. (1991). The 
retention times appear consistent from run to run, although they fluctuate 
slightly with temperature, and change slightly when the mobile phase is 
changed.
The main problems appear to be associated with the digestion protocol. 
Changing the concentration of enzyme changes the area of the disaccharide 
peaks. More surprisingly, the digestion time has a strange effect on the size 
of the peaks. Peaks are detectable after 0.5 hour digestions, but not 1 or 2 
hours digestion under the same conditions. Then the peaks reappear after 4 
hours digestion and remain after 16 hours digestion.
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5.4.2 Issues with chondroitinase digestion
There is a possible explanation for the changes in the relative sizes of the 
peaks. The bacterium, Proteus vulgaris, which produces chondroitinase ABC 
also produces chondrosulphatases (Dodgson and Lloyd 1957). These are 
enzymes that remove the sulphate groups from chondroitin sulphate. If the 
chondroitinase ABC was contaminated by some residual 
chondrosulphatases then this would explain why there was a shift from the 
sulphated disaccharides to the non-sulphated disaccharides with more 
enzyme. More enzyme would result in more contaminating 
chondrosulphatases, resulting in the removal of more sulphate groups from 
the chondroitin sulphate disaccharides.
Another result that needs to be understood is the difference between the 
digestion of hyaluronic acid and the digestion of chondroitin sulphate. 
According to the literature, hyaluronic acid is degraded much slower than 
chondroitin sulphate (Yamagata et al. 1968). Unfortunately, there is little 
consensus as to the correct protocol for complete hyaluronic acid digestion: 
Yamagata et al (1968) reports complete digestion of hyaluronic acid after 5 
hours digestion of 20pg with 0.008U of enzyme for two hours, followed by the 
addition of 0.15U for the last three hours (although the change of the slope of 
the curve suggests that the digestion was complete long before the three 
hours ended).Yamagata et al (1968) found that the initial rate of reaction for 
hyaluronic acid is 2% of that for chondroitin sulphate A or C. Koshiishi et al 
(1998) found complete digestion of 2 pg hyaluronic acid with 0.025U of 
enzyme in one hour. Imanari et al (1996), in their review of HPLC procedures 
for quantifying glycosaminoglycans, suggest that for up to 100pg of 
glycosaminoglycan 0.05U of chondroitinase ABC for three hours is sufficient.
The chondroitin sulphate peaks occurring in the hyaluronic acid digestion are 
presumably due to chondroitin sulphate being a contaminant of the 
commercial hyaluronic acid used.
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The more disconcerting problem is that of the disappearance of the peaks at 
one and two hours. All the samples were prepared at the same time, using 
the same reagents so differences between reagents on the other runs are 
not a possible explanation. The most likely explanation is that another 
enzyme is contaminating the digestion. The most likely explanation is that it 
contains a (3-glucuronidase, which is capable of digesting the disaccharides 
further. Such enzymes are known to be produced by other chondroitinase 
producing bacteria, such as Aeromonas sp. 83 (Kitamikado and Lee 1975), 
and Flavobacterium heparinum (Suzuki et al. 1968), although this has not 
been reported for Proteus vulgaris. The strange disappearance and 
reappearance of the peaks might be explained if the (3-glucuronidase was 
affected by product inhibition.
5.4.3 Papain digestion
The problem of the papain digestion adding noise to the HPLC analysis 
appears to be soluble by running the standards on top of a blank papain 
digestion. This approach might reduce the sensitivity of the assay, but this 
approach, combined with more modern chromatography equipment still 
results in a technique that is roughly an order of magnitude more sensitive to 
most disaccharides than the published technique of Zebrower et al. (1991).
5.4.4 Current solutions
The major problem appears to be the presence of contaminating enzymes. 
This appears to vary from batch to batch of the enzyme, the first batch of 
enzyme used behaved as if it were contaminated by a chondrosulphatase; 
the second batch behaved as if contaminated by a p-glucuronidase. As the 
influence of the putative p-glucuronidase appears to be limited at 16 hours 
with 0.025U of chondroitinase ABC with tris-HCI buffer, these digestion 
conditions will be used. As the samples will all undergo the same treatment 
by the same batch of enzyme, it should be possible to compare them. To 
control for the effects of chondrosulphatases, the data for the chondroitin 
sulphate disaccharides will be pooled. The principal downside to this
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approach is a loss of sensitivity, which can be mitigated by using large 
sample sizes.
5.4.5 Possible future solutions
In order to get as much sensitivity as possible, the problems with the 
enzymes would be better by preventing these unwanted digestions. Two 
options are possible: the first is that enzymes could be inhibited by specific 
inhibitors, for instance chondrosulphatase activity can be inhibited with 
sodium fluoride without affecting the activity of chondroitinase ABC (Dodgson 
and Lloyd 1957). The other options would be to compare chondroitinases 
from different suppliers to identify one with minimal contamination, or to 
further purify the enzyme before use.
Once these problems have been solved, another problem is identifying the 
best protocol to isolate the glycosaminoglycans from the scaffold. Papain 
was chosen for this work as it is widely used, but perhaps other enzymes 
would work better in conjunction with this HPLC assay and not produce the 
peaks associated with blank papain digests. An alternative might be to use 
chaotropic agents to recover the ECM components, guanidine hydrochloride 
followed by guanidine thiocyanate had been tried with engineered cartilage, 
but it was necessary to use papain subsequently to digest all the 
glycosaminoglycans (Hoemann et al. 2002).
Finally, it might be possible to achieve greater sensitivity by using fluorescent 
probes if the equipment were available. This might also reduce the noise 
from the papain digest as fluorophores have been identified that respond 
with a much stronger emission in the presence of disaccharides than 
potential contaminants (Imanari et al. 1996).
5.5 Conclusions
In conclusion, it is possible to replicate the separation achieved by Zebrower 
et al (1991). With a more modern chromatography system this technique is
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roughly an order of magnitude more sensitive, in spite of the need to run the 
standards on top of a blank papain digestion. The sensitivity is limited by the 
unwanted side effects of the enzymatic digestion. For this project, these side 
effects will be mitigated by using a large sample size, and pooling the 
chondroitin sulphate disaccharide results. In the future, it might be possible 
to eliminate these side effects by inhibiting them, or by identifying a better 
source of chondroitinase.
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6 Control of Pore Structure from film-like to fibrous 
in Porous Silk Scaffolds
6.1 Introduction
6.1.1 Silk fibroin as a biomaterial for tissue engineering
Porous silk fibroin (SF) scaffolds are promising biomaterials for tissue 
engineering. Recent work has shown that they are a promising material for 
growing cartilage in vitro (Wang et al. 2005b), and bone in vitro and in vivo 
(Kim et al. 2005a; Meinel et al. 2006). One of the major advantages of silk 
over other biomaterials is that a lot more is understood about how the body 
reacts to silk due to the extensive use of silk sutures, allergy to silk is 
normally a response to sericin (Kurosaki et al. 1999), a protein that can be 
easily removed by thorough degumming (Altman et al. 2003). Allergy to the 
major remaining proteins is rare, but not unknown (this might be caused by 
sensitisation to sericin) (Kurosaki et al. 1999). The evidence from silk sutures 
is that silk causes a mild inflammation response, although suture structure 
might be playing a role (Altman et al. 2003). When implantation of SF films 
was compared to implantation of collagen and poly-lactic acid films, the SF 
films caused a milder inflammatory reaction than the other films (Meinel et al. 
2005). As SF is a protein it will be broken down into peptides, which will be 
less problematic than the acids released by the hydrolysis of poly-lactic and 
poly-glycolic acids. Silk fibroin is also a very thermally stable protein, 
intramolecular and intermolecular hydrogen bonds are broken between 150 
and 180°C, then the silk filament begins to gradually lose weight at 175 °C 
(Nakamura et al. 1994). These properties allow silk to be safely autoclaved.
6.1.2 Effects of pore size on tissue engineering
Three of the important variables in controlling the behaviour of cells grown 
upon scaffolds are pore size, pore structure, and porosity. When 
regenerating musculoskeletal tissue there appears to be a range of pore
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sizes that are ideal for encouraging good tissue formation, although it is not 
clear whether differences in the optimal pore size range found in different 
experiments reflect differences in the behaviour of different types of 
connective tissue cell, differences between biomaterials or different 
experimental set ups. This section will focus on the effect of pore size in 
bone and cartilage engineering; the role of pore size in connective tissue 
engineering will be discussed further in Chapter 7.
When regenerating bone in vivo there is a recommendation for the pores to 
be at least 300pm to allow good vascularisation, below this pore size the new 
tissue becomes more fibrous (Hulbert et al. 1970; Karageorgiou and Kaplan 
2005) (although pore size does not appear to be an important variable under 
non-load bearing conditions (Itala et al. 2001)). The effects of pore size on 
articular cartilage growth are less clear. Traditionally, it has been thought that 
small pores (~20pm) to limit nutrient supply and/or promote cell-cell contact 
were advantageous (Woodfield et al. 2005). Recently, positive results have 
been achieved by both: dynamic pore reduction, in which large pores (to 
promote cell seeding) are contracted by the cells to form small pores to 
encourage chondrogenesis, resulted in elevated levels of collagen II and a 
more chondrocytic morphology of the cells (Vickers et al. 2006). In contrast a 
very different scaffold with a gradient of pores designed to mimic the 
superficial, middle, and lower zones was given very large pores in the medial 
and deep zones, intended limit cell-cell contact and cell-matrix ratio, showed 
increased collagen II accumulation compared to superficial zone with smaller 
pore sizes (200pm) and cellular organisation reminiscent of the zones of 
immature cartilage (Woodfield et al. 2005).
6.1.3 Effects of porosity and pore structure on tissue engineering
Porosity has primarily been of interest due to its potential to control mass 
transfer of nutrients to cells. Higher porosity generally results in better bone 
formation in vivo presumably due to better vascularisation (Karageorgiou and 
Kaplan 2005); although some in vitro studies show increased osteogenesis 
with lower porosity, and better cell proliferation with higher porosity
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(Karageorgiou and Kaplan 2005). For cartilage engineering, a multivariate 
study found that pore structure can be a very important variable. It was found 
that scaffold structure (mesh vs. sponge) was a more important determinant 
of chondrogenesis in vitro than scaffold material (benzylated hyaluronan vs. 
polyglycolic acid) when comparing highly porous (>90%) biomaterials grown 
in either Petri dishes or rotating wall bioreactors (Pei et al. 2002). A more 
recent study has shown that, surprisingly, a pore structure with less well 
connected pores appeared to maintain higher chondrocyte viability when 
implanted into osteochondral defects (Emans et al. 2006). It is striking that 
there has been very little work comparing the effect of two or more scaffold 
fabrication variables on tissue engineering outcomes despite the importance 
of this work for our ability to rationally develop better biomaterials.
6.1.4 Porous silk scaffolds
There have been four main methods used to make porous silk scaffolds, 
these methods have recently been reviewed (Wang et al. 2006). The first of 
these is silk hydrogels; these are typically made by changing the chemical 
environment of the silk in solution, for instance, by changing pH, or 
evaporating water. Hydrogels have been used to promote the healing of 
critical sized cancellous bone defects (Fini et al. 2005) and for cartilage 
tissue engineering (Kim et al. 2004). One limitation of this approach is that 
only hydrogels with relatively small pores can be prepared.
The second approach is to make non-woven mats of microfibres or 
nanofibres (Min et al. 2004; Unger et al. 2004). Microfibres are made by 
spinning silk solutions into a coagulant bath (Urn et al. 2004), whereas 
nanofibres are made by electrospinning, where a silk solution is forced out 
through a charged syringe needle, and attracted to a metal plate carrying the 
opposite charge to the needle (Min et al. 2004). Nanofibres are of great 
interest to tissue engineering for their unique properties such as their very 
high specific surface area. However, currently there is limited control of the 
pore size in non-woven mats, and the process results in noticeably 
anisotropic materials. The third approach is a development of the second
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approach, this approach is to weave silk fibres into 3D structures (Horan et 
al. 2005b). These are intentionally anisotropic to take advantage of silk’s 
mechanical properties, but this approach results in scaffolds with limited 
porosity.
The final approach is to use techniques such as freeze drying, gas foaming 
and salt leaching to make 3D porous scaffolds (Kim et al. 2005b; Nazarov et 
al. 2004). These are made by adding a porogen to a silk solution, then 
evaporating the solvent and removing the porogen; in the case of freeze 
drying the formation of ice crystals in the solvent acts as the porogen. These 
methods have the advantages of creating scaffolds with high porosity and 
the allowing control of the pore size, especially when salt is used due to the 
availability of salt with a large range of particle sizes. The first methods to 
make silk scaffolds with these techniques used organic acids to dissolve 
regenerated SF, this allowed scaffolds to be with small or large pores, but 
the interconnectivity between the pores was limited (Nazarov et al. 2004). 
More recently, scaffolds have been made using water as the solvent, this 
increased the interconnectivity, but it was only possible to make scaffolds 
with large pores (over 500pm) (Kim et al. 2005b). A porous silk scaffold that 
combined well connected pores with smaller pore sizes would be potentially 
very useful for tissue engineering.
6.1.5 Outline of experimental work
This chapter will report the invention of porous silk scaffolds that allow 
control of both pore size and pore structure. The minimal pore size of the 
fibrous scaffolds with well connected pores is roughly half that achieved by 
Kim et al (2005b). These scaffolds will be characterised by a combination of 
SEM, FTIR and light microscopy to determine porosity. Changes in the 
fabrication process will be made in order to better understand how these 
scaffolds are formed. Finally, a variety of musculoskeletal cell types will be 
cultured on the new scaffolds to determine the scaffold’s effects on cell 
viability.
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6.2 Materials and methods
Cell culture methods for this chapter are described in Section 4.2.1; 
regenerated silk fibroin preparation in 4.2.2; procedures to determine the 
solubility of silk in various solvents in 4.2.3; fabrication of silk scaffolds is 
described in Section 4.2.4; and decorating the scaffolds with RGD in Section 
4.2.5. The analytical methods used to characterise the scaffold are: SEM 
(4.3.1), FTIR (4.3.2) and light microscopy (4.3.3). To quantify cell number 
after cell culture on the scaffolds, Picogreen (4.3.4) was used.
6.3 Results
6.3.1 Solubility of silk in aqueous organic acid solutions
The starting point for this work was the hypothesis that the failure to form 
porous silk scaffolds with pore sizes of less than 500pm was due a 
combination of the high solubility of salt in water, and the larger specific 
surface area of the smaller salt particles resulting in the rapid precipitation of 
SF when small salt particles were used. Therefore it was decided to try to 
limit the solubility of salt in silk by dissolving the silk in an aqueous organic 
acid. The organic acid initially chosen was formic acid as silk dissolves 
readily in this organic acid (Urn et al. 2004). SF was soluble in all tested 
mixtures of formic acid and water at 5% w/v, but only dissolved at 10%w/v in 
20% v/v formic acid; it did not dissolve completely at 15% w/v in any of the 
solvents tested (Table 6-1).
Subsequently, HFIP and acetic acid were tested as solvents. HFIP as it is 
also a known solvent for SF (Zhao et al. 2003), and acetic acid was chosen 
due to its chemical similarity to formic acid. When 10% w/v SF was placed 
into aqueous HFIP or acetic acid, the SF formed a white gel at 10% w/v in 
20% v/v HFIP, and in 20% v/v acetic acid, but it did not form a solution at any 
concentration of acetic acid or HFIP (Table 6-1). These solvents were 
unsuitable for further use for fabricating porous silk scaffolds as the white gel 
was did not flow.
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Table 6-1 Solubility of regenerated SF in formic acid, acetic acid and 
hexafluoroisopropanol
Organic Acid % w/v of 
SF
% v/v Organic Acid
20% 40% 60% 80%
Formic Acid
5% Y Y Y Y
10% Y X X X
15% X X X X
Acetic Acid 10% G X X X
Hexafluoroisopropanol 10% G X X X
Key:
s  - SF dissolves completely
x - SF does not dissolve completely
G - SF forms a gel
6.3.2 Preparation of silk fibroin scaffolds with aqueous formic
acid
The next step was to test whether it was possible to make scaffolds using 
10% w/v SF dissolved in 20% v/v formic acid; these first scaffolds were made 
by pouring the silk solution into the mould, followed by salt. At first inspection 
by eye, this method appeared to make porous silk scaffolds. The top 
surfaces of these scaffolds were noticeably smoother than scaffolds made 
with 100% FA, almost appearing to be a single film, and contained a small 
dimple where the solution was pipetted in (cf. Figures 6-1 a & b).
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(a) (b)
Figure 6-1 Comparison of whole scaffolds: (a) Scaffolds made by salt leaching with 
100% FA, and (b) Scaffolds made by salt leaching with 20% v/v FA. MeOH was used as 
a coagulant for all these scaffolds.
To understand how the solvent affected the pore structure, these scaffolds 
were examined further with SEM. Two types of scaffold were compared by 
using either 20% v/v FA or 100% FA as the solvent, both were made with 
10% w/v silk. The scaffolds made with 100% formic acid had pores with a 
predominately film-like character (Figures 6-2a &b); whilst the scaffolds 
made with 20% FA had a more fibrous character (Figures 6-2c & d), with 
pores that were noticeably better connected than the scaffolds made with 
100% FA.
The limitation of these new scaffolds was a marked heterogeneity between 
pores between different scaffolds upon visual inspection of SEM images. The 
difference between Figures 6-2c and d shows the difference between pores 




Figure 6-2 Pore structure of two scaffolds made using the initial process: (a) & (b) 
made with 100% formic acid, and (c) & (d) made with 20% v/v formic acid. Scale bars = 
100pm.
To try and eliminate this heterogeneity a number of different variations on the 
original method (Method A) were tried, these methods are described in detail 
in Section 4.2.4:
• salt was put in the mould after the silk (Method B);
• the weight of salt was increased, keeping the ratio of silk : salt the 
same (Method C);
• the percentage of silk in the solvent was varied to 5% (Method D) and 
7.5% (Method E) as well as 10%;
• a PTFE lid was placed onto some of the scaffolds (Method F).
101
Only one of these variations failed to produce scaffolds for SEM: Method D 
(5% w/v SF) resulted in very friable scaffolds that largely disintegrated during 
salt leaching. The other scaffolds were compared with SEM, and it was found 
that adding salt to the mould before silk was put in (Method B) resulted in a 
more homogenous pore structure. This result was clarified by the deeper 
scaffolds made with a greater amount salt (Method C), which showed these 
scaffolds were more film-like towards the top surface, and more fibrous 
towards the bottom surface (Figure 6-3), suggesting that there was more SF 
towards the top of the scaffold. Decreasing the percentage of silk to 7.5% 
w/v (Method E) had the interesting effect of making the scaffold more fibrous 
(Figure 6-4a), whereas using a Teflon lid made the scaffold more film like 
(Figure 6-4b). It was decided to investigate the contrast between scaffolds 
made with 7.5% w/v and 10% w/v SF further.
To confirm that scaffolds could be made with small pore sizes with 20% FA 
as the solvent and either 7.5% and 10% w/v silk dissolved in it. Salt was 
sifted to give salt particles of between 125 and 250pm. Scaffolds were 
successfully made with these small particles and both 7.5% w/v and 10% w/v 
SF dissolved in aqueous formic acid (Figures 6-5a & b).
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Figure 6-3 Scaffold made with 10%w/v silk dissolved in 20% v/v formic acid added to 




Figure 6-4 (a) scaffold made with 7.5% w/v silk dissolved in 20% v/v formic acid 
pipetted onto 0.6g salt (Method E); and (b) scaffold made with 0.6g of salt added to 
10% w/v silk dissolved in 20% v/v formic acid and covered with a Teflon cap (Method 
F). (Scale bars = 100pm)
6.3.3 Scaffolds made with aqueous formic acid saturated with salt
To better understand the effect that salt has on the formation of these 
scaffolds, scaffold formation with saturated salt solutions was studied. First, 
the solubility of SF in aqueous formic solutions was determined by dissolving 
10% w/v silk in 10-90% aqueous formic solutions. Silk dissolved fully in 40%, 
80%, and 90% FA solutions saturated with salt (Table 6-2). The 40% solution 




Figure 6-5 Pore structure of a scaffold made with: (a) 10% w/v silk dissolved in 20% 
v/v formic acid added salt with particles of 125-250pm, and (b) 7.5% w/v silk dissolved 
in 20% v/v formic acid added to salt with particles of 125-250pm (x200). Scale bars = 
100pm
The 40% and 80% FA solutions saturated with salt were investigated further 
to see how they would influence pore structure. The scaffolds made with 
40% FA saturated with salt appeared to consist of interconnected sheets of 
SF, towards the ends of the sheets there were fibrous SF structures (Figure 
6-6a). In contrast to the 100% FA scaffolds (Figures 6-2a & b), where it 
appears that entire salt particles were coated with SF, with 40% FA saturated 
with salt it appears that many of the surfaces of the salt particles do not 
result in SF sheets, resulting in a much more interconnected scaffold 
structure (Figure 6-6a). The scaffolds made with 80% FA saturated with salt 
(Figure 6-6b) appear much more similar to those made with 100% FA 
(Figures 6-2a &b) than those made with 40% FA saturated with salt (Figure 
6-6a).
Table 6-2 Solubility of silk in aqueous formic acid solutions saturated with salt
% Formic Acid 10 20 30 40 50 60 70 80 90
Dissolves 10% w/v silk? X X X S* X X X
(* - required brief vortexing to dissolve the silk)
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(a) (b)
Figure 6-6 SEM of pore structure of silk scaffolds made with aqueous formic acid 
solutions saturated with salt: (a) 40% v/v formic acid and (b) 80% v/v formic acid. Both 
at x 250.
6.3.4 Fourier transform infrared spectra of silk scaffolds
SF exists in at least three crystalline forms: silk II is the form of natural silk 
fibres; silk I and random coil silk can be produced by chemical processing of 
these fibres. The process of regenerating SF changes its crystalline structure 
from silk II to random coil. Fourier transform infrared spectroscopy (FTIR) is 
commonly used to determine whether silk is in its silk II form or not. The 
position of the peaks of the amide I (C=0 stretching), II (secondary NH 
bending), and III (C-N stretching) vibrational bands is determined by 
presence or absence of hydrogen bonding therefore whether or not the silk is 
in silk II form (Ha et al. 2005). Peaks at 1630cm'1 (amide I), 1520cm-1 
(amide II) and 1270cm'1 (amide II) correspond to the silk II form; peaks at 
1650cm'1 (amide I), 1540cm'1 (amide II) and 1230cm'1 (amide II) correspond 
to the silk I or random coils forms (Asakura et al. 1985). The FTIR spectra 
were compared for silk scaffolds treated with methanol prior to salt leaching 
with scaffolds left untreated prior to salt leaching. The results obtained were
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almost identical for all scaffolds and show that the silk was in the silk II form 
(Figure 6-7).
FTIR Spectra of SF scaffolds
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Figure 6-7 FTIR Spectra of SF scaffolds: percentage refers to the percentage FA in the 
solvent, NoOH indicates no coagulant and MeOH indicates methanol as a coagulant
6.3.5 Porosity
Scaffolds were made with 10% w/v SF with formic acid, and 7.5% and 10% 
w/v SF with aqueous formic acid. The scaffolds were cut to 2mm height to 
remove the more film-like top of the scaffold. It was found to be necessary to 
soak the scaffolds in methanol prior to cutting to prevent them from splitting 
whilst being cut. FTIR had shown that this treatment had no effect on the 
crystalline structure (Figure 6-5). The porosity for the scaffolds was: 0.964 +/-
0.009 for 10% silk dissolved in formic acid; 0.971 +/- 0.005 for 10% silk in 
aqueous formic acid; and 0.964 +/- 0.005 for 7.5% silk in aqueous formic 
acid (Figure 6-8). The differences between the scaffold types were not 
significant, F(2,8)=1.16 p>0.05. This shows that these scaffolds can be used 
to examine the effects of pore size and structure without differences in 
porosity affecting the results.
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Scaffold type
Figure 6-8 Effect of scaffold type on porosity (Error bars are +/-1 s.d.)
6.3.6 Cell proliferation & attachment
In order to confirm that cells survive on these scaffolds, they were seeded 
with ligament fibroblasts and DNA content was quantified after 24 hours (to 
determine cell attachment) and 7 days (to confirm cell survival). The cell 
attachment study was also used to determine whether decorating the 
scaffolds with a peptide containing RGD would improve cell attachment with 
these silk scaffolds as it does to other porous silk scaffolds (Sofia et al. 
2001).
To quantify cell attachment twelve scaffolds were made with each of these 
solvent/solute combinations: 7.5% w/v SF 20% FA, 10% w/v SF 20% FA, 
and 10% w/v SF 100% FA. From each of these conditions four scaffolds 
were decorated with GRGDS peptide using EDC:NHS, four scaffolds were 
reacted with EDC:NHS alone to control for any effect the crosslinking 
process had on the SF, and four scaffolds were soaked in PBS with no 
EDC:NHS (Table 6-3).
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Table 6-3 Outline of experimental design for cell attachment experiment
Scaffold type
7.5% w/v SF 
20% FA
10% w/v SF 
20% FA







EDC/NHS + RGD 
7.5% w/v SF 20% FA
4 x
EDC/NHS + RGD 
10% w/v SF 20% FA
4 x
EDC/NHS + RGD 
10% w/v SF 100% FA
EDC/NHS 4 x
EDC/NHS (no RGD) 
7.5% w/v SF 20% FA
4 x
EDC/NHS (no RGD) 
10% w/v SF 20% FA
4 x
EDC/NHS (no RGD) 
10% w/v SF 100% FA
None 4 x
no EDC/NHS 
7.5% w/v SF 20% FA
4 x
no EDC/NHS 
10% w/v SF 20% FA
4 x
no EDC/NHS 
10% w/v SF 100% FA
The results are shown graphically in Figure 6-9. It appears from the graph 
that there is no consistent improvement in attachment for either of the 
EDC:NHS groups, there might be an effect of scaffold structure with the 10% 
SF 100% FA scaffolds increasing cell attachment. Two-way ANOVA 
effectively pools the results across single independent variables to determine 
if that independent variable has an effect. This analysis showed that there 
was no effect of reacting the scaffolds with either the EDC:NHS and the 
GRGDS peptide or EDC:NHS in the absence of the peptide (F(2,35)=1.83, 
p>0.05; Figure 6-10a). However there was an effect of scaffold structure 
(F(2,35)=9.43, p<0.01; Figure 6-1 Ob). The Tukey HSD procedure revealed 
the cells attached significantly better to scaffolds made with formic acid than 
to scaffolds made with aqueous formic acid and either 7.5% w/v SF (p<0.05) 
or 10% w/v SF (p<0.01) (see Figure 6-1 Ob). No interaction between 
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Figure 6-10 DNA content of scaffolds following 1 day attachment: (a) by decoration 
type, and (b) by scaffold structure; * p<0.01, t  P<0.05 by Tukey HSD, error bars show 
95% confidence intervals.
Scaffold structure showed a similar effect on cell proliferation after 7 days as 
it did on attachment. For this experiment, six of each type of scaffold (7.5% 
w/v SF 20% FA, 10% w/v SF 20% FA, and 10% w/v SF 100% FA) were 
seeded with ligament fibroblasts and cultured for 7 days. There was a 
significant difference between DNA content of the scaffolds (F(2,17)=3.805, 
p<0.05); post-hoc Tukey HSD tests revealed that there was a significant 
difference in DNA content between cells grown on scaffolds made with 10% 
w/v SF and 100% FA, and cells grown on scaffolds made with 10% w/v SF 
and 20% FA (p<0.05). There was no significant difference between scaffolds 
made with 7.5% SF and aqueous formic acid and either of the other two 
types of scaffold (Figure 6-11), this might be due to the smaller sample size 
and / or use of one way ANOVA instead of two way ANOVA.
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7.5% silk 10% silk 10% silk
20% FA 20% FA 100% FA
Scaffold
Figure 6-11 DNA content of scaffolds following 7 days proliferation: * p<0.05 by Tukey 
HSD, error bars show + 1 standard deviation.
This experiment was repeated with human osteoblast (MG63; n=3) and 
murine chondrocyte (ATDC-5; n=3) cell lines to confirm the viability of using 
these scaffolds for osteochondral engineering. A similar pattern was obtained 
to the results of ligament fibroblasts. Two way ANOVA revealed a significant 
effect of scaffold type: F(2,10) = 10.98, p<0.005, and cell type: F(1,12) = 
97.45 p<0.00001, but no interaction: F(2,10)=2.77 P>0.05. Post-hoc tests 
showed that the effect of scaffold type was due to greater proliferation on 
100% FA scaffolds than the 7.5% SF 20% FA scaffolds (Figure 6-12). The 
effect of cell type shows that the osteoblast cell line proliferates better on 





7.5% silk 10% silk 10% silk
20% FA 20% FA 100% FA
Figure 6-12 Results of osteochondral proliferation for 7 days: * p<0.05 by Tukey HSD, 
error bars show + 1 standard deviation.
6.4 Discussion
6.4.1 Scaffold fabrication
Silk scaffolds with a pore structure that varies from fibrous to film-like have 
been successfully developed by using aqueous formic acid solutions, and a 
variety of musculoskeletal cells cultured upon them. The principal initial 
problem was that there was a great deal of heterogeneity between scaffold 
samples; this problem was solved by adding the silk solution to the salt 
rather than salt to silk solution. The SEM results from this change suggested 
that the SF was precipitating soon after contact with the salt (Figure 6-3), 
potentially explaining the heterogeneity found when salt was added to silk 
solution in the mould: the initial salt crystals would receive a more substantial 
SF coating than later particles, but the distribution of these particles would be 
somewhat random within the scaffolds, producing the heterogeneity.
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The new process produced scaffold structures that were anisotropic. On 
visual inspection this anisotropy was visible as a film like layer on top of the 
scaffolds, for cell culture and porosity studies this top layer was removed to 
leave the more fibrous bottom layer. Comparisons between the porosity of 
the scaffolds made with 100% FA (which are close to isotropy), and those 
made with 20% FA suggest that removing this layer does not affect the 
porosity significantly. The fibrous structure of these scaffolds remains to be 
explained. Some clues come from observation of the fabrication process. 
Whereas scaffolds made with 100% FA remain rather malleable until the FA 
is evaporated, scaffolds made with 20% FA quickly form a solid upper crust 
that becomes the film described above. This suggests that the silk’s 
crystalline form changes from soluble to insoluble once the silk solution is 
added to the salt. In the case of the SF dissolved in water, it seems to be that 
interaction with the salt causes the formation of a silk hydrogel, and a change 
to insoluble silk II (Kim et al. 2005b), a similar process is possible with silk 
dissolved in 20% FA. Although it is unclear how this alone would account for 
the structures observed with 20% FA (Figure 6-3) as scaffolds made with 
40% FA saturated with salt have markedly different structures (Figure 6-6a). 
Comparing made with 40% FA saturated with salt with scaffolds made with 
80% FA saturated with salt (Figure 6-6) suggests that increasing the amount 
of salt dissolved by aqueous formic acid reduces the number of sides of each 
salt crystal that form silk sheets, but the increased amount of salt dissolved 
in 40% FA does not appear to result in a more fibrous structure than 
scaffolds made with 100% FA, similar fibrous structures can be seen in both 
types of scaffolds (cf. Figures 6-2b and 6-6a).
Trying to make scaffolds with pores smaller than those reported here results 
in a high failure rate, producing scaffolds with a dense top film and a very 
fragile bottom. It appears possible to make scaffolds with smaller pore sizes 
reliably by cooling the mould, the salt, and the silk solution to 4°C. This fits 
with the idea that the silk is precipitating soon after contact with salt particles, 
and that this precipitation is driven by the salt that dissolves in the silk 
solution from the salt particles, changing the silk into its insoluble silk II form. 
There are two possible causes of this increased precipitation: first, the
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smaller the particles are the greater their surface area, increasing the rate at 
which silk dissolves; second, to get sufficient salt with small particle sizes to 
make a number of scaffolds it was necessary to use a different source of 
salt, as the mass of sub-180pm particles in the original salt was vanishingly 
small. This new salt was from a different source and appeared to carry some 
contaminating salts: scaffolds made with it have a bluish tinge, suggesting 
the presence of copper. There is increasing evidence that copper plays an 
important role in the transition of silk from its soluble forms to insoluble silk II 
(Zhou et al. 2006; Zhou et al. 2003; Zong et al. 2004), with increased copper 
ii content can trigger the transition to silk II at low concentrations (0.02M). It 
should be noted that the copper content within the silkworm is roughly 1000 
times smaller. According to the certificate of analysis (Appendix C), the new 
salt contains at most 5mg/kg copper; if all the copper in the salt crystals 
dissolved in the solvent this would be enough copper to form a copper 
solution stronger than 0.015M, clearly there is the possibility that slight 
contamination with copper could dramatically affect the results.
That it is possible to slow this process with cooling indicates that it might be 
possible to get scaffolds closer to isotropy by changing the process in other 
ways. Adding the silk solution to the salt by centrifugation could accelerate 
the speed at which the solution penetrates the salt, reducing the amount of 
precipitation. Various metal ions have also been shown to impact upon the 
process of silk crystallisation (Zhou et al. 2003; Zhou et al. 2004), and by 
changing the concentrations of these ions, it might be possible to slow the 
process down, and create more regular scaffolds.
6.4.2 FTIR
The FTIR results strongly suggest that the solvent is having no effect on the 
eventual silk structure. In the case of pure formic acid, this is thought to be 
because the silk is partially dissolved in formic acid as the silk II form, and 
then the rest of the SF is rearranged into silk II form as it dries (Ha et al.
2005). As suggested above, it appears that SF dissolved in 20% FA 
undergoes the transition to silk II as salt dissolves in the solvent. This result
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indicates that the chemistry of the SF scaffolds made with formic acid and 
aqueous formic acid is identical, allowing investigation of the effects of pore 
size and pore structure without different scaffold chemistry complicating the 
results.
6.4.3 Cell attachment and proliferation
The results from growing cells on scaffolds modified with RGD contradict the 
published reports of the effect of linking an RGD containing peptide to silk 
scaffolds (Sofia et al. 2001). The most likely explanation for this is that the 
precise molecular structure of biomaterials appears to be important in 
determining the effect of RGD on cells. Work on hydrogels and membranes 
shows that RGD works best when it is separated from the bulk of the 
hydrogel or surface by a short (~0.5-3.5kDa) spacer molecule (De Bartolo et 
al. 2005; De Bartolo et al. 2006; Hern and Hubbell 1998; Park et al. 2005). 
An alternative hypothesis for the absence of an effect of RGD is highlighted 
by the fact that when compared to fibronectin RGD enables sub-optimal 
attachment (Mardilovich et al. 2006). It could be that silk processed with 
formic acid allows better adsorption of fibronectin from FCS, eliminating the 
effect of RGD. Recently a new peptide containing two sequences from 
fibronectin, RGD and PHSRN, has been synthesised that increases cell 
attachment to levels indistinguishable from fibronectin (Mardilovich et al.
2006); with this new peptide it might be possible to enhance cell attachment 
to silk.
The cell attachment and proliferation results taken together show that varying 
pore structure whilst keeping pore size, scaffold chemistry and porosity 
constant can change the way that cells behave on a scaffold. Mathematical 
modelling appears to suggest a trade off between some of the scaffold 
parameters that are important for mass transfer such as porosity and specific 
surface area which is important for cell attachment (Lemon et al. 2006). 
Whilst no model is yet sophisticated enough to explain the data in this 
chapter, a trade off between mass transfer and cell attachment would explain 
these attachment results. Some of the theoretical models of permeation
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though porous materials also suggests a trade off between permeability and 
specific surface area (Sander and Nauman 2003). Given that cell attachment 
is a good predictor of subsequent proliferation (Bigerelle and Anselme 2005), 
the cell proliferation results might be explained largely by the initial cell 
attachment. These are unexpected results, the objective of developing these 
scaffolds with better connected pores was to improve mass transfer and 
thereby improve tissue engineering outcomes. This appears to be somewhat 
different to the results found by Pei et al with chondrocytes (Pei et al. 2002), 
who found that HYAFF-II® mesh performed significantly better than the 
HYAFF-11® sponge in a bioreactor. This suggests that the optimal 
biomaterial design may well be a function of other parameters such as the 
fluid flow conditions.
Multivariate analysis of scaffold parameters is a useful tool to analyse how 
different biomaterial parameters affect tissue engineering. Some questions 
can only be answered with multivariate experiments, for instance, if there is 
an interaction between pore size and pore structure. Currently, the numbers 
of these experiments that have been carried out have been limited by the 
complexity of biomaterials; this complexity makes it difficult to keep one 
parameter constant without affecting other parameters. The new silk 
scaffolds allow the independent control of pore size and pore structure. This 
will allow new questions to be asked. Chapter 7 uses these scaffolds to 
understand what the optimal pore size and pore structure for the initiation of 
ligament engineering is.
6.5 Conclusions
This chapter reports the invention of porous silk scaffolds that allow the 
control of pore structure from fibrous to film-like by using 20% v/v formic acid 
to make fibrous scaffolds, and 100% formic acid to make film-like scaffolds. 
By reducing the silk content in the solvent from 10% w/v to 7.5% w/v the 
scaffolds can be made more fibrous. Fibrous scaffolds with pores smaller 
than 250pm can be made with thee new methods; this is roughly half the
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pore size of the scaffolds with well connected pores made by Kim et al 
(2005b). SEM characterisation revealed an anisotropic structure that might 
be the result of a liquid-liquid separation during scaffold formation caused by 
sodium chloride dissolving in the silk solvent. Saturating the silk solvent with 
sodium chloride resulted in markedly different scaffold structures supporting 
this suggestion. FTIR results showed identical chemistry when comparing 
the fibrous and film-like scaffolds. No significant differences were found 
between the porosity of the fibrous and film like scaffolds. Decorating the 
scaffolds with RGD does not appear to improve attachment of ligament 
fibroblast, but ligament fibroblasts do appear to attach better to the film-like 
scaffolds. The improved attachment appears to improve cell proliferation of 
ligament fibroblasts at 7 days. In addition to the successful culture of 
ligament fibroblasts, human osteoblast and murine chondrocyte cell lines 
have been successfully cultured on the scaffolds for 7 days, again the cells 
appeared to proliferate better on the film-like scaffolds.
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7 Effect of Pore Size, Pore Structure, and Animal on 
Ligament Fibroblasts in Porous Silk Scaffolds
7.1 Introduction
7.1.1 Initiation of ligament engineering
There is growing evidence that ligament regeneration in vitro is a multi-stage 
process. This evidence comes from work looking at the differentiation of 
bone marrow stromal cells towards a ligament fibroblast like phenotype. Two 
different lines of evidence are available: differentiating BMSCs with growth 
factors, and differentiating BMSCs with mechanical stress.
When the differentiation of BMSCs with growth factors in 2D culture was 
attempted it was found that treating them with epidermal growth factor (EGF) 
for a week followed by TGF-p for a week gave the best results in terms of 
collagen type I and III expression, cell morphology, and proteoglycan 
expression, when compared to TGF-p, insulin-like growth factor II, insulin, 
bFGF, or insulin + TGF-p for two weeks or bFGF for one week followed by 
TGF-p for one week (Moreau et al. 2005a). Similar results were found in 3D 
culture: when BMSCs were seeded onto bundles of twisted silk fibres and 
cultured in petri dishes and treated with either bFGF, EGF, or nothing for five 
days, followed by TGF-P1 or nothing for nine days, it was found that bFGF 
followed by TGF-p 1 resulted in the greatest cell metabolic activity, and 
collagen I production at the end of the culture period (Moreau et al. 2005b). 
Taken together these results suggest that there are at least two different 
phases to ligament engineering in vitro, a first phase lasting around about a 
week when mitogens such as EGF or bFGF have a positive impact on the 
outcome, then a second phase where TGF-p has a positive impact on the 
outcome.
A second line of evidence comes from the mechanical differentiation of 
BMSCs in 3d culture. The BMSCs were seeded onto bundles of twisted silk 
fibres and cultured in Petri dishes for 1, 3, or 9 days and then transferred to a
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bioreactor for mechanical stimulation for 6 days. Transferring the cells after 1 
or 3 days caused a large drop cell metabolic activity. In contrast, after 9 days 
of Petri dish culture, mechanical loading increased cell metabolism 
significantly. The experiment also measured mRNA levels of fibronectin, 
integrins a2, a5 and p1, collagen type I and heat shock protein 70 (HSP-70) 
on day 1, 3, 5, 9, 11 and 15 of Petri dish culture. Transcript levels of the 
integrins, fibronectin and collagen type I, peaked at or around day 9. HSP-70 
was highest on day 1, possibly correlating with the large decline in cell 
metabolism when cells were mechanically stimulated after 1 day. Levels of 
all the integrins were low at three days, possibly partially explaining the poor 
cell metabolism triggered by mechanical stimulation after 3 days of Petri dish 
culture. Similarly, fibronectin levels were low at days 1 and 3 which might 
also be connected with the poor cell metabolism (Chen et al. 2006). This 
paper suggests again that there are two stages to ligament engineering, in 
the first stage the cells lay down ECM components such as fibronectin and 
express cell surface receptors such as the integrins to enable the cells to 
detect mechanical stimulation. A successful first stage can greatly improve 
the cellular response to subsequent mechanical stimulation.
These two approaches are connected by the fact that TGF-p1 is a key 
mediator of the response of ligament fibroblasts to cyclical tensile strain 
(Hsieh et al. 2000; Kim et al. 2002). Taken together this work suggests that 
the conditions needed for the first stage of ligament engineering are different 
from those when cyclical tensile strain or TGF-p is applied. This chapter will 
investigate whether biomaterial structure can enhance the initiation of 
ligament engineering.
7.1.2 Effect of pore size and scaffold structure on connective 
tissue engineering
Very little work has been done on optimising pore size and scaffold structure 
for connective tissue engineering. Surprisingly, the consensus that fibrous 
tissue needs small pores of around a 100pm comes from work on implanting 
scaffolds to promote bone repair. It was found that scaffolds with pores larger
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than 100|jm promoted the formation of bone (Hulbert et al. 1970). However, 
this was in an osteogenic environment, and in an environment that promotes 
fibrous tissue formation a different pore size might be optimal. It is revealing 
that the optimal pore size for bone tissue engineering is thought to be over 
300 pm to promote vascularisation (Karageorgiou and Kaplan 2005).
Work has been done with collagen-glycosaminoglycan scaffolds grafted onto 
mice to regenerate skin (Yannas et al. 1989). In this case the outcome 
variables considered were how well the scaffold resisted contraction of the 
wound, and how normal the regenerated tissue was, judged by histology. It 
was found that scaffolds with pore sizes of 20 -125pm were ideal for resisting 
wound contraction, and that these scaffolds promoted partial regeneration of 
skin with a less fibrotic character than scar tissue. Further work showed that 
cells attached better to scaffolds with smaller pore sizes and higher specific 
surface areas (O'Brien et al. 2005). More recently, work has been done on in 
vitro connective tissue engineering with PEGT/PBT scaffolds that were 
seeded with adipose tissue fibroblasts (Wang et al. 2005a). This suggested 
that by using a bioreactor pores of up to 273pm might be filled and that 
scaffolds of 1.5-1.6mm in depth could be completely bridged by connective 
tissue within two weeks of culture; with larger pores of up to 401pm cells 
could still bridge the gap between fibres, but the result was a more loosely 
organised ECM. This work has also shown that scaffolds with average 
interconnected pore sizes of 160pm produced homogenous tissue, scaffolds 
with higher or lower interconnectivity did not (Wang et al. 2005a). It should 
be noted that speed of tissue bridging in these results may well be connected 
to the great number of mesenchymal stem cells in adipose tissue (Strem and 
Hedrick 2005).
There has been no quantitative investigation of the impact of pore size and 
structure on matrix synthesis for connective tissue engineering. It is 
conceivable that the looser tissue found in the larger pores by Wang et al 
(2005) was indicative of hyaluronic acid being synthesised to fill the void 
space. Therefore when the initiation of ligament tissue engineering is being 
considered, and high intial levels of hyaluronic acid are desired, larger pores
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might be superior to smaller pores. Larger pores should also promote mass 
transfer, possibly aiding cell survival and penetration of the scaffold.
7.1.3 Advantages of novel porous silk scaffolds
A number of attempts to develop engineered ligaments have focused on 
developing biomaterials that mimic the mechanical properties of ligament 
(Altman et al. 2002a; Murray and Macnicol 2004; Sahoo et al. 2006). When 
this approach uses biodegradable biomaterials, the idea of these scaffolds is 
that the cells should synthesise ECM at the same rate as the material 
degrades to maintain constant mechanical properties.
The major limitation of this approach is that achieving sufficient mechanical 
strength requires a lot of biomaterial, limiting the porosity. Porosity is very 
important is determining the mass transfer properties of a tissue engineering 
scaffold. For instance, for porosities below 0.8 the following equation 
provides a good approximation of the intrinsic permeability (Equation 7-1; 
where k = intrinsic permeability,^ = porosity, So = Specific Surface Area, 
and K = Kozeny constant (this includes tortuosity and a shape factor)).
k = y/3
(1 -^ )2 S>K
Equation 7-1 Estimation of permeability from material properties (Sander and Nauman 
2003).
Clearly, lower porosities result in much lower permeabilities; this will result in 
much less efficient mass transfer, especially in a bioreactor. This limited 
mass transfer might limit cell metabolism and ECM production, especially 
towards the centre of scaffolds. This effect is most clearly shown in the work 
of Moreau et al (2006) who cultured BMSCs seeded on bundles of twisted 
silk fibres in Petri dishes for 28 days under stimulation by various growth 
factors. In all cases the BMSCs form a dense ECM on the surface of the 
scaffold, but not inside the scaffold. This suggests that there might be an
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advantage to increasing porosity and mass transfer at the expense of 
mechanical strength.
The second problem will be matching the degradation rate of the scaffold to 
the rate at which the cells produce ECM. The experience with the Leeds- 
Keio non-degradable artificial ligament in which ali patients show signs of 
knee degeneration in the long term (Murray and Macnicol 2004), suggests 
that any replacement ligament will need to be biodegradable. If the scaffold 
degrades too quickly then the construct risks mechanical failure; on the other 
hand if the scaffold degrades too slowly then this might adversely affect 
subsequent ECM production. To take an extreme example, histological 
examination of Leeds-Keio artificial ligaments several years after 
implantation reveals evidence of a sustained foreign body reaction, and 
extensive remodelling continuing for years after implantation (Nomura et al. 
2005). Closely matching scaffold degradation with ECM production will be a 
major challenge.
The third major problem with strong biomaterials is that they might result in 
the cells receiving sub-optimal mechanical stimulation. There is growing 
evidence that some tendinopathies do not heal as the injured part of the 
tendon is shielded from stress (Maganaris et al. 2004; Rees et al. 2006). A 
scaffold composed of strong fibres is likely to transmit the majority of the 
stress via the fibres, limiting the mechanical stimulation that the cells receive, 
particularly if the cells are not directly attached to the scaffold. A related 
issue is that cells in tendons in vivo are primarily exposed to shear stress, 
not tensile stress (Screen et al. 2004); whereas cells attached to long fibres 
running from end to end of a scaffold will be exposed to much more tensile 
stress than in vivo.
On the other hand, some notable successes have been achieved with weak 
biomaterials. Mechanically stimulated MSC seeded collagen gels appear to 
be capable of approaching the normal mechanical properties of tendon after 
12 weeks when used to repair full length patellar tendon defects in rabbits 
(Juncosa-Melvin et al. 2006). Calve et al (2004) managed to make tendon
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with similar mechanical properties to embryonic tendon, by enabling cells to 
self assemble themselves without a scaffold into a cylinder suspended 
between two posts.
The novel silk scaffolds reported in Chapter 6 will be used for this 
investigation of the initiation of ligament tissue engineering as they allow 
independent control of pore size and pore structure, two variables that have 
not been considered for ligament tissue engineering. These scaffolds should 
allow collagen fibrils to form and interact with minimal interference from the 
scaffold itself due to the high porosity of the scaffolds. In addition, these 
scaffolds can be autoclaved to sterilise them, which simplifies their handling.
7.1.4 Predictions
The work studying collagen fibrillogenesis in tendons suggests several 
predictions that should be met, if ligament engineering follows a similar path 
to collagen fibrillogenesis in vivo:
1. The percentage of glycosaminoglycan that is hyaluronic acid should 
be high initially and then drop (Parry et al. 1982).
2. The percentage of glycosaminoglycan that is chondroitin and 
dermatan sulphate (the two will not be distinguished in this 
experiment) should increase with time (Parry et al. 1982).
3. The amount of chondroitin sulphate should tend to drop over the 
course of the experiment (Scott et al. 1981).
4. The amount of hydroxyproline (an amino acid unique to collagen) 
should increase over the course of the experiment (Scott et al. 1981).
5. The ratio of glycosaminoglycan : hydroxyproline should drop rapidly 
(Scott etal. 1981).
In addition, work on ligament engineering in vitro suggests that cell number 
should fluctuate over the course of the experiment (Moreau et al. 2006). The 
main objective of this work is to identify a combination of pore size and pore 
structure that maximises the number of predictions met.
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7.2 Materials and Methods
Methods for cell culture are detailed in Section 4.2.1; methods for 
regenerating silk fibroin and preparing scaffolds are in 4.2.2 and 4.2.4. DNA 
quantification is in Section 4.3.4 The method for papain digestion is 
described in Section 4.3.5. The method for hydroxyproline analysis is in 
Section 4.3.6, and HPLC analysis of glycosaminoglycans is detailed in 
Section 4.3.7.
7.3 Results
7.3.1 Overview of experimental design
For each time point of this experiment, 54 scaffolds were sacrificed. These 
54 scaffolds consisted of 6 sets of the 9 combinations of different scaffold 
types arising from 3 pore sizes and 3 pore structures (Table 7-1); each set 
was seeded with cells from one sheep, and a different sheep supplied the 
cells for each set. Thus, the 54 scaffolds were made of the combinations of 3 
pore sizes x 3 pore structures x 6 sheep. Scaffolds were sacrificed after one 
day, one week, two weeks and three weeks. The same 6 sheep were used to 
supply cells at each time point, so that the effect of individual differences 
between animals could be investigated.
Table 7-1 The nine different combinations of pore size and pore structure
180-250pm 
7.5% silk 20% FA 
(Highly fibrous)
180-250pm 
10% silk 20% FA 
(Fibrous)
180-250pm 
10% silk 100%FA 
(Film like)
300-355pm 
7.5% silk 20% FA 
(Highly fibrous)
300-355pm 
10% silk 20% FA 
(Fibrous)
300-355pm 
10% silk 100%FA 
(Film like)
425-500pm 
7.5% silk 20% FA 
(Highly fibrous)
425-500pm 
10% silk 20% FA 
(Fibrous)
425-500pm 
10% silk 100%FA 
(Film like)
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On the first day only DNA was quantified; DNA, hydroxyproline, and GAGs 
(hyaluronic acid and chondroitin sulphate) were determined at the 
subsequent time points. This gives a total of four dependent variables; 
analysing each dependent variable with a factorial ANOVA would increase 
the chance of a type I error to almost 20%, so the alpha level needs to be 
corrected to 0.0125 instead of 0.05, using the Bonferroni correction. As it is 
difficult to hypothesise what effects this experiment will detect, the data will 
be analysed using exploratory ANOVA of all main effects, and two-way and 
three-way interactions to determine the important effects. Then the 
significant results will be plotted and subjected to a post-hoc analysis where 
appropriate.
The following sections will describe the results of ANOVA following DNA, 
hydroxyproline, chondroitin sulphate, and hyaluronic acid quantification. 
Then correlations between the outcome variables will be examined.
7.3.2 DNA
Three main effects are found to have a significant impact on the amount of 
DNA within the scaffolds (Table 7-2): Time, pore size and animal. Three two 
way interactions are significant: time x pore size, time x animal, and pore 
size x animal. The only significant three way interaction is time x pore size x 
animal. Of these effects, the most important variable is time x animal, 
explaining 36% of the variance in the population alone. Time accounts for 
16% of the variance. Time x pore size x animal and animal each account for 
a further 8%. The last three significant effects account for less than 10% of 
the variance together: time x pore size for 3%, pore size x animal accounts 
for 3%, and pore size accounts for 1%. In total, these variables account for 
75% of the variance in the population.
The effect of time is a significant reduction in DNA at day 21, compared to 
days 1, 7 and 14 (Figure 7-1). Post-hoc tests do not reveal what the effect of 
pore size is, but the graph suggests that the smallest pore size limits cell 
number (Figure 7-2). This failure to identify a difference with post hoc tests 
is consistent with the very small effect size.
126
Table 7-2 Exploratory ANOVA of DNA quantification. (Probability is left blank where 
data is not significant, F-vales and effect size rounded to 2 decimal places, probability 
rounded to 2 significant figures)
Variable / Interaction F value Probability Effect size
Time F(3,60) = 43.05 5.7E-15 0.16
Pore structure F(2,60)= 1.91
Pore size F(2,60) = 4.93 0.010 0.01
Animal F(5,60) = 14.28 3.4E-09 0.08
Time x Pore structure F(6,60) = 0.74
Time x Pore size F(6,60) = 4.68 0.00058 0.03
Time x Animal F(15,60) = 20.74 2.7E-18 0.36
Pore structure x Pore size F(4,60)= 1.63
Pore structure x Animal F(10,60) = 0.98
Pore size x Animal F(10,60) = 3.81 0.00050 0.03
Time x Pore structure x Pore size F(12,60)= 1.01
Time x Pore structure x Animal F(30,60) = 0.51
Time x Pore size x Animal F(30,60) = 3.18 6.7E-05 0.08










Figure 7-1 DNA content of scaffolds on different days (Error bars show 95% 
confidence intervals, * P<0.001 by Games-Howell post-hoc test)
Cells from animal 4 appears to have a consistently higher cell number than 
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Figure 7-3 DNA content of scaffolds with respect to animal (Error bars show 95% 
confidence intervals, * P<0.05 by Games-Howell post-hoc test)
Simple effects analysis shows that the interaction between time and pore 
size is related to significant differences between scaffolds with different pore 
sizes (Table 7-3). Pairwise comparison shows that the scaffolds with 425-
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500|jm pores have most DNA on day 1, and scaffolds with either 300-355pm 
or 425-500pm pores have more DNA than scaffolds with 180-250pm pores 
on day 14 (Figure 7-4).
Table 7-3 Simple effects analysis of the effect of pore size within time on scaffold DNA 
content. (Based on the linearly independent pairwise comparisons among the 
estimated marginal means).
Variable F value Probability
Pore size within day 1 F(2,72) = 8.18 0.001
Pore size within day 7 F(2,72) = 3.11
Pore size within day 14 F(2,72) = 7.00 0.002
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Figure 7-4 DNA content of scaffolds showing the interaction between pore size and 
time (Error bars show 95% confidence intervals; * P<0.005 and $ P<0.05 by pairwise 
comparison with Sidak correction)
There are significant differences between DNA content with respect to 
animal at all four time points studied (Table 7-4). On day 1, DNA content of 
the cells from the first three animals is significantly different from that of the 
cells from the last three; in addition, the DNA content of the cells from animal 
5 is significantly different to that of cells from animals 4 and 6. On day 7, the
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each of the first three animals is again significantly different to the last three. 
By day 14 the pattern has changed: DNA content of cells from animal 6 is 
significantly lower than from the first four, and the DNA content of cells from 
animal 5 is significantly lower than from cells of animals 1, 3 and 4. On day 
21, pairwise comparison reveals no significant differences; the difference 
found in the simple effects analysis reflects pooled differences (Figure 7-5).
Table 7-4 Simple effects analysis of the effect of animal within time on scaffold DNA 
content. (Based on the linearly independent pairwise comparisons among the 
estimated marginal means).
Variable F value Probability
Animal within day 1 F(5,72) = 41.00 9.6E-20
Animal within day 7 F(5,72)= 18.83 6.4E-12
Animal within day 14 F(5,72) = 13.21 4.0E-009
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Figure 7-5 DNA content of scaffolds showing the interaction between animal and time 
(Error bars show 95% confidence intervals; * P<0.001 and J P<0.05 by pairwise 
comparison with Sidak correction)
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For half the cells from the animals the interaction with pore size has no 
significant effect (Table 7-5). For the cells from animal 2 it the largest pore 
size increases cell number, for animal 3 300-355pm pores result in a higher 
cell number than 425-500pm pores, and for the cells from animal 4 it the two 
largest pore sizes increase cell number. (Figure 7-6)
Table 7-5 Simple effects analysis of the effect of pore size within animal on scaffold 
DNA content. (Based on the linearly independent pairwise comparisons among the 
estimated marginal means).
Variable F value Probability
Pore size within animal 1 F(2,72) = 0.60
Pore size within animal 2 F(2,72) = 7.25 0.001
Pore size within animal 3 F(2,72) = 5.21 0.008
Pore size within animal 4 F(2,72) = 7.012 0.002
Pore size within animal 5 F(2,72) =2.96
Pore size within animal 6 F(2,72) =0.97
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Figure 7-6 DNA content of scaffolds showing the interaction between pore size and 
animal (Error bars show 95% confidence intervals; * P<0.01 and t  P<0.05 by pairwise 
comparison with Sidak correction)
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Finally, the three way interaction between pore size, time and animal, is 
related to different behaviour in response to different pore sizes for cells from 
animals 4 and 5 on days 1 and 7, and cells from animals 2, 3, and 4 on day 
14 (Table 7-6). On day 1 cells from animal 4 attach better to the scaffolds 
with the largest pores than to scaffolds with the smallest pores; cells from 
animal 5 attach least well to scaffolds with the middle pore size, and attach 
best to scaffolds with the largest pores. The pattern is different on day 7, 
DNA content is higher in scaffolds with the middle pore size than the largest 
pore size for cells from animal 4; for cells from animal 5, DNA content is 
lower for scaffolds with the largest pores than the other two. On day 14, 
scaffolds with the largest pores result in most DNA for cells from animal 2, for 
cells from animal 3 scaffolds with the middle sized pores perform best, and 
the largest pores result in more DNA than the smallest pores (Figure 7-7).
Table 7-6 Simple effects analysis of the effect of pore size within animal within time 
on scaffold DNA content. (Based on the linearly independent pairwise comparisons 
among the estimated marginal means).
Variable F value Probability
Pore size within animal 1 within day 1 F(2,72) = 0.05
Pore size within animal 2 within day 1 F(2,72) = 0.23
Pore size within animal 3 within day 1 F(2,72) = 0.06
Pore size within animal 4 within day 1 F(2,72) = 5.69 0.005
Pore size within animal 5 within day 1 F(2,72) = 26.00 3.2E-9
Pore size within animal 6 within day 1 F(2,72) =2.09
Pore size within animal 1 within day 7 F(2,72) = 0.05
Pore size within animal 2 within day 7 F(2,72) = 0.02
Pore size within animal 3 within day 7 F(2,72) = 0.002
Pore size within animal 4 within day 7 F(2,72) = 6.17 0.003
Pore size within animal 5 within day 7 F(2,72) = 4.26 0.018
Pore size within animal 6 within day 7 F(2,72) = 0.35
Pore size within animal 1 within day 14 F(2,72) = 2.47
Pore size within animal 2 within day 14 F(2,72)= 16.40 1.4E-6
Pore size within animal 3 within day 14 F(2,72)= 13.48 1.1E-5
Pore size within animal 4 within day 14 F(2,72) = 4.17 0.019
Pore size within animal 5 within day 14 F(2,72) = 0.26
Pore size within animal 6 within day 14 F(2,72) = 0.54
Pore size within animal 1 within day 21 F(2,72) = 0.05
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Pore size within animal 2 within day 21 F(2,72) = 1.03
Pore size within animal 3 within day 21 F(2,72) = 0.42
Pore size within animal 4 within day 21 F(2,72) = 1.87
Pore size within animal 5 within day 21 F(2,72) = 0.023
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Figure 7-7 Bar chart of DNA content in scaffolds showing the interaction between 
pore size, animal and time (Error bars show 95% confidence intervals; + P<0.05, * 
P<0.01, $  P<0.005 and x P<0.001 by pairwise comparison with Sidak correction)
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Overall, there appears to be divergent cell attachment, accounted for by 
differences between cells from different animals (Figure 7-5), with cells from 
the last three animals attaching better than the first three; most of these 
differences remain significant at day 7; by day 14 this pattern appears to be 
somewhat reversed. Cell number at day 21 is significantly lower than at the 
first three time points (Figure 7-1). Averaged across the experiment, cells 
from animal 4 have a higher cell number than cells from animals 1, 2 and 3 
(Figure 7-3). There are also complex differences in the way cells from 
different animals respond to different pore sizes at different time points 
(Figure 7-7). For those cells from animals who respond differently to different 
pore sizes, either the middle or largest pores result in the highest cell number 
(Figures 7-4 and 7-7).
At day 7 conditions that produced high cell numbers at day 1 tend to result in 
a reduction of cell number, conditions that allowed fewer cells to attach tend 
to maintain a similar cell number, although in a couple of cases cell number 
increases (Figure 7-8). At day 14 the trend for conditions that attached better 
to decline in cell number continues, whereas conditions that resulted in lower 
cell numbers at day 7 tend to have higher cell numbers at day 14, this is 
particularly noticeable in some animals with one or more of the larger pore 
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Figure 7-8 Line chart of DNA content in scaffolds showing the interaction between 
pore size, animal and time
7.3.3 Hydroxyproline
Fewer variables and interactions have an impact on hydroxyproline levels 
(Table 7-7). The most important effect is time, accounting for over 20% of 
the variance in the population. This is because hydroxyproline levels are 
higher at day 21, than days 7 and 14 (Figure 7-9). The second most
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important effect is the animal, accounting for 11% of the variance. Cells from 
animal 6 produce significantly less hydroxyproline than cells from animals 1, 
2, and 3; whilst cells from animal 5 produce less hydroxyproline than cells 
from animal 3 (Figure 7-10).
Table 7-7 Exploratory ANOVA of hydroxyproline results. (Probability is left blank 
where data is not significant, F-vales and effect size rounded to 2 decimal places, 
probability rounded to 2 significant figures)
Variable / Interaction F value Probability Effect size
Time F(2,40) = 28.58 2.0E-08 0.21
Pore structure F(2,40) = 1.48
Pore size F(2,40) = 0.69
Animal F(5,40) = 6.8 0.00011 0.11
Time x Pore structure F(4,40) = 0.49
Time x Pore size F(4,40) = 1.08
Time x Animal F(10,40) = 3.05 0.0058 0.08
Pore structure x Pore size F(4,40) = 0.29
Pore structure x Animal F(10,40) = 0.993
Pore size x Animal F(10,40) = 1.02
Time x Pore structure x Pore size F(8,40) = 0.52
Time x Pore structure x Animal F(20,40) = 0.88
Time x Pore size x Animal F(20,40) = 1.34
Pore structure x Pore size x Animal F(20,40) = 0.883
The last significant effect: time x animal, accounts for 8% of the variance. 
This interaction seems to be caused by the cells from first three animals 
producing more hydroxyproline at day 7, and cells from animal 6 producing 
less hydroxyproline at day 21 than cells from animals 1, 3 and 4, and in 
addition, cells from animal 4 producing more hydroxyproline than cells from 




















Figure 7-9 Hydroxyproline content of scaffolds on different days (Error bars show 
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Figure 7-10 Hydroxyproline content of scaffolds with respect to different animals 
averaged over all three time points (Error bars show 95% confidence intervals, * 
P<0.005 and t  P<0.05 by Games-Howell post-hoc test)
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Table 7-8 Simple effects analysis of the effect of animal within time on scaffold 
hydroxyproline content. (Based on the linearly independent pairwise comparisons 
among the estimated marginal means).
Variable F value Probability
Animal within day 7 F(5,48) = 5.56 0.00041
Animal within day 14 F(5,48)= 1.36
Animal within day 21 F(5,48) = 7.11 4.8E-5
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Figure 7-11 Hydroxyproline content of scaffolds showing the interaction between 
animal and time (Error bars show 95% confidence intervals; +, P<0.05, * P<0.01, x 
P<0.005 and t  P<0.001 by pairwise comparison with Sidak correction)
Overall, the largest effect is that hydroxyproline levels increase at day 21. 
There are also significant differences in the amount of hydroxyproline cells 
from different animals produce (Figure 7-10), and the relative performance of 
cells from different animals changes with time (Figure 7-11).
7.3.4 Chondroitin sulphate
The same three effects that were significant in explaining the variance in 
hydroxyproline levels are those that are important in explaining chondroitin 
sulphate levels. Again, time is the most important variable (Table 7-9)
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explaining 36% of the variance in the population; although with chondroitin 
sulphate there is a significant drop at days 14 and 21 compared to day 7 
(Figure 7-12). The second most important effect is the differences between 
the animals, explaining 9% of the variance. Post-hoc comparisons reveal that 
cells from animal 1 produce significantly more chondroitin sulphate than cells 
from animal 6 (Figure 7-13). in should be noted that in some cases 
chondroitin sulphate was not detectable.
Table 7-9 Exploratory ANOVA of chondroitin sulphate results. (Probability is left blank 
where data is not significant, F-vales rounded to 2 decimal places, probability and 
effect size rounded to 2 significant figures)
Variable / Interaction F value Probability Effect size
Time F(2,40) = 62.39 5.05E-13 0.36
Pore structure F(2,40) = 2.28
Pore size F(2,40)= 1.10
Animal F(5,40) = 7.22 6.74E-05 0.09
Time x Pore structure F(4,40) = 1.29
Time x Pore size F(4,40) = 0.24
Time x Animal F(10,40) = 3.82 0.0011 0.08
Pore structure x Pore size F(4,40) = 1.64
Pore structure x Animal F(10,40) = 2.00
Pore size x Animal F(10,40) = 0.58
Time x Pore structure x Pore size F(8,40) = 1.64
Time x Pore structure x Animal F(20,40) = 1.07
Time x Pore size x Animal F(20,40) = 0.32
Pore structure x Pore size x Animal F(20,40) = 0.965
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Figure 7-12 Chondroitin sulphate content of scaffolds on different days (Error bars 
show 95% confidence intervals, * P<0.001 by Games-Howell post-hoc test)
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Figure 7-13 Chondroitin sulphate content of scaffolds with respect to different 
animals averaged over all three time points (Error bars show 95% confidence 
intervals, * P<0.05 by Games-Howell post-hoc test)
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The interaction between time and animal explains almost as much variance 
(8%) as the main effect for animal. This interaction appears to be due to 
elevated chondroitin sulphate produced by cells from animal 1 relative to 
cells from animals 3, 4, 5 and 6 at day 1, and by cells from animal 2 relative 
to cells from animals 3 and 6 (Figure 7-14). No significant differences were 
found after day 7 (Table 7-10).
Table 7-10 Simple effects analysis of the effect of animal within time on scaffold 
chondroitin sulphate content. (Based on the linearly independent pairwise 
comparisons among the estimated marginal means).
Variable F value Probability
Animal within day 7 F(5,48)= 11.79 1.8E-7
Animal within day 14 F(5,48) = 0.635
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Figure 7-14 Chondroitin sulphate content of scaffolds showing the interaction 
between time and animal (Error bars show 95% confidence intervals; * P<0.05, x 
P<0.005, and J P<0.001 by pairwise comparison with Sidak correction)
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In summary, the most important effect is that of time, there are high 
chondroitin sulphate levels at day 7, which drop at day 14 and remain low at 
day 21 (Figure 7-12). Cells from animal 1 produce more chondroitin sulphate 
than cells from animal 6 (Figure 7-13), and cells from some animals produce 
significantly more chondroitin sulphate on day 7.
7.3.5 Hyaluronic acid
Very little hyaluronic acid was detected, in most cases the level of hyaluronic 
acid was below the limit of detection, the errors bars in Figure 7-18, 
combined with the very low levels indicate this fact. This limited detection 
resulted in no significant differences being found (Table 7-5).
Table 7-11 Exploratory ANOVA of Hyaluronic Acid results. (No significant differences 
were found).
Variable / Interaction F value
Time F(2,40) = 3.35
Pore structure F(2,40) = 0.13
Pore size F(2,40)= 1.88
Animal F(5,40)= 1.19
Time x Pore structure F(4,40) = 0.134
Time x Pore size F(4,40)= 1.88
Time x Animal F(10,40)= 1.19
Pore structure x Pore size F(4,40) = 0.45
Pore structure x Animal F(10,40)= 1.09
Pore size x Animal F(10,40) = 0.90
Time x Pore structure x Pore size F(8,40) = 0.46
Time x Pore structure x Animal F(20,40)= 1.09
Time x Pore size x Animal F(20,40) = 0.90
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Figure 7-15 Hyaluronic acid content of scaffolds on different days (Error bars show 
95% confidence intervals)
7.3.6 Correlations between data
Another way of investigating the relationships is to correlate the results from 
the different measurements from different days, hyaluronic acid results were 
excluded due to limited detection (Table 7-12). It should be noted that as the 
results from different days are determined from different scaffolds, the 
correlations between results on different days will underestimate the 
correlations due to intra-individual variability.
The DNA results show that DNA levels on day 1 have a moderate correlation 
of 0.437 with DNA on day 7, and a small, negative correlation of -0.291 with 
DNA on day 21. It is also negatively correlated with chondroitin sulphate on 
day 14 (-0.308) and day 21 (-0.305), and hydroxyproline on day 7 (-0.608). 
DNA on day 7 is negatively correlated with DNA on day 14 (-0.458) and day 
21 (-0.585). It has similar relationships to chondroitin sulphate and 
hydroxyproline as DNA on day 1, but the correlations appear marginally 
stronger.
DNA on day 14 strongly predicts DNA on day 21 (0.772), and is also 
correlated positively with chondroitin sulphate on day 21 (0.300), and 
hydroxyproline on days 7 (0.313) and 21 (0.384). DNA on day 21 is
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correlated with chondroitin sulphate on day 7 (0.281), and day 21 (0.383) 
and hydroxyproline on days 7 (0.430) and 21 (0.399).
The correlations between the productions of different matrix components are 
as follows. Chondroitin sulphate at day 7 is correlated with chondroitin 
sulphate at day 21 (0.461), and hydroxyproline at day 21 (0.443). Chondroitin 
sulphate at day 14 is only correlated with chondroitin sulphate at day 21 
(0.461). On day 21 chondroitin sulphate is correlated with hydroxyproline at 
days 14 (0.378) and 21 (0.365). No further correlations exist.
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DNA1 DNA7 DNA14 DNA21 CS7 CS14 CS21 Hy7 Hy14 Hy21
DNA1 Pearson Correlation 1 437** -.141 -.291* -.259 -.308* -.305* -.608** -.030 .059
Sig. (2-tailed) 0 0 1 .308 .033 .058 .024 .025 . 0 0 0 .827 .674
N 54 54 54 54 54 54 54 54 54 54
DNA7 Pearson Correlation .437** 1 -.458** -.585** -.237 -.314* -.362** -.620** -.165 -.123
Sig. (2-tailed) .0 0 1 .0 0 1 . 0 0 0 .084 0 2 1 .007 . 0 0 0 .234 .376
N 54 54 54 54 54 54 54 54 54 54
DNA14 Pearson Correlation -.141 -.458** 1 .772** .254 .039 .300* .313* .148 .384**
Sig. (2-tailed) .308 0 0 1 . 0 0 0 .063 .782 .027 .0 2 1 .287 .004
N 54 54 54 54 54 54 54 54 54 54
DNA21 Pearson Correlation -.291* -.585** .772** 1 .281* .141 .386** .430** .099 .399**
Sig. (2-tailed) .033 . 0 0 0 .0 0 0 .040 .311 .004 .0 0 1 .478 .003
N 54 54 54 54 54 54 54 54 54 54
CS7 Pearson Correlation -.259 -23 7 .254 .281* 1 .032 .383** .255 . 2 0 0 443**
Sig. (2-tailed) .058 084 .063 .040 .820 .004 .062 .147 0 0 1
N 54 54 54 54 54 54 54 54 54 54
CS14 Pearson Correlation -.308* -.314* .039 .141 .032 1 .461** .110 .248 .129
Sig. (2-tailed) .024 .0 2 1 .782 .311 .820 . 0 0 0 .430 .070 .351
N 54 54 54 54 54 54 54 54 54 54
CS21 Pearson Correlation -.305* - 362** .300* .386** .383** .461** 1 .151 .378** .365**
Sig. (2-tailed) .025 007 .027 .004 .004 . 0 0 0 .276 .005 007
N 54 54 54 54 54 54 54 54 54 54
Hy7 Pearson Correlation -.608** -.620** .313* .430** .255 . 1 1 0 .151 1 .028 -.016
Sig. (2-tailed) . 0 0 0 . 0 0 0 .0 2 1 .0 0 1 .062 .430 .276 .842 .911
N 54 54 54 54 54 54 54 54 54 54
Hy14 Pearson Correlation -.030 -16 5 .148 .099 2 0 0 .248 .378** .028 1 .223
Sig. (2-tailed) .827 234 .287 .478 .147 .070 .005 .842 .104
N 54 54 54 54 54 54 54 54 54 54
Hy21 Pearson Correlation .059 -.123 .384** .399** 4 4 3 ** .129 .365** -.016 .223 1
Sig. (2-tailed) .674 .376 .004 .003 .0 0 1 .351 .007 .911 .104
















7.3.7 Summ ary of quantitative data
A similar pattern is found across DNA, hydroxyproline and chondroitin 
sulphate levels. Consistently, time, animal and the interaction between time 
and animal are the most important parameters (Figure 7-16). DNA levels are 
also affected by pore size and the interactions: time x pore size, pore size x 
animal and time x pore size x animal. One prediction is implied to be 
accurate by the data, but has not been demonstrated explicitly. That 
prediction is that the glycosaminoglycan : hydroxyproline ratio should fall 
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Figure 7-17 Glycosaminoglycan : hydroxyproline ratio
7.4 D iscu ss io n  
7.4.1 DNA
The amount of DNA is a direct indicator of the cell number. Cell attachment 
at day 1 appears to be an important determinant of subsequent cell number. 
In those combinations of pore size and animal that promote high attachment 
at day 1 cell number gradually drops to below 500ng of DNA per scaffold. It 
appears that the 300-355pm pores might accelerate this process, but this 
acceleration might also be accounted for by a slightly higher initial cell 
number causing a greater drop. However for a majority of the combinations 
that promote cell attachment, the drop is sharpest between day 7 and 14 
(Figure 7-8).
For those combinations that limit cell attachment, cell number appears to be 
maintained at day 7, at day 14 some of these combinations (typically with 
larger pore sizes) promote dramatic increase in cell number, whilst some 
combinations maintain cell number. By day 21 the different combinations 
appear to converge at a similar level of DNA (Figure 7-8).
This pattern is borne out by the correlations between DNA levels on different 
days, there is a positive correlation between DNA on day 1 and 7, fitting with 
cell number being maintained. Then a negative correlation between DNA on 
day 7 and 14 fits with the sharp drops seen in many of the combinations that 
promote cell attachment and sharp increases in some of the combinations 
with limited cell attachment. Levels on day 21 are strongly correlated with 
levels on day 14, but negatively correlated with levels on days 1 and 7. This 
could be a remaining effect of factors that promoted cell loss, although as the 
media was changed regularly perhaps the remaining cells remain inhibited 
by the high initial cell number in some way. Another factor is that DNA on 
days 14 and 21 correlates with hydroxyproline on day 7 (Table 7-12), 
perhaps the greater amount of collagen enables greater cell attachment.
One rule appears to emerge from the patterns described above: above 
roughly 500ng of DNA cell number drops, below this level cell number is 
maintained or increased. Larger pore sizes appear to increase the chance of 
a dramatic increase, although this appears to interact with the animal that the 
cells came from (Figure 7-7). Collagen levels at day 7 also seem to increase 
cell number (Table 7-14).
Fluctuations have been described in other systems measuring cell number or 
cell viability, for instance, Moreau et al (2006), looking at bundles of twisted 
silk fibres seeded with BMSCs found fluctuations in cell metabolism, and 
fluctuation, which were also found with BMSCs seeded in collagen gels 
(Orban et al. 2004). The exact time course of these fluctuations is unclear; it 
may well be shorter than 7 days, Orban et al (2004) measured cell 
metabolism more frequently and there does not appear to be a set period for 
those fluctuations. Moreau et al. (2006) assessed cell metabolism every 
three days after the first five for 28 days, and their results suggest that the 
length of the fluctuations increases as the experiment progresses. If these 
fluctuations take less than 7 days, then the pattern observed in Figure 7-8 
which suggests that for some combinations of conditions cell number drops
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continually over the three weeks might be misleading, as cell number might 
have risen on an unobserved day.
It is unclear exactly what these fluctuations indicate in this system. When the 
scaffolds were checked for signs of infection during the culture period there 
were normally a large number of cell floating in the media outside the 
scaffold. Therefore drops in cell number retained within the scaffold might 
reflect changes in cell attachment, rather than cell death. In 2d culture 
ligament fibroblasts detach for the surface in order to divide, this is 
particularly noticeable when the cells are expanding most rapidly following 
passaging. Two ways of preventing this loss of cells have been investigated 
for ligament tissue engineering: one is to increase the specific surface area 
by adding electrospun nanofibres to scaffolds (Sahoo et al. 2006), this 
appeared to increase cell proliferation, and expression of collagen I, decorin 
and biglycan; the other approach is to use a physical barrier to prevent the 
cells from escaping: for instance, wrapping a PGA scaffold seeded with 
tenocytes with intestinal submucosa and implanting the construct into a 
tendon defect resulted in a tendon that reached 83% of the breaking strength 
of normal tendon after 14 weeks implantation (Cao et al. 2002). Either of 
these approaches might help to support cell retention and thus proliferation if 
this system were developed further. Another problem might be that the 
absorption of FCS proteins to silk could be unstable causing cells to detach 
from the silk as the absorption fails.
One way of disambiguating these fluctuations would be to quantify DNA in 
the media, and to quantify cell death within the scaffold and in the media 
(possibly by quantifying lactate dehydrogenase activity by quantifying 
conversion of a substrate for lactate dehydrogenase that cannot cross an 
intact cell membrane, allowing indirect quantification of the number of cells 
with permeable membranes that can be assumed to be dead). If cells are 
dying then this should apparent, and effort should be focused on preventing 
cell death, perhaps by increasing mass transfer with a bioreactor; if many 




The pattern for hydroxyproline production is much simpler than that for DNA. 
The most important result is that hydroxyproline levels increase significantly 
from day 14 to day 21 (Figure 7-9). The second most important result is that 
cells from some animals synthesise less hydroxyproline than others (Figure 
7-10). Finally, different animals appear to respond differently to the effect of 
time. Cells from animal 4 produce little hydroxyproline initially, but this rapidly 
increases so that it appears to produce the highest level of hydroxyproline at 
day 21. Cells from the first three animals produce a lot of hydroxyproline on 
day 7, and then gradually produce more hydroxyproline. Cells from animals 5 
and 6 produce very little hydroxyproline on day 7 and then gradually produce 
more (Figure 7-11).
The significant increase in hydroxyproline between day 14 and day 21 could 
be the response of cells responding to mechanical stimulation by fluid shear 
stress induced by the orbital shaker. The principal reason to suggest this, is 
that it is known that it takes BMSCs 14 days to upregulate collagen mRNA in 
response to cyclical tensile strain (Altman et al. 2002b), so a similar period 
might be necessary for response to other mechanical stresses, including fluid 
shear stress. That work measured collagen mRNA, whereas in this 
experiment, hydroxyproline was measured, and the impact of up-regulation 
in collagen genes might not be apparent until several days had passed to 
allow sufficient collagen to be synthesised for the change to be detectable. 
The only result to corroborate this suggestion is the finding of Chen et al 
(2006) that BMSCs subjected to fluid flow synthesise produce as much 
mRNA for collagen as BMSCs subjected to fluid flow and cyclical tension.
DNA on days 1 and 7 is negatively correlated with hydroxyproline on day 7 
(Table 7-12). Cells from some animals lay down collagen prior to day 7 whilst 
not proliferating, and then proliferate on subsequent days. If the higher cell 
number for cells from animals 4, 5 and 6 reflects greater proliferation (with 
many cells being lost to the media) then this would explain their lower
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collagen synthesis. In bone tissue engineering there is thought to be a 
tension between proliferation and matrix synthesis, a similar tension might 
exist in ligament engineering, this has been reported for tenocytes at high 
cell densities (Zayas and Schwarz 1992). After day 7 this trend is reversed 
and hydroxyproline on day 7 correlates positively with DNA on day 14 and 
day 21, perhaps the additional collagen for cells from the first three animals 
allows better attachment to the scaffolds, increasing cell number. The lack of 
correlations between hydroxyproline on day 14 and DNA might be explained 
by the lack of significant differences between cells from different animals on 
day 14 (Figure 7-11). Hydroxyproline on day 21 is positively correlated with 
DNA on days 14 and 21, suggesting that by this stage cell number has a 
positive impact on collagen synthesis.
The other striking correlation is that of chondroitin sulphate at 7 days with 
hydroxyproline at 21 days; this is in contrast to the lack of correlation 
between hydroxyproline at days 7 or 14 with day 21. This is further evidence 
that there at least two stages to ligament regeneration. Chondroitin sulphate 
might be useful biomarker for this first stage, possibly in conjunction with 
other putative biomarkers for the first stage suggested by the work by Chen 
et al (2006), such as mRNA for integrins, and heat shock protein 70. Further 
work might be able to identify how non-destructive assays might be used to 
predict the ligament engineering process and account for some of the 
individual differences between cells from different animals. This result also 
raises questions about the utility of many short term studies of ligament and 
tendon cell biology, where the principal outcome measure is collagen 
production; if it were confirmed that collagen content in the first two weeks 
was a poor predictor of subsequent collagen content in other systems then 
measuring collagen would be of limited importance for the first two weeks, 
and cell biology studies that wanted to study collagen production would have 
to run for longer than two weeks.
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7.4.3 Chondroitin sulphate
In some respects the pattern of the chondroitin sulphate content of the 
matrices is the opposite of that of hydroxyproline. In particular, chondroitin 
sulphate levels are significantly higher at day 7 than days 14 and 21 (Figure 
7-12). Cells from animal 1 produce significantly more chondroitin sulphate 
than cells from animal 6 (Figure 7-13). On day 7, cells from animal 1 appear 
to produce more chondroitin sulphate than cells from animals 3, 4, 5, and 6; 
and cells from animal 2 produce more than cells from animals 3 and 6 
(Figure 7-14). Then overall trend is for chondroitin sulphate levels to drop 
over the course of the experiment.
DNA at day 7 and at day 14 is negatively correlated with chondroitin sulphate 
at days 14 and 21 (Table 7-12). This might be the result of cells synthesising 
chondroitinases to remove chondroitin sulphate after day 7, which would fit 
with the sharp drop. DNA at days 14 and 21 is positively correlated with 
chondroitin sulphate at day 21, which might indicate that after day 14 cells 
begin to synthesise more chondroitin sulphate at higher cell numbers. 
Chondroitin sulphate at day 21 is correlated with hydroxyproline levels at 
days 14 and 21, suggesting that more collagen might be result in more 
chondroitin sulphate, possibly as the chondroitin sulphate containing 
proteoglycans have more collagen to bind to. Chondroitin sulphate at day 21 
is also correlated with chondroitin sulphate at days 7 and 14. Given the 
absence of a correlation between chondroitin sulphate at days 7 and 14, this 
suggests that levels of chondroitin sulphate at day 21 is a combination of two 
processes, for instance, retention of chondroitin sulphate from day 14, and 
synthesis of new chondroitin sulphate, reflecting the correlation with day 7.
Chondroitin sulphate at day 7 is an interesting predictor of the outcome 
variables at day 21 (Table 7-12). Of the outcome variables prior to day 21, it 
alone is correlated with DNA, chondroitin sulphate and hydroxyproline levels 
at day 21. There are a number of possible explanations for these 
correlations:
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• It is possible that higher initial levels of chondroitin sulphate improve 
the assembly of the extracellular matrix as glycosaminoglycans, they 
are a couple of possible mechanisms known for this: 
glycosaminoglycans self-aggregate (Scott 1992), more chondroitin 
sulphate might provide more binding sites for this self-aggregation to 
encourage matrix assembly; it is also known that the quantity of some 
polysaccharides such as alginate or hyaluronic acid alters the self 
assembly of collagen fibrils (Tsai et al. 2006).
• More chondroitin sulphate might indicate greater levels of the small 
proteoglycans that bind TGF-(31 (Hildebrand et al. 1994), this might 
result in alteration of the TGF- (31 signal, changing cell behaviour.
• It could indicate other differences between proteoglycans such as a 
change in the biglycan to decorin ratio, as biglycan binds two 
chondroitin sulphate chains (Young et al. 2002), and decorin only one 
(lozzo 1998)
• Alternatively, the correlation might not be a cause of the improved 
properties at 21 days, and instead be due to some other property that 
results in elevated chondroitin sulphate levels.
Chondroitin sulphate merits further investigation as a possible outcome 
marker for the initiation of ligament engineering, and a way of predicting 
something of the individual differences.
7.4.4 Hyaluronic acid
The striking result from the analysis of hyaluronic acid production is the very 
low levels of hyaluronic acid produced. This might be a limitation of the 
sensitivity of the HPLC assay, but much more chondroitin sulphate was 
detected suggesting that hyaluronic acid production was, in fact, much lower. 
This result shows that this process for ligament engineering produces results 
dissimilar to those that might be expected for embryonic ligament. This might 
be because it is not the ligament fibroblasts that are laying down hyaluronic 
acid in the embryo. Hyaluronic acid is laid down early in development, in part 
to facilitate to cell migration (Nathanson 1990). It is known that in other
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mesodermic tissues, primitive mesenchymal cells lose the ability to 
synthesise hyaluronic acid (Toole et al. 1989).
If ligament fibroblasts do lose most of their ability to synthesise hyaluronic 
acid then there is possibly a paradox if fibrotic tissue is associated with 
elevated levels of hyaluronic acid (Riley et al. 1994) and this is not produced 
by ligament fibroblasts. The obvious alternative is that hyaluronic acid is 
produced by other cells. Mesenchymal stem cells migrating to the wound site 
would be one option, but these seem only to migrate to the surface of 
tendons (Zavahir et al. 2001). Alternatively, the same study identified a new 
class of cells in the tendon that respond to injury by sending out lots of 
cytoplasmic processes that appear to force the collagen fibrils apart. These 
cells may well be producing hyaluronic acid to force the fibrils apart. Another 
possibility is that this system could be missing the growth factors required to 
produce hyaluronic acid. Macrophages appear to produce growth factors the 
stimulate hyaluronic acid production by synovial fibroblasts (Pulkki 1986; 
Wells et al. 1992); TGF-p1, interleukin-1, and tumour necrosis factor a 
appear to be important mediators of this stimulation (Haubeck et al. 1995; 
Konttinen et al. 1991).
7.4.5 Hydroxyproline : glycosaminoglycan ratio
These results show a partial confirmation of the prediction that the 
glycosaminoglycan : hydroxyproline ratio should drop rapidly, although in 
absolute terms the ratio of glycosaminoglycan : hydroxyproline is higher than 
in the published reports (Scott et al. 1981). There are several possible 
explanations for this: the Scott et al (1981) paper only measures this ratio 
following birth, and the initiation of tissue engineering should perhaps be 
analogous to embryonic tissue when it would be anticipated that chondroitin 
sulphate levels would be higher; the higher level could be indicative of fibrotic 
development, as tendonitis results in elevated levels of glycosaminoglycans 
(Riley et al. 1994); or the synthesis of ECM might be appropriate, but 
chondroitin sulphate might be adsorbed better onto the scaffold. To 
distinguish these possibilities it would be helpful to have more than three
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weeks’ data, and have measurements for other indicators of fibrosis such as 
fibril diameter.
7.4.6 Possible improvements to experimental design
It should be noted that statistics are all based on mathematical models, and 
make a number of simplifications and assumptions about the data and the 
experiment, they are only as useful as the experimental design, and should 
not be taken as a definitive model of how a particular experiment works. To 
quote one introduction to statistics: “all statistical models are wrong” 
(Crawley 2005). In this case, more information about the animals that 
provided the cells would be useful (gender, age, location of farm, breed, 
farming methodology, etc.) to see if these differences could explain the 
difference seen between cells from different animals.
With the benefit of hindsight, the results of this experiment might have been 
clearer if more time had been spent optimising the cell number with which to 
seed the scaffolds. A lower cell number should have promoted a growth 
phase so the kinetics of cell growth on the scaffolds more closely resembled 
the textbook examples.
A third area for improvement would have been to identify additional useful 
assays, such as quantifying lactate dehydrogenase to quantify cell death. 
This would help to explain why cell number fluctuates: were the cells dying, 
or just de-attaching from the scaffold? Assays of fibrosis such as collagen 
type III : type I ratio would be useful in further quantifying what sort of matrix 
the ligament fibroblasts were producing.
Finally, given that cell number over long durations appears to fluctuate, these 
fluctuations would be better characterised by more frequent sampling. As this 
would require a large number of scaffolds to be sacrificed, a better solution 
would be to adapt a non-destructive test of cell viability to work with 3d 
scaffolds, allowing the fluctuations to be tracked better without sacrificing a 
large number of scaffolds.
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7.5 Conclusions
Overall, the combination of large sample size with factorial ANOVA and 
correlations enabled a large amount of useful information to be gained about 
the initiation of ligament engineering. By considering several independent 
variables it is possible to determine which are the most important, and also 
how the variables interact. By using a large sample size it is possible to 
correlate the outcomes, which gives new information about how ligament 
engineering works. Of the six initial predictions about the outcome (Section 
7.1.4), four have been met at least partially. The level of chondroitin sulphate 
dropped; the level of hydroxyproline increased; the ratio of 
glycosaminoglycan to hydroxyproline fell rapidly, and for some combinations 
of conditions, the cell number fluctuated. The two results that were not 
predicted were that for some combinations of animal and pore size cell 
number would appear to drop; and that almost no hyaluronic acid was 
detected.
The results show that the differences between cells from different animals 
are important in determining both proliferation and matrix synthesis of 
ligament fibroblasts. The effect of differences between animals varies with 
time. Pore size, and the two and three way interactions between pore size, 
animal and time only affect proliferation, not matrix synthesis. Pore structure 
has no detectable effect in this study.
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8 Conclusions and Future Work
8.1 Introduction
This thesis has reported a new porous silk scaffold that allows independent 
control of pore size and pore structure, and the use of this scaffold to better 
understand the role of pore size and structure in ligament regeneration. The 
main findings of this work are summarised below, followed by discussions of 
how this work fits into the wider picture, and how this work could be taken 
forward.
8.2 Conclusions
8.2.1 Control of pore structure from film-like to fibrous in porous 
silk scaffolds
The solubility of regenerated silk fibroin in aqueous formic acid, acetic acid 
and hexafluoroisopropanol solutions was investigated. It was found that silk 
was only soluble in 20% (v/v) aqueous formic acid.
Porous scaffolds were prepared using aqueous formic acid by using salt 
leaching. Initially there were problems with variability in scaffold structure 
within batches. By varying the process used to make the scaffolds, it was 
discovered that by adding the silk fibroin solution to the salt, rather than salt 
to the silk fibroin, repeatable scaffold structures were obtainable, and that the 
pore structure of these scaffolds became more fibrous as the percentage of 
silk in the solvent was reduced.
To further understand the role of salt in the scaffold fabrication process, 
scaffolds were made with silk fibroin solutions saturated with salt. Aqueous 
formic acid solutions saturated with salt were tested to see if silk fibroin 
would dissolve in them. Silk fibroin dissolved in two concentrations of formic 
acid: 40% and 80%. In contrast to the fibrous pore structure of scaffolds 
made with 20% formic acid, scaffolds made with both solutions had rather
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“cubic” pore structures, reflecting the particle structure of the salt crystals that 
the solution was added to. The difference between the 40% and 80% formic 
acid solutions was that the scaffolds made with 40% formic acid had a 
number of faces missing reflecting the greater solubility of salt in 40% formic 
acid.
FTIR was used to characterise the crystalline structure of the silk in the 
scaffolds. Peaks at 1630cm'1, 1520cm'1, and 1270cm'1 indicate that the silk 
was in the silk ii form. Spectra from scaffolds made with 20% formic acid 
appear identical to scaffolds made with 100% formic acid.
Porosity was investigated by sectioning scaffolds, then using image analysis 
to quantify the percentage of images of the stained sections that was silk. 
The scaffolds compared were made with: 7.5% w/v silk fibroin in 20% formic 
acid, 10% w/v silk fibroin in 20% formic acid, and 10% w/v silk fibroin in 
100% formic acid. The porosity for the scaffolds was: 0.964 +/- 0.009 for 10% 
silk dissolved in formic acid; 0.971 +/- 0.005 for 10% silk in 20% formic acid; 
and 0.964 +/- 0.005 for 7.5% silk in 20% formic acid. The differences 
between the scaffold types were not significant.
To confirm that these scaffolds were suitable for tissue engineering, cell 
attachment and proliferation were assessed. Twelve scaffolds were made 
with each of: 7.5% w/v silk fibroin in 20% formic acid, 10% w/v silk fibroin in 
20% formic acid, and 10% w/v silk fibroin in 100% formic acid. To investigate 
the effect of linking a peptide containing the RGD sequence, the twelve 
scaffolds with each structure were divided into three equal groups, one group 
was decorated with RGD using EDC:NHS, one was reacted with EDC:NHS 
alone and one was not reacted. The results showed that at 24 hours 
attachment was greatest to scaffolds made with 10% silk in 100% formic 
acid. Scaffold decoration made no significant difference.
Cell attachment was investigated with ligament fibroblasts and osteoblast 
and chondrocyte cell lines after 7 days proliferation on the scaffolds made 
with: 7.5% w/v silk fibroin in 20% formic acid, 10% w/v silk fibroin in 20%
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formic acid, and 10% w/v silk fibroin in 100% formic acid. Ligament 
fibroblasts proliferated better on scaffolds made with 10% silk in 100% formic 
acid than scaffolds made with 10% silk in 20% formic acid. Osteoblast and 
chondrocyte cell lines grew better on scaffolds made with 10% silk in 100% 
formic acid than scaffolds made with 7.5% in 20% formic acid.
8.2.2 Implementation of HPLC GAG analysis
In order to quantify GAG produced by ligament fibroblasts, a published HPLC 
protocol was adapted for use as a tissue engineering analysis protocol. In 
order, to do this first some of the results of the paper were observing the 
retention times of chondroitin sulphate disaccharides produced by enzymatic 
digestion relative to purchased GAG disaccharide standards. The retention 
times were similar, but the quantity of enzyme appeared to affect the relative 
heights of the peaks.
In order to optimise the digestion protocol, hyaluronic acid, and chondroitin 
sulphates C were digested with 0.025U of chondroitinase ABC over half and 
hour to 16 hours. Surprisingly, peaks that were apparent after 0.5 hours 
digestion of chondroitin sulphate disappeared after 1 and 2 hours digestion, 
reappearing at 4 hours digestion. The hyaluronic acid peak showed a similar 
pattern, but the peak was largest after 16 hours digestion. It was therefore 
decided to use 16 hour digestions.
A final issue examined was how to digest the tissue engineered construct 
prior to GAG analysis. The solution resulting from a blank papain digestion 
(i.e. a papain digestion without a construct to digest) were analysed by 
HPLC, these revealed several peaks that might confound the HPLC analysis. 
By dissolving the standards in the blank papain digestion solution it was 
found that the assay could still be successfully calibrated using the GAG 
disaccharides.
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8.2.3 Effect of pore size, pore structure, and animal on ligament 
fibroblasts in porous silk scaffolds
The scaffolds developed in Chapter 6 were used to examine the effect of 
pore size (180-250pm, 300-355pm, and 425-500pm) and pore structure 
(7.5% silk 20% formic acid, 10% silk 20% formic acid, and 10% silk 100% 
formic acid) on cell number (quantified as the amount of DNA present), and 
matrix synthesis: collagen (quantified as hydroxyproline), and
glycosaminoglycans. Due to the number of primary cells needed, cells from 6 
animals were used. DNA was quantified after 1, 7, 14 and 21 days. 
Glycosaminoglycans and hydroxyproline were quantified at 7, 14 and 21 
days. Therefore in addition to pore size, pore structure, and animal, time was 
also analysed as an independent variable.
The results of quantifying DNA showed that time x animal interaction was the 
most important determinant of DNA levels, explaining 36% of the variance in 
the population, followed by time (16%), animal (8%), time x pore size x 
animal (8%), time x pore size (3%), pore size x animal (3%), and pore size 
(1%). Cells from different animals attached differently to the scaffolds, cells 
from the first three animals attached better, there was a trend for cell to 
attach better to cells with the largest pores, but this was limited to cells from 
a couple of animals. At day 7, the overall cell number was similar to day 1, 
those cells from animals with the best attachment on day 1, retained the 
highest cell number, although for the cells from animals for which the large 
pores had improved attachment, large pores now resulted in significantly 
lower cell number. On day 14, cell number was again similar. However, two 
of the cells from animals with the highest cell number on days 1 and 7, now 
had lower cell number than some, or, all of the other cells from four animals, 
and cell number for the cells from first three animals had increased. For cells 
from one animal, the middle pore size performed best; for another the largest 
pore size worked best, and for a third the largest pore size was better than 
the smallest. At day 21 the overall cell number decreased. There was a 
significant difference between the animals, but this could not be identified 
more precisely.
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The largest effect on hydroxyproline levels is time, accounting for 21% of the 
variance in the population. Hydroxyproline levels are significantly higher at 
day 21 than day 14 or day 7. Animal is the second most important effect 
(11%), cells from animal 6 produced less hydroxyproline than cells from the 
first three, and cells from animal 5 produced less than cells from animal 3. 
The final significant effect is time x animal (8%), cells from animal 2 
produced more hydroxyproline on day 7 than cells from the last three 
animals. On day 21, cells from animal 6 produced less than cells from 
animals 1, 3 and 4, and cells from animal 4 more than cells from animals 2, 
5, and 6.
With chondroitin sulphate, time was again the largest effect (36%), CS was 
higher at day 7 than day 14 or 21. Animal was again the second most 
important effect (9%). Overall, cells from animal 1 produced more chondroitin 
sulphate than cells from animal 6. Time x animal accounted for 8% of the 
variance in the population. On day 7, cells from animal 1 produced more CS 
than cells from the last four animals, and cells from animal 2 more than cells 
from animals 2 and 6. Very little hyaluronic acid was produced, and no 
significant differences were found.
When the results from different days were correlated, it was found that DNA 
on day 1 positively correlated with DNA on day 7, and negatively with DNA 
on day 21, negatively with CS on day days 14 and 21, and negatively with 
hydroxyproline on day 7. in addition to the previous correlation, DNA on day 
7 was also negatively correlated with DNA on day 14, and day 21, and with 
chondroitin sulphate on days 14 and 21, and hydroxyproline on day 7. DNA 
on day 14 was positively correlated with DNA on day 21, with CS on day 21 
and with hydroxyproline on days 14 and 21. DNA on day 21 was positively 
correlated with CS on days 7, and 21, and hydroxyproline on days 7 and 21. 
CS on day 7 was correlated with CS on day 21 and hydroxyproline on day 
21. CS on day 14 was positively correlated with CS on day 21. CS on day 21 
was positively correlated with hydroxyproline on day 14 and day 21. The only
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variable from the first three time points to be correlated with all three 
outcomes on day 21 was CS on day 7.
8.3 Relevance of this work to ligament engineering
Ligament engineering is attempting to repair ligaments ex vivo. In order to 
understand how this work fits into the wider picture it is useful to consider 
ligaments in vivo and how engineers might try to replicate the in vivo 
environment (Figure 7-1).
















Figure 8-1 Overview of the ligament’s environment in  v iv o
This thesis has focused on understanding the effects of pore size and pore 
structure on ligament engineering. This could be expected to alter nutrient 
supply by changing the mass transfer properties of the material, and cell 
response and autocrine signalling if the cells can detect differences in the 
materials. The results showed that pore size had a small effect on cell 
number, but not matrix synthesis. This absence of an effect might be due to 
the absence of some other factor that is present in vivo, in bone, mechanical 
stimulation is required for pore size to affect bone regeneration 
(Karageorgiou and Kaplan 2005). Instead, it was found that variation
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between animals was consistently important in determining cell number and 
matrix synthesis, further, animal (along with time) interacted with pore size in 
determining cell number. This variation between cells from different animals 
might confound biomaterials experiments, a positive result in one experiment 
and negative result in an attempted replication might be the result of 
individual differences between animals.
The correlation results suggest a major issue for ligament cell biology as it is 
currently studied. If early collagen synthesis does not correlate with 
subsequent collagen synthesis, then the usefulness of short term (two week) 
cell biology experiments where collagen synthesis is the major outcome is 
questionable. These results also suggest that chondroitin sulphate levels 
might be more important in the early stages of ligament repair.
These results show the importance of determining how cells from different 
animals respond to different materials. After time, animal was the most 
important independent variable in determining ECM synthesis (Figure 7-19). 
The interaction between time and animal was also very important. As 
ligaments are predominately made out of collagen, collagen production is 
normally considered the most important outcome for ligament tissue 
engineering. In this system, the mean hydroxyproline level at day 21 differs 
by a factor of 4 depending on which animal the cells came from(Figure 7-14). 
This result has especially important implications for potential therapies where 
autologous cells might be used as a key problem will be predicting their 
behaviour. The problems this would pose are two fold: firstly logistical, 
without more knowledge it will be difficult to predict how long it will take to 
synthesise new tissue for any given patient, making it difficult to set a date 
for surgery; second, it will be difficult to design biomaterials that degrade at a 
similar rate to the synthesis of new ECM if the rate of ECM production varies 
so much. One possible solution to the second problem would be to use 
materials that allow the cells control the degradation rate. Silk degrades 
enzymatically (Horan et al. 2005a), but it is unclear which enzymes are 
responsible for this in vivo. Materials such as collagen and fibrin are 
degraded by well understood biochemical pathways, and it might be possible
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to produce collagen or fibrin based biomaterials that respond to different 
levels of ECM synthesis by degrading at different rates.
This work suggests that pore size is of limited importance in determining the 
behaviour of ligament fibroblasts. Pore size has a very limited effect on cell 
number, and interacts with time and differences between cells from different 
animals to produce other small effects on cell number, but in this system, 
dramatic differences in response to pore size were not observed. Possibly, 
this is due to the absence of mechanical stimulation. Despite the extensive 
literature of pore size effects on osteogenesis in vivo, it has not been 
possible to identify such effects in vivo in the absence of mechanical loading 
(Itala et al. 2001). In this system the only loading is driven by the orbital 
shaker that the six well plates were incubated on. The fluid flow supplied by 
this system might be inadequate to drive pore size effects. No effect of pore 
structure was found, although it was found in the preliminary work on cell 
attachment and proliferation in Chapter 6. Two possibilities stand out: the 
scaffolds used in Chapter 6 had a larger diameter than the scaffolds used in 
this study. It is possible that pore structure effects are dependent on the 
scale of the ligament engineering system, with different pore structures 
having different influences at different scales, and these differences being 
undetectable at small scale. Otherwise, it could be that the wider range of 
salt particle sizes used in Chapter 6 (125-425pm) enabled pore structure to 
have an effect.
8.4 Future work
There are many aspects of the ligament in vivo not addressed by this work. 
Perhaps the most important are the paracrine signals from adjacent tissue, 
muscle-tendon crosstalk is known to be important to tendon development 
(Rodriguez-Guzman et al. 2007), bone-ligament crosstalk is probably 
important to ligament development; and mechanical stimulation which was 
discussed in Section 2.3. This section will consider how this work might be 
extended to see if mechanical stimulation is necessary for pore size to affect 
ligament repair, and to what extent this generalises to other materials.
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8.4.1 Bioreactor design
Fluid flow to enhance mass transfer, and cyclical mechanical tensile strain 
are the two parameters that have been shown to be important for ligament 
engineering (Altman et al. 2002b; Chen et al. 2006). Less is known about the 
ideal characteristics of cyclical mechanical tensile strain to best stimulate 
regeneration. Low tensile strain (2-8% strain) decreases levels of 
inflammation markers in osteoblast-like periodontal ligament cells, whereas 
higher levels of strain (>12.5% strain) increase inflammation markers 
(Agarwal et al. 2003). Currently, 10% strain is typically used for ligament 
engineering, but it seems prudent to investigate multiple strains, on the basis 
of Agarwal et al. (2003), 6 and 12% with an unstrained control seem like 
sensible starting parameters.
8.4.2 Biomaterials
Silk scaffolds with variable pore size have been described in this paper, but 
an important question is whether these results are generalisable to other 
materials. In order to answer this question, scaffolds made from alternative 
materials should be tested. Scaffolds can be made with salt leaching using 
poly-lactic-co-glycolic acid (Suh et al. 2002), suggesting an useful contrast 
between the two materials. During this work the cell attachment and retention 
processes could be studying further in order to optimise attachment and 
retention of the cells.
8.4.3 Experimental design
Once the component systems had been optimised, this new study would 
resemble this study, five independent variables would be considered: time, 
biomaterial, mechanical regime, pore size and animal/subject. Ideally, human 
cells would be used so as to maximise clinical relevance. Instead of the time 
points used in this study, matrix synthesis would be studied at one, three and 
six weeks. This would demonstrate to what extent the results from one and 
three weeks correlated with the results at six weeks. It would be useful to
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extend the matrix synthesis outcome measures to quantify the collagen I : III 
ratio, to measure levels of CS proteoglycans, and to examine histological 
measures of fibrosis such as fibril diameter. These additional measurements 
would help to either eliminate or confirm some of the main hypothesises 
generated in this work.
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Appendix A -  Reagent preparation
A.1. Analytical reagents
A.1.1. Papain buffer
Stored at 4°C for up to three months
1.42g sodium phosphate, dibasic
0.0788g cysteine hydrochloride
0.1861 ethylenediamine tetraacetic acid (EDTA)
1M hydrochloride acid for pH adjustment
The sodium phosphate, cysteine hydrochloride, and EDTA were dissolved in 
90ml of roH20. The pH was adjusted to 6.5 with the 1M Hydrochloric acid, 
and then the volume was topped up to 100ml.
A.1.2.Hydroxyproline assay buffer
Stored at 4°C in a dark bottle for up to two months
13.3g Citric acid (1H20 )
3.2ml Glacial acetic acid 
32g Sodium acetate (3H20 )
9.1g Sodium Hydroxide 
80ml Propan- 7-ol
The reagents above are combined and made up to 300ml with roH20 . The 
pH is adjusted to 6.0-6.5 with 0.2M sodium hydroxide, and the volume made 





Chloramine-T is dissolved in 100ml roH20 .
A.1.4.Ehrlich’s reagent
Use within 1 hour
7.5g p-dimethylaminobenzaldehyde 
30ml Propan- 1-o\
I I .5ml 70% Perchloric acid
Reagents are combined and volume is increased to 50ml with roH20.
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